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General Introduction 
Chapter 1 
Background 
Otitis Media with Effusion (OME) is one of the most common diseases in childhood. The 
term O M E refers to an accumulation of fluid in the middle ear cavity behind an intact 
tympanic membrane without the signs and symptoms of an acute infection. " The functional 
effect of O M E is conductive hearing loss of 15-40 dB, associated with the fluid in the middle 
ear." The etiology and natural history of O M E are still only partly understood; it is therefore 
considered to be a multi-factorial disease process with a variety of etiological mechanisms.3"'' 
However, many investigators subscribe to the view that early acute otitis media (AOM) is 
associated with and predisposes to OME. 7 Rhinosinusitus is reported to be a high nsk factor 
for developing otitis media. This provides important indications about the pathogenesis, 
namely that the Eustachian tube plays a role as a portal of entry for pathogenic organisms.8 
In addition, local and systemic immunity appears to play a key role. 
The most common surgical intervention for O M E is the insertion of ventilation tubes , a 
technique introduced by Armstrong in 1954.'" In the Netherlands, 50,000 children aged 
between 0-12 years are treated with ventilation tubes each year." '2 
Over the past three decades, many studies have been performed on the disease. Since 1983, 
the Departments of Otorhinolaryngology and Epidemiology of the University of Nijmegen 
have been working together on the epidemiology of O M E in children. The epidemiological 
characteristics of O M E were evaluated in a large follow-up study: 80% of the children 
experienced at least one episode of O M E before the age of four years.' However, every 
three months, about 50% of the middle ear effusions resolved spontaneously.14 The effect of 
treatment with ventilation tubes was evaluated by assessing language perfonnance in a small 
initial study. No benefits of early detection and treatment could be demonstrated, chiefly 
because of the high rate of spontaneous recovery.11 
The same study population was investigated again by Schilder1" and Grievink & Peters"' in 
1990 to estimate the long-term effect of OME. The results indicated that a conservative 
approach to treatment wasjustified as the effects of OME at 2-4 years of age on later language 
skills were negligible. 
Nowadays a large number of children are found to be suffering from OME at a younger age, 
due to widely accepted screening for hearing loss at the age of 9 months. This thesis 
describes a third project started in 1996, which focussed on O M E in younger children (1-2 
years of age) recruited from this screening programme. Evidence from the literature on the 
effect of early persistent O M E on language performance remains controversial. Some studies 
found an early association between otitis media and language development'7"10, while others 
did not find any association31""14. The conflicting findings may be due to limitations in 
methodology.11 "^46 Some studies failed to confirm the duration and severity of the OME, or 
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did not measure hearing levels. Other studies used a retrospective design, included only a few 
cases and/or a specific group of children. In addition, it is important to account for other 
factors that might contribute to a child's language performance (confounders), such as the IQ 
of the child or the educational level of the mother.^"17 
Thus, adequately designed prospective studies on the effects of O M E on development are 
rather scarce.46 Experimental studies on the effect of treatment with ventilation tubes in 
children have been described, but only in children of 3 years and older. An example is a 
recent study by Maw et al.48 who performed a trial on 186 children of 3-4 years old. At 9 
months follow-up, a marginally significant difference was found in comprehensive and 
expressive language between the ventilation tube group and the watchful waiting group. 
However, 18 months after randomisation, 85% of the children in the watchful waiting group 
had received ventilation tubes and the groups no longer differed. So far, no experimental 
studies have been published on younger children, although nowadays, O M E is detected at 
an earlier age and ventilation tubes are therefore inserted at a younger age. Moreover, the 
essence and rate of language development is different in infants and pre- school children. 
There are some reports on non-experimental studies on children of younger than 3 years. 
Wright et al. did not find an association between O M E and speech and language scores in 
children of 2 years. Friel-Patti and Fimzo" found effects on receptive language in one-year-
old children and on expressive language in 1.5-year-old children, but not during the other 
periods between 1-2 years of age. Vernon-Feagans et al.3 and Roberts et al." found an 
association between O M E and language development, but their analyses suggested that this 
association was probably confounded by the environment of the child (e.g. educational level 
of the mother). 
Therefore, there is a need for more prospective studies, preferably randomised controlled 
trials to evaluate the effect of treatment with ventilation tubes, because this is the accepted 
way of dealing with (unknown) confounding. 
Objective 
The objective of this thesis is to study the effect of treatment with ventilation tubes on 
hearing, language development and quality of life in infants with persistent bilateral OME, 
traced by a population-based screening programme. 
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Specific research questions were: 
A. What is the natural course of O M E dunng the first year of life? 
B. Is treatment with ventilation tubes at this age more effective than watchful waiting? 
C. Are there specific subgroups of infants with persistent bilateral O M E who benefit 
more from treatment with ventilation tubes? 
D. How can we implement the findings of this study in clinical practice? 
Moreover, the cost-effectiveness of treatment with ventilation tubes versus watchful waiting 
will be assessed. 
Study design 
Etiological model 
Figure 1 shows the etiological model of the study, which was partly based on the language 
model of Vemon-Feagans and Roberts et al. ' The hearing loss resulting from fluid in the 
middle ear can be expected to influence general development (IQ), language development 
and behaviour. These and other (mediating and/or moderating) variables were added to the 
model: first, speech and language development interact with general development and the 
behaviour of a child; second, general development and behaviour interact with each other. 
It is possible that some children with persistent O M E and hearing loss will be protected 
against negative effects by moderating variables (e.g. compensating mechanisms by the child 
itself or by the parents). This calls for a study on interactions. 
Parent-child interactive behaviour acts as an intermediary variable in speech-language 
development, general development and behaviour. Adjusting for such an intcmiediary 
variable is impossible. Other important issues were that speech-language development, 
general development and behaviour together reflect the general health status/quality of life. 
This quality of life focussed on parents' subjective perception of their child's health status. 
Tests used for each of the components in the etiological model are shown sideways in the 
figure. 
According to this model, a causal association exists between the level of hearing loss and 
development. It can also be expected that the hearing deficit in children with persistent 
bilateral O M E will be larger than that in children without persistent bilateral OME; thus the 
effects of ventilation tubes might be larger in the former children. 
An additional or alternative treatment for O M E is adenoidectomy. However, it is usually 
only performed when a child has obvious upper respiratory tract complaints. As screen-
Figure 1. The etiological model 
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detected children mostly do not have any obvious complaints and as the additional effect of 
adenoidectomy is still controversial, we confirmed our study to the effect of treatment with 
ventilation tubes. 
Study population 
The source population comprised all children b o m in the eastern part of the Netherlands 
between 1 January 1996 and 1 April 1997 (n=30,099). These children were scheduled to 
undergo screening for hearing impairment at the age of nine months. Children who failed 
a hearing test were recalled one month later. Those who failed three times in succession were 
(only for the purpose of this study and with explicit permission from the Dutch General 
Practitioners association) referred directly to an Ear Nose and Throat (ENT) outpatient clinic 
for diagnosis and follow-up (N=l()81). Infants who had bilateral O M E for 4-6 months 
(N=386) were invited to participate in the randomised clinical trial. Exclusion critena were: 
Down's syndrome, schisis, asthma, cystic fibrosis and sensorineural hearing loss. The children 
for whom the parents gave informed consent were randomly allocated to one of two groups: 
group A (N=93) was treated with ventilation tubes (VT group), while group Β (Ν=94) 
underwent watchful waiting (WW group). The two groups were followed-up for one year. 
Tympanometry and otoscopy were performed every three months; audiometry, behaviour, 
language and cognitive development, and parent-child interaction were evaluated every 6 
months. All measurements were performed on location at each of the 13 participating 
hospitals. 
Outline of the thesis 
Chapter 2 aims to put O M E in infants in perspective and describes some epidemiological 
characteristics: risk factors {Chapter 2.1), prognostic factors (Chapter 2.2), a review of the 
literature on a specific prognostic factor, namely day care (Chapter 2.3) and seasonal variation 
in the prevalence of persistent O M E (Chapter 2.4). 
Before starting the core trial, several methodological issues had to be settled. These issues are 
described in Chapter 3: the choice ofbalanced allocation in multi-centre randomised trials 
(Chapter 3.1), a simulation study on suitable analyses for balanced and random allocation 
(Chapter 3.2), the performance of the CAPAS and Ewing hearing tests (Chapter 3.3). the 
validity of the portable audiometry set used in the tnal (Chapter 3.4) and the generalisability 
of clinical mal results on O M E (Chapter 3.5). 
The actual trial is described in Chapter 4. Effects of ventilation tubes versus watchful waiting 
were investigated on heanng (Chapter 4. Î), language development (Chapter 4.2) and quality 
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f life (Chapter 4 3) Chapter 4 4 compares the results obtained from children included in the 
indomised tnal to those obtained from a group of children who were eligible for 
irticipation, but who were treated according to their parents' (or clinicians') preferences 
ion-randomised group) A cost-effectiveness analysis is made at the end chapter (Chapter 
5) 
ι Chapter 5, the tnal results are discussed in the light of actual clinical practice (Chapter 
1) In addition, the research questions raised in the introduction are addressed and some 
'commendations are made for future research (Chapter 5 2). A summary completes the 
lesis 
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Chapter 2.1 
Prognostic factors for Otitis Media with Effusion in infants 
Maroeska M. Rovers, Eugenie A.H. Hofstad, Kirsten Ι.M. Franken-van den Brand, 
Huub Straatman, Koen Ingels, Gert-Jan van der Wilt, Gerhard Α. Zielhuis 
Clinical Otorhinolaryngology 1998; 23: 543-546 
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Abstract 
To determine prognostic factors for Otitis Media with Effusion (OME) in one-year-old 
infants, we studied 240 patients and 366 controls in a case-cohort study. 
On univanate analysis factors which were associated with O M E were family history, older 
siblings, upper respiratory infections and Acute Otitis Media. After multivariate analysis, 
however, only the occurrence of more than four upper respiratory infections and children 
with older siblings were associated with OME. Thus, upper respiratory infections and older 
siblings appear to be related to the development of O M E . 
Introduction 
Otitis media with Effusion (OME) is a very common disease in young children and is defined 
as inflammation of the middle ear accompanied by accumulation of fluid in the middle ear 
cleft, without the signs and symptoms of acute infection . In a review of 23 studies Zielhuis 
et al found a typical age prevalence curve: a bimodal curve with its largest peak at about two 
years and a second peak at about 5 years of life. The rate of improvement is about 50% every 
three months. Before the age of four, 80% of the children have had O M E at least once.1 
The main factors responsible for the development of O M E are infection and 
eustachian tube dysfunction. Besides these factors many other prognostic and nsk factors have 
been described. Factors considered to influence the occurrence of O M E can be divided into 
intrinsic (host) factors and extrinsic (environmental) factors73'. 
Intrinsic factors are: race7 ;'"":'4, gender7 D2 3 "" l 7 , Down's syndrome1", cleft palate12, early onset 
of Acute Otitis Media (AOM)8*'1''"65, siblings751576S ' ,7, family history of otitis 
j 7 52 51 Î-) ()()()·> 67 68 j . .. „ • r ^ 7 61162 65 69 72 x- ,. r .. 
media and respiratory tract infections . Extrinsic factors are: 
61(67 7174 ι „ . i r ι 7 -tl ι 7 H 56 57 M 67 68 75-77 ι ι 7 53 39 62 77-8(1 
season , bottle feeding , day care and passive smoking 
However, different studies found contradictory results, which can be explained by differences 
in methodology and study population. 
The present investigation constitutes on a ongoing large multi-centre tnal in the 
Netherlands. The objective of this tnal is to study the effect of early screening and treatment 
with ventilation tubes on heanng, language development, cognitive development and quality 
of life of infants with O M E . 
The aim of this paper is to analyse the prognostic factors for O M E in one-year-old 
infants. Children with these prognostic factors might benefit from more frequent follow-up 
and early intervention such as treatment with ventilation tubes. 
Epidemiology of OME in infants 
Patients and methods 
The base population for this study are infants born between January and July 1996. These 
children were screened for heanng impairment at nine months of age. Those who failed three 
times were referred to an E N T outpatient clinic for diagnosis, comprising both 
tympanometry and otoscopy. During this visit parents were asked to complete a questionnaire 
with a number of questions on prognostic factors. Infants who met the criteria for O M E 
diagnosis (a type 13 tympanogram and/or fluid seen at otoscopy) form the cases for this study 
(N=240). The control group consisted of 450 children randomly sampled from those who 
had participated in the first out of three heanng tests. The part of the questionnaire about 
prognostic factors was sent to the parents of these control children. Parents who did not 
return the questionnaire were approached again by telephone. Only children bom between 
March and July 1996 were sampled to get an equal age distribution at the time the 
questionnaire was administered. 
To obtain a more valid estimate of the relative risk, we performed a case-cohort 
study8182: Controls were selected from the source population (in our study all children who 
participated in the first out of three hearing tests). A child in the control group might 
therefore be both case and control. 
From the questionnaire Acute Otitis Media (AOM) was positive if a child had ever 
had earache with fever or if a GP had given treatment for earache. 
A sibling or parental history of O M E was considered to be positive if one of the family 
memben had A O M or O M E once, and children who had a respiratory illness more than four 
times were classified as children with upper respiratory tract infections (URTIs). 
Statistical procedures 
For each prognostic factor the risk of O M E was estimated by means of an odds ratio with 
a 95% confidence interval. 
Multiple logistic regression was used to examine prognostic factors simultaneously. 
Only prognostic factors which showed an association with O M E in univanate analysis and 
factors with a high degree of credibility on the basis of the literature were selected for the 
multivariate models. 
The prognostic value of the models was evaluated using the c-index. This index has 
a theoretical range ofO.5 (no prognostic value) to 1.0 (maximum prognostic value). The c-
index is equal to the area under a receiver operating charactenstic curve." 
Given the method of Schouten et al."2 we were able to calculate prevalences. For the 
logistic models we had to calculate a corrected ß,, =ß0 - log(/) with ƒ representing the 
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probability that a subject in the cohort is selected from the random sample and where 
sampling is independent of the outcome. 
Analyses were performed using the statistical package SAS. 
Results 
The response of the control group was 81 % (366 children). The age and gender distribution 
of the cases and the controls is very similar (Table 1). 
Table 1. Charactenstics of the patients and the controls. 
Characteristics Patients (N = 240) Controls (N = 366) 
1 1 - 1 5 months 
188 (51%) 
IUI (28%) 
139 (38%) 
133 (36%) 
197 (54%) 
80 (22%) 
85 (23%) 
29 (8%) 
19 (5%) 
109 (30%.) 
The results of the univariate analysis are given in Table 2. Factors associated with OME 
were (1) family history (odds ratio = 1.77 [95% CI 1.26-2.48]); (2) older siblings (odds ratio 
= 3.13 [95% CI 2.17-4.50]); (3) upper respiratory tract infections (URTI's) (odds ratio = 3.82 
[95% CI 2.72-5.38]) and (4) AOM (odds ratio = 1.37 [95% CI 0.96-1.96]. Low birth weight 
had a negative relation with O M E (odds ratio = 0.41 [95% CI 0.19-0.88]. The other 
variables did not show an association with O M E . 
Age 
Boys 
AOM 
Upper respiratory infections (URTIs) (>4) 
Family history 
Older siblings 
Day care 
Breast feeding (> 6 months) 
Birth weight (< 2500 g) 
Prematunty (< 37 weeks) 
Parental smoking 
11 -
131 
79 
167 
113 
187 
60 
45 
8 
9 
74 
15 months 
(55%) 
(33%,) 
(70%,) 
(47%) 
(78%) 
(25%) 
(19%) 
(3%) 
(4%) 
(31%) 
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Table 2. Univariate analyses of potentially prognostic factors for O M E . 
Prognostic factor 
Gender (male/female) 
AOM (yes/no) 
URTIs (>/<= 4) 
Family history (yes/no) 
Older siblings (yes/no) 
Day care (yes/no) 
Breast feeding (>/<= 6 months) 
Birth weight (</>= 2500 g) 
Prematunty (</>= 37 weeks) 
Parental smoking (yes/no) 
O R 
1 14 
1 37 
3.82 
1 77 
3 13 
1 21 
0.83 
0.41 
0.70 
1.06 
95% CI 
0 82-
0 96-
2.72-
1 2 6 -
2 17-
0.83 -
0.54 -
0 19-
0 30 -
0 74-
- 1 58 
- 1.96 
- 5.38 
-2.48 
-4.50 
- 1 78 
-1.27 
- 0.88 
-1.65 
- 1.51 
If children with U R T I s were subdivided into children with and children without older 
siblings, the odds ratios differed. The odds ratio of children with both older siblings and 
U R T I s was 2.95 (95% CI 1.94 - 4.50), while the odds ratio for children without older 
siblings but with U R T I s was 5.12 (95% CI 2.60 - 10.08). The odds ratios also differ in the 
strata of day care. Children not attending day care but with older siblings had an odds ratio 
of 4.22 (95% CI 2.65 - 6.73), while children attending day care had an odds ratio of 1.74 
(95% CI 0.88 - 3.43). 
Multiple logistic regression was used to investigate the association between upper 
respiratory infections, family history, older siblings, A O M , low birth weight and O M E . In 
this model upper respiratory infections and older siblings only were associated with O M E 
(Table 3). The final logistic model is described by: 
r> /r\\Ar\ — Λ / π _L -(-I 77 + 1 24 * URTI» + π W * older ublimr.)! ,.• j r n - 7 1 
Ρ (OME) - l / [1+e v *·'], with a c-index of 0.71. 
Table 3 shows that after correction for older siblings, a child with U R T I s was 3.5 as 
likely to develop O M E as a child without. The adjusted odds ratio for older siblings was 2.5, 
which means that after correction for U R T I s a child with older siblings is 2.5 as likely to 
develop O M E as compared to a child without older siblings. 
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Table 3. Multivariate analysis of prognostic factors associated with OME. 
Prognostic 
Factor 
Intercept 
URTIs 
Older siblings 
Estimation 
-1.77 
1 24 
0 99 
SE 
0.19 
0 18 
0 20 
OIK. 
3.46 
2 69 
95% CI 
2.43 - 4.92 
1 82 - 3.98 
Inclusion of AOM, breast feeding, passive smoking and gender into the multivanate 
model did not increase the c-index. 
Using the method of Schouten et al"2 prevalences could be calculated (Table 4). Of the 
450 selected controls, 364 could be used in the multivanate analyses; 18 of these 364 children 
were both case and controls. If we suppose that the 237 cases with information about URTl 's 
and siblings also represents all children who participated in the first out of three heanng tests, 
it can be calculated that the total cohort compnsed 4793 infants. In this case f = 237/4793 
= 0.049 and ß0 = -4.77. The prevalence of OME in children without both older siblings and 
URTIs was 0.8%; in children without older siblings but with URTIs 2.3%; in children with 
older siblings, but without URTIs 2.9%; and in children with both older siblings and URTl's 
7.9%.* 
Table 4. Estimated prevalences using the case-cohort design. 
URTIs 
No 
Yes 
No 
Yes 
Having 
siblings 
No 
No 
Yes 
Yes 
older Prevalence 
0.8% 
2.3% 
2.9% 
7.9% 
Discussion 
In accordance with other studies, our results indicate that upper respiratory tract infections 
and older siblings are prognostic factors for O M E in one-year-old infants6"65 67 67 71 "4 B5. The 
final prognostic model including these factors has a reasonable prognostic value with a c-
index of 0.71. 
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In contrast to what was found in other studies, however, no association was found 
between day care, breast feeding, passive smoking and gender and OME. 
Family history and low birth weight, although associated with OME in univariate analysis did 
not show any added predicted value in multivariate analysis, perhaps because a positive 
history is correlated with having older siblings. Unexpectedly "'""li, low birth weight seemed 
to be a protective factor for OME, but this might be a result of selection in the patient group: 
children with a low birth weight who were monitored from birth might already have been 
treated for their ear problems and therefore less likely to participate in the heanng tests. 
Having older siblings seems to modify the effect of URTIs on OME. Children without 
older siblings but with URTIs are at higher nsk for O M E than children with both older 
siblings and URTIs . This might be due to immunity: children with older siblings have 
already been exposed to pathogens that cause URTIs , so that their immune system is 
stimulated to protect them against these pathogens. 
The results also suggest that day care modifies the effect of older siblings on OME. 
Children attending day care and having older siblings are at lower risk for OME than children 
who do not attend day care, but who have older siblings. In this study children not attending 
day care had more older siblings and may therefore be at higher nsk for OME. 
It should be noted that data on prognostic factors were based on questionnaires 
completed by the parents. Misclassification due to difficulties in interpretation of some 
questions and recall errors cannot be excluded. However, parental recall on prognostic factors 
forms the basis for information in clinical practice. 
Finally, the only prognostic factors for O M E strong enough to justify inclusion in 
medical decisions were URTIs and older siblings. 
Calculating the prevalence for OME in the cohort, the nsk for O M E among children 
with older siblings, but without URTIs will become around 2.9%; for children with URTIs, 
but without older siblings and for children with both URTIs and older siblings these 
estimated nsks are 2.3% and 7.9%, respectively. Physicians can therefore use infonnation on 
these factors if they have doubts about referring or treating a child for OME. 
According to Schouten /represent the probability that a subject in the cohort is selected from the random 
sample. In our calculation, however, / represent the probability to be a case. The real ƒ=364/4793=0 0759 
and ß,,* = -1.77+ln(0.0759)=-4 35 The prevalences then change to 1 3%; 3.5%, 4.5%, and 12.1%,, 
respectively. The conclusions, unfortunately, do not change. 

Chapter 2.2 
Prognostic factors for persistent Otitis Media with Effusion in 
infants 
Maroeska M. Rovers, Gerhard A. Zieihuis, Huub Straatman, Koen Ingels, Gert-Jan 
van der Wilt, Paul van den Broek 
Archives of Otorhinolaryngology Head & Neck Surgery 1999; 125: 1203-1207 
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Abstract 
Objective: T o study prognostic factors for persistent Otitis Media with Effusion (OME) in a 
birth cohort of 30.099 children bom in the Eastern part of the Netherlands between January 
1, 1996 and April 1, 1997. 
Design: Case-referent study. 
Subjects: Children who failed a triple heanng test before their first birthday and who were 
subsequently diagnosed with bilateral O M E during 3 out of the 4 bi-monthly visits to an Ear, 
Nose, and Throat (ENT) department (N=372). These persistent cases were compared with 
3 referent groups: (1 ) all the children who attended the first out of three hearing tests; (2) all 
the children of the birth cohort who were referred to an E N T department after the third 
heanng test; and (3) all the children who were diagnosed with bilateral O M E during the first 
visit to an E N T department. 
Results: When all the children who participated in the first hearing test were taken as 
referents, pensistent O M E was associated with upper respiratory tract infections, attending a 
day care centre, having older siblings and a family history of otitis media. When all the 
children who were referred to an E N T department were taken as referents, only attending 
a day care centre was associated with persistent O M E . When the children diagnosed with 
bilateral O M E during the first visit to an E N T department were taken as referents, no 
prognostic factors were found for O M E persistence. 
Conclusions: When a child is referred early, an otolaryngologist can ask the parent about the 
presence of prognostic factors. If the prognostic factors are present the clinician can follow 
the child more actively. 
Introduction 
In the literature, many prognostic and risk factors have been described for otitis media with 
effusion (OME) in children. The main factors considered responsible for the development 
of O M E are infections and eustachian tube dysfunction. Other factors that may influence the 
occurrence or O M E are: race , sex , acute otitis media , the presence or 
l i 7 65-67 r M l - . . C * .-· j · 7 6(1 65 67 68 89 . ,. . · r .· 7,6(1.65 69 70,72 
siblings , family history of otitis media , respiratory tract infections 
Down's syndrome1 8, cleft palate8', allergies04, season6 ' 6 7 7 1 7 4 , bottle feeding7, attending a day 
. 78566467 6875 77 · ι • 7,59 77-79 ι ι . ι u „85 88 I I ι A D L ^ * ) 
care centre , passive smoking , low birth weight , blood group A R h + , 
and socio-economic status '8:,'8 . 
Some studies investigated the nsk factors specific for persistent O M E such as male 
sex
1
''
H<
', sibling history of ear infection8'' '"', bottle feeding8', blood group A R h + 9 " , day care 
attendance 9 I , and season1''. The results of these studies have been contradictory, probably 
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owing to differences in methods and study populations. In addition, the definition of 
persistent O M E varies between studies In most studies, persistent O M E was defined as a 
minimum of 2 months of effusion, while the present guidelines for treatment with ventilation 
tubes recommend waiting 4-6 months 
The aim of this study was to analyse prognostic factors for persistent O M E of at least 
4 months duration, in a large population. Children with these factors might benefit from early 
detection, more frequent check-ups, and/or early intervention 
Patients and methods 
Patients and referents 
The population in this study comprised all the infants born in the eastern part of the 
Netherlands betweenjanuary 1, 1996 and April 1,1997 (N=30,099). These children were 
screened for hearing impairment (Ewing method) at age 9 months. Those who failed 3 
screening tests were referred to an ear, nose and throat (ENT) outpatient clinic for diagnosis 
with tympanometry and otoscopy. During this visit the parents were asked to complete a 
questionnaire with a number of items about prognostic factors. Infants with bilateral O M E 
(determined by a type-B tympanogram and/or fluid found dunng the otoscopy procedure) 
were recalled 2 months later, while the children with unilateral or no OME were not further 
observed. Otitis media with effusion was considered to be persistent when the diagnosis was 
made dunng 3 of the 4 bimonthly visits (over the subsequent 6 months). Those infants with 
penistent O M E comprised the cases in this study (N—372). 
T o make a valid estimate of the relative risk, we perfonned a case-referent study 82 This 
meant that controls needed to be selected from the source population. As a consequence, it 
was possible for a child in the referent group to be a case as well as a control. 
Our study had 3 possible source populations: (1 ) the children who participated in the first of 
3 hearing tests (a random sample of 450 children [366 respondents] bom between March and 
July 1996 was taken from this population to serve as controls, and the parents of these control 
children completed the same questionnaire on prognostic factors); (2) the children who were 
referred to an E N T department after failing the third hearing test (N=1083); and (3) the 
children who were diagnosed with bilateral O M E dunng their first visit to the E N T 
department (N=757). Companng the persistent cases to these three referent populations 
enabled us to study the effect of the prognostic factors over time. 
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Prognostic factors 
Day care attendance, breast feeding, prematurity and passive smoking were all studied as 
dichotomous variables (yes/no) and as continuous variables (days per week, number of weeks, 
and number of cigarettes). An infant was considered to have a history of acute otitis media 
if the child ever had an earache with fever or if a general practitioner had prescribed 
treatment for earache in the past 3 months. An infant was considered to have a family history 
of otitis media if a sibling or parent had acute otitis media or O M E once. There was a history 
of respiratory illness if upper respiratory tract infections had occurred more than 4 times in 
the first year of life. 
Statistical procedures 
For each prognostic factor, the risk ratio for persistent O M E was estimated by means of an 
odds ratio (OR) with a 95% confidence interval (CI). Multiple logistic regression was used 
to examine prognostic factors simultaneously. Only prognostic factors that showed an 
association with O M E in univariate analysis were selected for the multivariate models. 
The prognostic value of the models was evaluated using the c-index. This c-indcx is equal 
to the area under a receiver operating characteristic curve8 and has a range of 0.5 (no 
prognostic value) to 1.0 (maximum prognostic value). 
Because O R s do not show the absolute difference in nsk of O M E in children with and 
without the prognostic factors, we estimated the baseline prevalence of persistent O M E in 
the referents who participated in the first screening, using the method described by Schouten 
et al82: corrected β,, = ß0*+ log (J), where ƒ represents the probability that a subject in the 
cohort was selected from the random sample (assuming that sampling was independent of the 
outcome). 
AU analyses were performed using the statistical package SAS. 
Results 
The results of the univariate analyses are given in Table 1. In the analysis with the referent 
children who participated in the first screening, 5 factors were associated with persistent 
OME: sex ( O R = 1.4 [95% CI 1.0-1.8]), upper respiratory tract infections (URTIs) (OR 
= 2.6 [95% CI 2.0 - 3.6]), older siblings ( O R = 3.2 [95% CI 2.3 - 4.4]), attending a day care 
centre ( O R = 1.9 [95% CI 1.3 - 2.6]) and a family history of otitis media (OR = 1.9 [95% 
CI 1.4 - 2.5]). Other variables, such as prematurity, number of days in day care, breast 
feeding, duration ofbreast feeding, atopy, educational level of the parents, AOM, and passive 
smoking and number of cigarettes did not show an association with persistent OME. 
Epidemiology of OME in infants 
When all the infants who were referred to an ENT department were selected as 
:ferents, only day care attendance was associated with persistent O M E ( O R = l .5 [95% CI 
.1-1.9]). When the children diagnosed with bilateral O M E during the first visit to an E N T 
epartment were selected as referents, none of the factors was associated with persistent 
)ME. 
"able 1. Univanate analyses of potentially prognostic factors for persistent O M E 
II III 
Prognostic Factor 
>ex (male/female) 
\ O M (yes/no) 
JRTIs (> /<= 4) 
^amily history (yes/no) 
Dlder siblings (yes/no) 
Day care (yes/no) 
Days in day care (>= /< 4 days) 
îreast feeding (yes/no) 
Duration feeding (>= /< 6 months) 
Prematurity (yes/no) 
-"rematunty (</>=37 weeks) 
-"assive smoking (yes/no) 
dumber of cigarettes (>=/< 20) 
\topy (yes/no) 
Educational level father (low/high) 
Educational level mother (low/high) 
O R (95% CI) 
1.37(1.02-
1.31 (0 94-
2 64(1.97-
1 85 (1.38 
3.22 (2.34 -
1 85 (1.34-
0 49 (0.19-
1.06(0.77-
1.01 (0.71 -
1 14(0.83-
0 53 (0.25 -
1.01 (0.74-
1.01 (0.74-
1 41 (0.94 -
0 89 (0.63 -
1.06(0.74-
- 1.83) 
- 1.80) 
- 3.55) 
- 2.50) 
- 4.43) 
- 2.57) 
- 1.22) 
- 1.47) 
- 1.45) 
- 1.56) 
- 1.14) 
- 1.39) 
- 1 39) 
-2.13) 
 1.25) 
-1.51) 
O R (95% CI) 
1.06 (0 83 -
0.97 (0 74 -
1.18 (0 9 2 -
1.25 (0.98-
1.56(0.87-
1.45 (1.12-
0.72 (0.33 -
1.23(0.93-
1.13 (0.84-
0.93 (0.72 -
0.63 (0.32 -
0.90 (0.69 -
0.78 (0.34 -
0.99 (0.71 -
0.88 (0.66 -
0.85 (0.63 -
• 1 35) 
• 1 26) 
• 1 50) 
- 1.60) 
• 1.54) 
• 1.87) 
• 1.59) 
-1.61) 
• 1.53) 
• 1.20) 
- 1.23) 
• 1.16) 
•1.71) 
• 1.37) 
-1.17) 
•1.14) 
O R (95% CI) 
1 02 (0.77 -
0 96 (0.72 -
0.89 (0.68 -
1.15 (0.88-
1 16 (0 85 -
1 16 (0.88 -
0.73 (0.32 -
1.09(0 81 -
1.01 (0 7 4 -
1.03(0.78-
0.79 (0.38 -
0 97 (0 74 -
0 71 (0 30 -
0.94 (0 67 -
0.96 (0.71 -
0.94 (0.69 -
-1.32) 
- 1.26) 
-1 16) 
-1 49) 
-1 58) 
•152) 
-1.65) 
-1 46) 
• 1 39) 
- 1.36) 
- 1.62) 
• 1.28) 
• 1 66) 
-1.33) 
-1.31) 
- 1.29) 
The 366 infants sampled from those who participated in the first hearing test served as referents, II: 
-eferents sampled from the infants who visited an ENT department after failing the hearing test, III Referents 
impled from the children diagnosed with bilateral OME during the first visit to an ENT department. 
OM = Acute Otitis Media; URTIs = Upper Respiratory Tract Infections 
Tie O R for children with both older siblings and URTIs was 1.8 (95% CI 1.3 - 2.6), while 
ie O R for children with URTIs but without older siblings was 5.5 (95% CI 3.1 - 9.6). 
imilarly, children with older siblings and attending day care had an O R of 1.6 (95% CI 1.0 -
.4), while children without older siblings and attending day care had an O R of 4.2 (95% CI 
.4 - 7.3). The O R also differed within the strata of day care. Children attending day care 
/ho had older siblings showed an increased risk of 1.85 (95% CI 1.05 - 3.28), while children 
ot attending day care but who had older siblings had an O R of 5.0 (95% CI 3.3 - 7.5). 
When the children referred to the E N T department served as referents such effect 
lodification was also found, but the confidence intervals overlapped. The O R for children 
mh both older siblings and URTIs was 1.1 (95% CI 0.8 - 1.4), while the O R for children 
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with URTIs but without older siblings was 1.7 (95% CI 1.0 - 2.9). The odds ratio in children 
attending day care and who had older siblings was 1.4 (95% CI 1.0-1.9), while the odds in 
children attending day care but who did not have older siblings was 2.0 (95% CI 1.2 - 3.3). 
Children not attending day care who had older siblings had an O R of 1.0 (95% CI 0.7 -1.6) , 
while children not attending day care who had older siblings had an odds ratio of 1.5 (95% 
CI 1.0 - 2.2). When the children diagnosed with bilateral O M E dunng the first visit to an 
E N T department served as referents, the effect modification was even smaller. 
Multiple logistic regression was used to investigate the association between sex, URTIs , 
the presence of older siblings, day care attendance and family history. In this model only 
URTIs , older siblings, attending a day care centre and a family history were associated with 
persistent O M E (Table 2). The final logistic model can therefore be desenbed by: 
P(persistent OME)= 1 / [ I +e "("1 ' + "7 UK ' l s + " ol'k'r"bl,np + ""dav 'Jre + "4 hm,K h,it™)]. 
The c-index of this model was 0.70. When we adjusted for the above mentioned effect 
modification by adding 2 interaction factors (day care x URTIs and older siblings x URTIs) 
the c-index did not improve. 
Table 2 indicates that after correction for URTIs , day care attendance and a family 
history of otitis media, a child with older siblings was 3 times more likely to develop 
persistent OME than one without. After correction for the other factors, a child with URTIs 
was 2 times more likely to develop persistent OME. Children attending day care and children 
with a family history of otitis media were 1.9 and 1.5 times more likely to develop persistent 
O M E than children not attending day care or children without a family history, respectively. 
Inclusion of the other possible prognostic factors in the multivariate model did not increase 
the c-index. 
Table 2. Multivariate analysis of prognostic factors associated with OME (with 360 cases and 
352 referents) 
Prognostic factor 
Intercept 
URTIs 
Older siblings 
Day care 
Family history 
Estimate 
-1.48 
0.72 
1 11 
0 63 
0.40 
SE 
0 18 
0 17 
0.18 
0 19 
0 17 
O R 
2 05 
3.05 
1.88 
1.49 
95% CI 
1.47-2.87 
2 1 3 - 4 32 
1 30 - 2 72 
1.07-2.08 
Prevalences of O M E calculated using the method desenbed by Schouten et al142, are given in 
Table 3. In the sample of 352 referents who could be used in the multivariate analysis, 5 
children were both case and referent. If we assume that the 360 cases without missing values 
also represent all the children who participated in the first screening, the total cohort can be 
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calculated by (360 cases/5) x 352 referents = 25,344 infants. In this case, ƒ = 352/25,344 = 
0.0139 and ß0 = 1.48+log(0.0139)=-5.75. The prevalence is given by exp (β
π
+ 0.7 URTIs 
+ 1.1 older siblings + 0.6 day care + 0.4 family history). The prevalence of persistent OME 
in children without URTIs, older siblings, a family history of otitis media, attendance at day 
care was 0.3%, while the prevalence was 5.5% when all these factors were present. 
Table 3. Estimated prevalences using the case-referent design 
URTIs 
no 
no 
no 
no 
no 
no 
no 
no 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
Older 
Siblings 
no 
no 
no 
no 
yes 
yes 
yes 
yes 
no 
no 
no 
no 
yes 
yes 
yes 
yes 
Day 
tare 
no 
no 
yes 
yes 
no 
no 
yes 
yes 
no 
no 
yes 
yes 
no 
no 
yes 
yes 
Family 
History 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
Prevalence 
0.3% 
0.5% 
0.6% 
0.9% 
1.0% 
1.4% 
1.8% 
2.7% 
0.7% 
1.0% 
1.2% 
1.8% 
2.0% 
2.9% 
3.7% 
5.5% 
Prevalence - exp (-5.75 + 0.7 URTIs +1.1 older siblings + 0.6 day care + 0.4 family history) 
Discussion 
In accordance with other studies, we found that a history of URTIs, day care attendance, 
having older siblings and a family history of otitis media were prognostic factors for persistent 
OME.89~" However, this was only the case when a sample of the original screening 
population served as referents. When the children with persistent OME were compared with 
the children referred to an ENT department after the third screening, only day care 
attendance was associated with persistent OME. When the children diagnosed with bilateral 
OME during the first visit to an ENT department served as referents, no factors were 
associated with persistent OME. 
Having older siblings seemed to modify the effect of a history of URTIs on persistent 
OME. Children without older siblings but with a history of URTIs were at higher risk for 
persistent OME than children with both older siblings and a history of URTIs. Moreover, 
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children attending day care who did not have older siblings were at higher nsk for persistent 
O M E than children attending day care who did have older siblings. This suggests an 
important role of immune status: children with older siblings will have probably been 
exposed to pathogens that cause URTIs and OME, so their immune system may be 
stimulated to protect them against these pathogens. 
After the third hearing test 318 children (23%) were not referred to an E N T 
department for a vanety of reasons (mostly because the parents did not want to). This might 
have caused some bias if the infants lost to follow-up formed a selected group. For example, 
if these children did not have persistent O M E and did not score on the prognostic factors 
either, the calculated O R s would overestimate the true rates. But as it is unlikely that this was 
the case in a large proportion of the children lost to follow-up, the amount of bias can be 
considered small. 
It is possible that all the children referred to an E N T department had already been 
suffering from O M E for at least 3 months, since they failed the hearing test 3 times. This 
might explain the smaller effect of the prognostic factors when the children referred to an 
E N T department and the children diagnosed with bilateral O M E at an E N T department 
served as referents. 
Data on prognostic factors were based on questionnaires completed by the parents. 
Although, parental recall of prognostic factors also forms the source of information in clinical 
practice, it should be noted that recall errors and misclassification will lead to some degree of 
underestimation of the ORs . 
Children from the referent group who participated in the first of the 3 hearing tests 
were used as controls in an earlier study.'"1 These children were bom between March and July 
1996. We do not expect that the presence of prognostic factors depends on the month of 
birth, but we know that the prevalence of persistent O M E is highest during the winter 
months and lowest during the summer months. The children bom between March andjuly 
had their conditions first diagnosed at the E N T department at age 12 months. Therefore, 
fewer of the referents might have been diagnosed with OME, and the calculated O R s might 
be a little overestimated. 
To show the absolute difference in nsk of persistent O M E we estimated the 
prevalences. The nsk of OME in children without a history of URTIs , older siblings, a family 
history of otitis media, or day care attendance was 0.3%, while the estimated risk in children 
with a history of URTIs , older siblings, a family history of otitis media, and day care 
attendance was 5.5%. These differences show that information on prognostic faeton does not 
entirely discriminate between those who develop persistent O M E and those who do not, but 
the differences seem to be substantial enough to be used. 
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In conclusion, this study showed that children with all 4 prognostic factors at the time 
of screening were at higher risk for persistent OME. However, when these children were 
older and had been suffering from OME for some months, these factors were no longer 
prognostic. So when a child is referred early to a general practitioner, pediatncian or 
otorhinolaryngologist, and if these physicians must decide which policy to follow, they can 
ask the parents about the presence of the prognostic factors. If these prognostic factors indeed 
are present, the clinician can follow the child more actively and if the OME appears to be 
persistent he might decide to insert ventilation tubes earlier. 
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Day care and otitis media in young children: a critical overview 
Maroeska M. Rovers, Gerhard A. Zielhuis, Koen Ingels, Gert-Jan van der Wilt 
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Abstract 
To review the evidence concerning the association between (different forms of) day care and 
otitis media in children aged 0-4 yean, we performed a meta-analysis of studies identified by 
a systematic search with Medline from 1966 to July 1997, and by the reference lists. 
Seventeen articles were classified as useful, because these articles studied children of 0-4 years 
of age and because odds ratios as well as confidence intervals were presented or could be 
calculated. All these studies found a association between attending a day care centre and otitis 
media. The association between otitis media and family care was less clear. Differences in 
study design, age of the subjects, and controlled vanables did not explain the association. 
Conclusion: Day care is a nsk factor for developing otitis media: the number of children seems 
to be important for this effect, probably due to increased exposure to otitis media pathogens. 
Introduction 
Otitis media is one of the most common diseases in childhood and has been studied world-
wide with respect to its epidemiology, natural course, diagnosis, sequelae and nsk factors. 
Many risk factors have been identified such as gender, age, race, atopy, number of siblings, 
bottle feeding and smoking. 
A relationship between day care and the incidence of otitis media was reported by 
Hesselvic93 already 40 years ago. Children in day care had more attacks of both upper 
respiratory tract infections and A O M than children cared for at home. Subsequent studies 
confirmed that day care attendance is a nsk factor for otitis media, but differed in study 
design, effect measurement, forms of otitis media and types of day care. 
A more cntical evaluation of the available literature is now possible using the tools of 
meta-analysis. 
The purpose of this overview is: (1) to assess the relationship between day care and 
otitis media in children aged 0-4 yean; (2) to examine whether children in a special type of 
day care have otitis media more often; (3) to evaluate whether the number of children in day 
care is important; and (4) to determinate whether the different results can be explained by 
levels of immunity. 
From a methodological point of view a stronger relationship (higher odds ratio) can be 
expected for: (1) case-control studies with more severe cases than cohort studies; (2) smaller 
studies due to publication bias. 
If the relationship between day care and otitis media depends on increased exposure to 
pathogens and on differences in immunity between the children, we expect a stronger 
association (higher odds ratio) for: (3) children in day care versus home care; (4) young 
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children (less maturation of the immune system); (5) day care types with larger group sizes; 
(6) longer duration of day care; (7) children without siblings. 
Methods 
A systematic search was performed with Medline from 1966 onwards with the following key-
words: 'otitis media', 'nsk factors' and 'day care'. In addition, the proceedings of major 
international otitis media conferences and day care were included. Bibliographies of the 
articles identified were checked to find additional articles. Unpublished work was not 
reviewed. 
Abstracts were used for first selection: only studies that reported results on at least one 
of the study questions were selected. The selected articles were classified as 'very useful' if the 
study population concerned children of 0 - 4 years of age, and odds ratios as well as 
confidence intervals were presented or could be calculated. If there was information about 
day care and otitis media but no odds ratio and confidence interval could be calculated, an 
article was classified as 'useful'. 
A standardised data abstraction form including pubbcation date, study design, number 
of subjects, patients' age, outcome measure, and mentioned effect modifiers and confounders, 
was used to extract information from each study classified as 'very useful'. 
In the case of multiple reports on the same study, one paper was chosen that provided 
the best information on: 
1. Otitis media as the outcome, preferably specified into acute otitis media, otitis media 
with effusion and recurrent otitis media 
2. Type of day care: day care (> six children), family care (three-six children) and home 
care (mostly less than three children) 
3. Number of subjects 
Studies classified as 'very useful' were analysed with respect to forms of bias and confounding. 
Results 
Using the keywords 'otitis media', 'risk factors' and 'day care' 87 articles were identified in a 
Medline search. After reading the abstracts, 42 were regarded as informative. In addition, 11 
articles were found with other search strategies. From this total of 53 articles 17 were 
considered 'very useful', 16 'useful' and 20 'irrelevant'. Table 1 shows the main reasons for 
classifying a publication as useful or irrelevant. 
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Table 1. Main reason for classifying publications as useful or irrelevant 
Reason Number of 
publications 
Useful No odds ratios could be calculated 6 
No confidence intervals could be calculated 2 
Repiratory illness instead of otitis media 2 
No day care alone 2 
Other publication on the same population included 4 
Irrelevant Children > 4 year 11 
Only descriptive 4 
No day care/otitis media 5 
The results of the 17 studies classified as 'very useful' are presented in Table 2. All studies 
showed a positive association between day care and otitis media which was remarkedly 
consistent across various study-populations and designs. There seems to be a particularly 
strong risk when day care centres are compared to children cared for at home (see also figure 
1). The risk was less clear when children in day care centres are compared with children in 
family care, or when children in family care were compared to children cared for at home 
(Figures 2 and 3). Some studies found that children in family care were at higher risk for otitis 
media than children in home care9'1"99, while others did not find such a relationship77 m> l(,1. 
The odds ratios for family care versus home care varied from 1.1 (0.7-1.8) to 2.6 (1.2-5.5). 
None of the studies found that children in day care had a significantly higher risk than 
children in family care, but all the studies found an odds ratio for day care of more than 1.4. 
Some studies also investigated the effect of the number of hours spent in child care'"2 
and the group size97 ")2. Both studies found that group size is an important factor for the 
development of otitis media. This agrees with the finding that children in day care have a 
higher risk than children in family or home care, because the total number of children in day 
care usually exceeds six, while in family care the typical group size is three-six and in home 
care mostly less than three. In contrast, more time spent in child care did not increase the nsk 
of otitis media. 
Table 2. Studies on day care and otitis media 
Reference (year) Country Design Number of 
subjects 
Age of subjects Outcome Companson groups O K (95% C I) 
A l h o O et al (1990) 
(199S) 
Collet J 1J et al (1994) 
EyJ L et al (199 S) 
Fleming P W étal (1987) 
Hardy A et al (1991) 
Harsten G étal (1989) 
Kerol» étal (1987) 
MantJ étal (199S) 
Paradise J L étal (1997) 
l 'ukanderj (1982) 
l 'ultanderj étal (I9H5) 
Som M étal (1996) 
StahlbergM et al (1986) 
Strängen Κ (1977) 
TaiNo,V-M eta! (1988) 
V m t h e r U étal (1979) 
Sweden 
France 
USA 
USA 
USA 
Sweden 
Finland 
USA 
USA 
Finland 
Finland 
Finland 
Finland 
Sweden 
Finland 
Denmark 
Cohort 
Cohon 
C ohorx 
Survey 
Survey 
C ohon 
Cohort 
Survey 
C ohon 
C ase-control 
Case-Control 
C ohort 
C ase-Control 
C ohort 
Cohort 
C ohort 
2512 
1242 
1011 
575 
5818 
111 
5156 
1054 
1016 
2251 
101 cases 
97 controls 
264 cases 
207 controls 
2512 
115 cases 
121 controls 
207 
181 
494 
Ο­
Ι) -
0 -
0 -
< 
1 -
0 -
0 -
<1 
1 -
0 -
1 -
0 -
2 -
0 -
1 -
6 -
0 -
1 -
• 2 year 
• 1 year 
I year 
1 year 
1 year 
2 year 
1 year 
1 year 
year 
2 year 
• 1 year 
• 2 year 
• 4 year 
• 1 year 
2 year 
1 6 year 
17 months 
2 1 year 
4 year 
A O M 
O M E 
A O M 
A O M 
r O M 
A O M 
A O M 
r A O M 
A O M 
A O M 
A O M 
A O M 
A O M 
(> = 1) 
A O M 
(> = 1) 
A O M 
A O M 
(> = 1) 
A O M 
A O M 
(>=3) 
K I M 
O M E 
Day care vs home care 
Family care vs home care 
Day care vs home care 
Family day care vs home care 
Day care vs family day care 
Day care vs home care 
Day care vs home care 
Day care vs home care 
Day care vs family care 
Day care vs home care 
Day care vs home care 
Family care vs home care 
Day care vs home care 
Family day care vs home care 
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Figure 1. Summary of odds ratio (OR) estimates and their 95% confidence intervals for day 
care versus home care 
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family care versus home care 
I I ! 
) I 
I » I 
0 1 2 3 4 5 6 
OR (95% CI) 
7 8 9 10 
Epidemiology of OME in infants 
Figure 3. Summary of odds ratio (OR) estimates and their 95% confidence intervals for day 
care versus family care 
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Discussion 
Publication bias 
The problem of publication bias can only be solved completely when both accepted and 
well-conducted unpublished studies are included irrespective of the statistical significance of 
their results. Retrieval of information from all studies is infeasible, because registers for non-
expenmental studies have not yet been created. " Publication bias can therefore not be 
precluded. To assess the impact of publication bias in this review we made a funnel plot 
(Figure 4) which selectively misses studies with negative results, so that it is possible that 
studies which found no effect were never published. Particularly in studies on multiple nsk 
factors 3 6 7 7 8 3 9 6 9 8 '""1"4 ""' publication bias cannot be precluded, yet none of the studies that 
were explicitly designed to study the effect of day care showed a negative 
association9197 "" l 0" " l " ι β. Moreover, the data of the funnel plot converged to a log odds of 
0.5 which corresponded to an odds ratio of 1.65. 
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Figure 4. Plot of the log odds ratio of the 17 studies by sample size 
2 
1,8 
1,6 
1,4 
1,2 
1 
0,8 
0,6 
0,4 
0,2 
0 
• * 
* A 
+ + + 
• <% care va horre care 
• famly care vs home care 
* day care vsfanily care 
H 
1000 2000 3000 4000 5000 6000 7000 
Differences in study design 
The studies used different designs, there were three case-control studies, three surveys and 
11 cohort studies. Cases in the case-control studies were typically children who visited an ear, 
nose and troat department for obvious complaints and were subsequently diagnosed with 
otitis media, while in the surveys, parents were asked about their children's history of otitis 
media (at least once). In contrast, in cohort studies the children were examined every few 
months, which resulted in more precise diagnoses of otitis media. As a consequence, it might 
be expected that the highest nsk were to be found in case-control studies. At first sight, there 
appeared to be a higher nsk in case-control studies, but in two of these studies7 7 '9 the 
investigators considered three or more episodes of otitis media, while in the third study, the 
cut-off point was one or more episodes N o differences were found between the case-control 
study with a cut off point of one episode""' and the results of the other study designs 
Some studies made a clear distinction between day care, family care and home care, 
, 1 1 „ ι „ j •>() 77 8-, 8-, 97 98 100 102 l(>4-l(IH „ i
 t , ι /-„, ι >, . , , 
while in other studies the parents were asked if their child attended 
some form of day care and different definitions were used for family or home care. Coping 
with the difference between family care and home care in various studies can therefore pose 
a problem. However, the calculated odds ratios for the studies did not differ very much 
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Since otitis media is a dynamic disease in which some forms lead to others all forms 
of otitis media are presented in Table 2. N o systematic differences in nsk appeared between 
the vanous forms of otitis media. 
Differences in precision between the studies were expected to be related to the number 
of subjects. Studies with a smaller number of subjects will give an imprecise estimate of the 
odds ratio, as shown by a broader confidence interval The study by Harsten et al , which 
followed a cohort with only 113 infants, did indeed result in a relatively high odds ratio of 
6.1 [1.0-36.7]. All the other studies had a larger sample size with smaller confidence intervals. 
Results of the latter studies were fairly consistent. 
Selection 
It should be noted that selection of subjects in the studies cannot be excluded. More otitis-
prone children might be in family or home care because they had recurrent infections when 
they were cared for at day care centres. If this is the case, the calculated odds ratios will 
underestimate the real association. 
Misdassification 
Parents can be expected to know whether their child attended some form of day care. 
Misdassification of exposure is therefore negligible. Misdassification of outcome, on the 
contrary, might be a problem in the selected studies: both under and over diagnosis of otitis 
media is possible. In some studies77 " '0<, only children who had had contact with a physician 
because of otitis media were selected, which may have resulted in under reporting. In other 
studies93 9 7 ' ϋ 2 ' 0 B parents were asked to report the number of ear infections, which may have 
resulted in both over- and under reporting. Only studies with prospective regular follow-up 
examinations will adequately monitor the number of ear infections. However, in the selected 
prospective studies the instruments used to diagnose otitis media were different. Most studies 
only used (pneumatic) otoscopy 3 6 1 0 1 "M 1 ( b and one study used both otoscopy and 
tympanometry106. Despite different forms of diagnosis and possible misdassification, the results 
were consistent. It can therefore be concluded that a causal association between day care and 
otitis media is very likely. 
Age, immunity and duration of exposure to pathogens 
Many authors consider otitis media to be a multi-factonal disease process with a vanety of 
etiological mechanisms3 6. However, local and systemic immunity appear to play a key role 
in the frequency and seventy of otitis media. Anmanson et al. ' found that the frequency of 
A O M was lower among children without siblings or day care centre contacts. These factors 
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are known to influence the acquisition of nasopharyngeal flora during the first year of life. 
Rhinosinusitis is reported to be a high nsk factor for developing persistent effusion in 
children8. Day care attendance increases the occurrence of respiratory infections and AOM, 
especially during the first 2 years of life, after which the effect decreases. ' ' ' These observations 
suggest that day care may be associated with otitis media by an infectious mechanism. Collet 
et al.93 desenbed that children who attend day care for more than six months were at lower 
nsk for infections than children cared for at home. This finding can be explained by faster 
maturation of their immune system, or by stimulation of nonspecific immunity factors that 
assist in eliminate micro-organisms not previously encountered by the body This learning 
effect of the specific and non-specific immune system is age-dependent, although the selected 
studies hardly distinguish between age groups Strangert and Marx et al. found a stronger 
relationship in the first year of life, but others " ' did not find such a strong relationship. 
However, the distinctions made between age groups may be too crude to find an association. 
Controlling for confounders 
Some of the studies mentioned in Table 2 controlled for confounding vanablcs, although 
with different sets of vanables. 
r^ .. π ι i l ι ii>85')6-'JH 102 Uli 1 Γ U l 5ίι Hi 96'JH 105 1 
Controlled vanables were: gender , number of siblings , breast 
C J id »5 98 105 .. ι ι 56 97 9H 105
 t 56 97 98 if, ι ι ι ,. Hi 
feeding , parental smoking , atopy , season and maternal education 
However, the adjusted odds ratios did not differ from the odds ratios in the studies that did 
not control at all. 
The possibility of uncontrolled confounding cannot be ruled out. However, the association 
between day care and otitis media was remarkably consistent across the diverse populations, 
so it is unlikely that there is no relationship at all. 
Generalnation 
The proportion of children in day care as well as the number of day care centres will differ 
from country to country. Eleven of the selected studies were performed in Scandinavian 
. 16 77 8-1 8i96 98 101 KM 107 £- „ ι Τ Τ .. J C .. 97 102 l ib lofi 108 j ,. j r- 91 
countnes , five in the United States and one study in rrance . 
N o differences were found between those countnes, so the relationship between day care and 
otitis media appears to be consistent, at least in 'Western societies'. 
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Circumstantional evidence 
All the articles classified as 'useful' found that children in day care had otitis media more often 
than those cared for at home' '7 7 1"0 1 2 1 . In two studies no confidence interval could be 
calculated, but the odds ratios were 1.8867 and 2.0"2 , respectively. Also studies in which risk 
ratios, incidence density ratios, regression coefficients or percentages were calculated, showed 
an association between day care and otitis media71113 '" ' l 20 . 
Hurwitz et al.1"1 found that the nsk of respiratory illness was associated with day care 
attendance, although it was statistically significant only for children in the younger age group 
and children without older siblings in the 18 to 35-month age group. In the latter group (not 
in day care) the odds ratio was associated with older siblings, but this was of smaller 
magnitude than the odds ratio for day care among those without older siblings. Prolonged 
exposure owing to older siblings therefore appears to reduce the nsk of respiratory illnesses. 
This finding can be explained by stimulation of nonspecific immunity factors and by 
maturation of the immune system, as mentioned above. 
In the studies classified as 'very useful' the number of children in a room appeared to 
be an important factor. Bell et al.12" also found that a major risk was the number of children 
in the room, but no dose-response relationship could be found. The latter result was 
confirmed in the study by Louhiala et al. 
A study performed to determine the effect of day care on respiratory infections also 
showed that children in day care had more infections than those in home care"' . While otitis 
media is recognised as a frequent complication of respiratory infections, these data also 
confimi the observations of other studies that children in day care expenence otitis media 
more often than those cared for at home. 
We found strong evidence for an association between day care and otitis media. The 
highest nsk was associated with attending day care centres; the risks for in family care or in 
home care were markedly lower. 
Differences in study design, age of the subjects and controlled variables did not explain 
the association between attending day care centres and otitis media, but there are indications 
that the size of day care attendance is an important factor. A large number of children in a 
group may contnbute to increased exposure to pathogens that may cause otitis media. 
Additional research into the effect of immunity on the relationship between day care and 
otitis media is needed to confirm this. 
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Summary 
The objective of this population based cohort study was to evaluate the prevalence of 
penistent Otitis Media with Effusion (OME) and its seasonal variation in 12 month-old 
infants. 
All 30,099 infants bom in the Eastern part of the Netherlands between 1 January 1996 
and 1 April 1997 were invited for hearing screening, comprising a protocol of three possible 
tests. Those who failed all three screening tests were referred to an E N T clinic for 
examination. 
Prevalences (i.e. the probability that a child would fail all the screening tests) were 
calculated, by searching for the best logistic model for the first, second and third screening 
test as well as for the visit to an E N T department. By multiplying the prevalences found by 
the different models with each other, a prevalence was calculated that accounted for 
increasing age and the timing of the successive hearing tests. Furthermore, 95% confidence 
intervals were calculated for this age-season-corrected prevalence. When all the children 
attended the hearing tests at 9, 10,11 and 12 months of age and when the number of births 
was the same in all months, the overall prevalence was 4.8% [95% CI 4.3 ,5.2]. The highest 
prevalence (8.0%) was found in Apnl, while the lowest prevalence (1.5%) was found in 
October. Rates of bilateral O M E during the late winter months were twice as high as those 
dunng the late summer. 
Introduction 
Otitis Media with Effusion (OME) is one of the most common diseases in childhood. It is 
responsible for a heanng loss of 10-40 dDl2'124 and is assumed to interfere with early language 
development21 '2126 271l ,2 l ,2<>. As the disease mostly remains unnoticed, the idea of active 
screening appears to be quite naturally. The implementation of mass screening programs in 
populations of children has therefore increased throughout the years. 
Owing to the wide variety of methods used in different studies, it is difficult to draw 
conclusions about the prevalence of OME. For example, some investigators counted ears 
instead of children with uni- or bilateral otitis media; some authors did not differentiate acute 
otitis media (AOM) from otitis media with effusion, while others preferred to include only 
A O M , but their diagnostic technique often also included cases with OME. ' 3 1 2 7 
Tympanometry appears to be the most objective and reliable method for diagnosing 
OME.3" " " Although different prevalences were found in studies using this tympanometry, 
it appears that the prevalence of O M E follows a bimodal curve with age: there is a peak 
occurrence just before age two years' ' " and another at around five years of age13'32. 
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As about 50% of ears14 ' 1 I recover spontaneously within 3 months, only children with 
persistent (bilateral) O M E are cause for concern with respect to delay in language 
development and might therefore benefit from treatment with ventilation tubes. So far, no 
studies have been published reporting the prevalence of persistent O M E in the first year of 
life. Only Alho et al. reported on the prevalence of chronic otitis media defined as 
asymptomatic middle ear effusion for at least two months. 
The most important factors affecting the prevalence are the age of the children1 , 2 m and 
the season: In general the prevalence increases in the first year of life to about 15% , and rates 
dunng the winter months are higher than those during the summer6" ''7 7λ 7A ' " . 
As mentioned, we already know that O M E displays seasonal variation. However, none 
of the previous studies quantified the prevalence of persistent O M E of more than 3 months 
in the first year of life precisely. This precise quantification is needed as background for policy 
decisions about screening and intervention before 2 years of age. Moreover, previous studies 
only investigated relatively small samples. Precise estimates of prevalences based on a large 
sample are rare. 
In the scope of a large ongoing epidemiological study on the treatment effect of 
ventilation tubes in children with O M E in the Netherlands, it was possible to study the 
prevalence of persistent O M E (more than three months) in the first year of life of all children 
born in 1996. In the analysis we were able to adjust for the apparent age effect due to actual 
variation in the timing of the measurements. 
Population and methods 
The study population comprised all the children b o m between 1 January 1996 and 1 April 
1997 in the Eastern part of the Netherlands, who were invited for hearing screening 
(comprising 3 possible tests) at the age of 9 months. All the children who failed the first 
screening test were invited for a second screening one month later. The children who also 
failed the second screening were invited for a more comprehensive third screening test. 
Those who failed three times were referred to an E N T outpatient clinic for examination with 
both tympanometry and otoscopy. 
The unadjusted prevalence of persistent O M E was calculated as the number of children 
diagnosed with O M E divided by the number of children who participated in the first 
screening. However, in practice the interval between the first screening test and the final 
diagnosis was not uniform and seasonal variation also had to be taken into account. It was 
clear that this problem was not as simple as counting the prevalence of blue eyes in a 
Chapter 2 
population at a given moment. We had to account for the longitudinal design of the study 
and the specific times that the four tests were earned out. 
The prevalence of persistent O M E (more than 3 months) at one year of age, for which 
we want to make a valid estimate, is defined as the conditional probability that a child failed 
the three screening tests as well as the E N T examination (Y= 1), and under the condition that 
the hearing tests were preformed at 9,10,11 months of age and the E N T examination at 12 
months of age. 
Formal equation, for a child born in February 1996: 
Pr[Y=l | A 1 =9,A 2 =10,A,= 11 ,A,=12,B=9602]. (1) 
This probability can be rewritten as the product of the four conditional probabilities 
(E,: 1=1-4). 
P r f E ^ - ^ , = 9 , 6 = 9 6 0 2 ] x 
P r [ E 2 = - | A 2 =10,B=9602, E l = - , A l = 9 J x 
Pr[E,= - | A,= 11,B=9602, £, = - ^ , = 9 , E 2 =-,A 2 =101x 
P r [ O M E = - | A 4 = 12,B=9602, £, = - ^ , = 9 , E 2 = - , A 2 = 1 0 , £ , = - ^ , = 11]. (2) 
This probability of persistent O M E could be estimated validly by restriction to only those 
children who participated at exactly age 9,10,11 and 12 months. Obviously, such selection 
would lead to the loss of much information. Therefore, we chose to model each of the four 
conditional probabilities by means of logistic regression. This modelling will only lead to valid 
estimates if all four models fit the data or allowance is made for extra variation. Below we 
discuss the modelling process for the first model. The process was the same in the next three 
steps. 
The covariables involved in the first logistic model for the probability of the event 
£, = - were 16 dummy variables for month of screening (#categories-l) denoted by P 9 6 1 0 , 
Ρ,,,,,, , P 9 8 ( ) l,and 12 dummy variables for month of birth denoted by B% ( ) | , B9603, ,Β,^,,,. 
The logistic equation for the probability that a child bom in month /; will faü the first hearing 
test and attend this screening test in penod ρ is given by 
Epidemiology of OME in infants 
Pr[E1 = - | P p = l , B b = l ] = 
[exp(a + δ ^ , , + ßbBb )J / [1 + exp(a + δ
ρ
Ρ
ρ
 + ßbBb)] (3) 
Standard errors and 95% confidence intervals were calculated for the probability that a child 
would fail the hearing test for each model, as well as for the probability of failing all four tests. 
The Appendix shows the calculation of the overall prevalence with a 95% CI when the total 
birth cohort attended the screening at age 9, 10, 11 and 12 months, and assuming that the 
number of births in each month was equal. 
Each of the four models was fitted to the separate effects of age, month of birth, month 
of screening, and the time between two tests using the G E N M O D procedure of the statistical 
package SAS with a logistic link function and a binomial distribution for the number of 
events within each age-birth-penod-time since previous-screening. To test the goodness-of-
fit of the models and to test a model against a model with more covanables that complicated 
one another, déviances and differences of déviances were used with appropriate degrees of 
freedom. '11"' " The final choice of model for the four tests was guided by the goodness-of-fit 
test and by the fact that a model with more covanables was not better. 
We also evaluated the bias in the estimates due to non-response to the screening 
invitation and subsequent loss to follow-up by checking the medical files of the infants born 
in two of the seven regions in 1996, who were treated at any of the five ENT departments 
in those regions. 
Results 
A total of 30,099 infants were bom between I January 1996 and I Apnl 1997,2660 (9%) did 
not respond to the invitation for screening; 8413 (31%) out of the 27439 infants failed the 
first screening test. In the second screening round 2841 (38%) out of the 7499 children 
visiting this second screening failed. In the third screening round 1338 (55%) out of the 2441 
children failed. The parents of 284 children refused to participate further for a vanety of 
reasons, such as 'already under treatment' or 'prefer going to their GP' Thus 1054 children 
were referred to an E N T department, but 186 (17.6%) of them never visited the E N T 
department. This left 868 children who were actually examined by an otorhinolaryngologist. 
At the E N T departments 602 (69%) of these infants were diagnosed with bilateral 
OME, 91 (11%) with unilateral O M E and 175 (20%) with no OME. This produced an 
unadjusted prevalence of persistent bilateral OME of 2.2% [95% CI 2 0,2.41. The prevalence 
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of umlateral O M E was 0.3% [95% CI 0.3, 0.41, while the prevalence of bilateral and 
unilateral O M E was 2.5% [95% CI 2.3, 2.7). 
The frequency of OME among children referred to an E N T department depended on 
age at the time of testing: 75% at the age of 12 months; 66% at 15 months (Table 1). 
Table 1. Age (in months) at the time of E N T examination 
Age Number of children 
(months) 
11 
12 
13 
14 
15 
16 
17 
21 
143 
318 
304 
189 
65 
23 
Biüteral OME 
18 
107 
231 
214 
125 
37 
15 
Frequency [95 
86% [71, 101] 
75% [68, 82) 
73% [68, 78) 
70% [65, 75] 
66% [59, 73] 
57% [45, 69] 
65% [46, 84] 
After statistical modelling, the model with month of birth and month of screening fitted best 
for the first and second screening, while the model with month of screening and time since 
the last screening fitted best for the third screening as well as the visit to an E N T department. 
In Table 2 and Figure 1 the prevalences are presented standardised for the optimal 
screening protocol, viz. at 9, 10, 11 and 12 months of age. Highest prevalence (8.0% [95% 
CI 6.1, 10.0]) was found in the children born in April 1996 and who therefore visited an 
E N T department in April 1997, while the lowest corresponding prevalence (1.5% [95% CI 
0.9, 2.2]) was found in October. The overall prevalence of persistent O M E was 4.8% [95% 
CI 4.3, 5.2] assuming equal numbers of births in each month and that all the children 
attended the heanng tests at 9, 10, 11 and 12 months of age. 
When the children were not screened at 9, 10,11 and 12 months of age, but at an older 
age, or when the interval between the screening tests was more than one month, the overall 
standardised prevalence was slightly lower. Nevertheless, the highest and lowest prevalences 
were still found in March-April and October, respectively. 
Table 2. Prevalences standardised to 12 months of age in the different seasons 
Birth month 
February 1996 
March 
Apnl 
May 
June 
July 
August 
September 
October 
November 
December 
January 1997 
TOTAL 
Prevalence of failing the 
first sc reemng (month of 
screening) 
0.301 
0.358 
0.339 
0 382 
0.396 
0 388 
0.330 
0 290 
0.274 
0.171 
0.242 
0.293 
0.314 
(November) 
(December) 
(January) 
(February) 
(March) 
(Apnl) 
(May) 
(June) 
(My) 
(August) 
(September) 
(October) 
Prevalence of failing the 
seconc screening (month 
of screening) 
0 363 
0 402 
0 461 
0.462 
0.410 
0.436 
0.301 
0.309 
0.192 
0.328 
0.311 
0.390 
0.364 
(December) 
(January) 
(February) 
(March) 
(Apnl) 
(May) 
(June) 
(Hy) 
(August) 
(September) 
(October) 
(November) 
Preval ;nce of failing the 
third screening (month 
of screening) 
0 639 
0.633 
0.659 
0.619 
0 609 
0.546 
0 570 
0.402 
0 500 
0.621 
0 611 
0 698 
0.592 
(January) 
(February) 
(March) 
(Apnl) 
(May) 
(June) 
(July) 
(August) 
(September) 
(October) 
(November) 
(December) 
Prevalence of OME 
diagno es at an ENT 
Department (month of 
examination) 
0714 
0 828 
0 785 
0.593 
0.659 
0 646 
0.369 
0 557 
0 584 
0 722 
0.709 
0 788 
0.663 
(February) 
(March) 
(Apnl) 
(May) 
(June) 
(July) 
(August) 
(September) 
(October) 
(November) 
(December) 
(January) 
Overall prevalence 
pl*p2*p3*p4 |95%CI | 
).050 | 
1075 | 
).()80 | 
1.065 | 
) 065 | 
).()6() | 
1.021 | 
) 020 | 
).015 | 
) 025 | 
1.033 | 
).()63 | 
0.048 
).031,()()68| 
).()55, 0.095] 
).061, 0.100] 
).046, 0 083] 
).048, 0.082] 
).()49, 0.076] 
) 013, 0.029] 
).012, 0.028] 
).0()9, 0.022] 
1.016, 0.034] 
1.021,0 044] 
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Figure 1. Standardised prevalence assuming participation in the hearing screening at age 9, 
10, 11 and 12 months of age and assuming equal numbers of births in each month 
Prevalence 
-·—Standardised prevalence 
— Overall prevalence 
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s V ovvv 
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W e also studied the loss to follow-up in a subsample of 6,337 infants b o m in 1996: 966 
(15.2 %) out of the 6,337 infants were lost to follow-up. Inspection of the medical files 
revealed that 80 of them had been treated by an otorhinolaryngologist. Nine of them would 
have been excluded from the study anyway, because of exclusion criteria such as Down's 
syndrome, sensorineural hearing loss, etc. Thus 71 (1.1% of the 6,337 in the subsample) 
remained, of whom 42 had been treated for O M E , 23 (0.4%) with ventilation tubes and 19 
(0.3%) with adenoidectomy. When these children were included in the overall prevalence, 
the unadjusted prevalence increased by about 0.5%, from 2.2% to 2.7%. 
Discussion 
In this study the unadjusted prevalences for persistent O M E and for persistent bilateral O M E 
were 2.5% [95% CI 2.3, 2.7] and 2.2% [95% CI 2.0, 2.4] respectively. After standardisation 
for attending the hearing screening tests at age 9, 10, 11 and 12 months, assuming equal 
numbers of births in each month and assuming that all the children followed the protocol, 
the prevalence of bilateral O M E was 4.8%. It is difficult to compare the results of this study 
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to those of other studies, because of differences in case-finding methods, prevalence windows 
and population characteristics. In most of the other cohort studies, the children were 
followed-up for one or more years, whereas in our study, only the children who failed the 
three screening tests were followed-up. We calculated the standardised prevalence using the 
best logistic model for each screening session. In most other studies prevalences were 
calculated by including all children who were diagnosed once with O M E in the numerator 
and the original cohort in the denumerator.11,27 n""14"The point-prevalences of these other 
studies are therefore much higher than our calculated prevalences. Moreover, the children 
in the other studies were mostly older. 
An exception is the study by Alho et al. ' ", who found a prevalence of 4.4% for chronic 
O M E among children up to 24 months of age. In this study of Alho et al. all children were 
followed over a period of 2 years and this original cohort also formed the denumerator, while 
in our study we only followed-up the children who failed the screening tests. In addition, 
Alho et al.11" defined chronic O M E as middle ear effusion with a duration of at least 2 
months, while in our study the infants had middle ear effusion for at least three months. 
The seasonal differences found in our study with the highest rates of O M E during the 
late winter months and lowest rates in the late summer months are in agreement with other 
studies.''" ''7 717413"1 it should be noted that apparently the winter plays a role in the persistence 
of bilateral OME, whereas the summer plays a role in healing it. 
Differences in the frequency of O M E dunng follow-up can be explained by the rate 
of spontaneous recovery, reported to be about 50% within three months and 65-75% within 
6 months.'"1 '31 The children were diagnosed from 11-17 months of age: 107 out of the 143 
children who were diagnosed at 12 months were suffering from bilateral OME, while this 
applied to 125 out of the 189 infants diagnosed at 15 months of age. These rates are slightly 
lower than the added recovery of 15-25% reported in the literature for the second tnmonthly 
penod. 
The differences between the logistic models can be explained by the screening protocol. 
The first and second screening tests were earned out frequently in every village in the Eastern 
part of the Netherlands. The third screening test, however, was only earned out in the larger 
villages and less often than the first and second test. The E N T examination was carried out 
in one of the 13 participating hospitals, which had different waiting lists. 
Moreover, we did not study the whole birth cohort (children bom between 1 January 1996 
and 1 April 1997), but just a one year birth cohort, because we wanted to evaluate seasonal 
variation. 
There are several reasons to believe that the estimated prevalence, even after 
standardisation, is slightly lower than the actual population prevalence of OME. 
Chapter 2 
Firstly, it should be noted that we have no information about the false positive and false 
negative rates of the screening tests. The false positives do not form a problem, because they 
will have been detected in the subsequent screening tests or at an E N T department. The false 
negatives, on the other hand, were not invited for another screening test and will therefore 
not have been detected. 
Secondly, 470 infants never visited an E N T Department for examination after failing the 
third screening test. Assuming that this loss to follow-up was random, then it can be expected 
that 70% of those infants will also have been suffering from O M E . When we include these 
children lost to follow-up in the analysis, the unadjusted prevalence was 2.7%. 
Thirdly, in the substudy on loss to follow-up in part of the study population, 42 out of the 
966 children could be considered otitis prone. Assuming that all those 42 otitis prone children 
would have been detected by screening (instead of via their medical files), the unadjusted 
prevalence would have increased by about 0.5%, to 3.2%. 
In view of these considerations, it might be concluded that the actual prevalence of 
O M E in infants is slightly underestimated. Nevertheless, this study clearly showed that 
persistent O M E is prevalent in very young infants and it has distinct seasonal variation. 
Whether such prevalence warrants active screening depends on the effectiveness of treatment 
with ventilation tubes on the hearing loss, language development, cognitive development and 
the quality of life. These questions are being addressed in ongoing multi-centre trials in 
several parts of the world. 
The method presented in this paper to calculate the probability that a subject will fail 
four successive hearing tests, in which only those were followed who had failed the previous 
test, can easily be applied to other fields. For example, in the Netherlands, in vitro fertilisation 
(IVF) is offered a maximum of 3 times to obtain one live birth. Only couples who fail the 
first IVF attempt are invited to proceed with the second, etc. If we want to estimate the 
probability that a couple will fail 3 successive IVF attempts, and we make optimal use of the 
information at each IVF cycle, the method presented in this paper can be used. The power 
of the method is the opportunity to include different covanables at each cycle. 
Appendix 
The standard error of expression (2) can be derived using Xbeta, (i= 1,2,3,4) the argument of 
the exp-function in the numerator of expression (3) in each of the four models with its 
standard error, which are given by the SAS procedure G E N M O D . Let σ ,, σ „ σ „ σ 4 
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denote the estimates for the standard errors of Xbetas. The standard error of the natural 
logarithm of equation (2) is given by: 
Sfi/(ln(equation 2)) , = 4 σ 
Σ{ ! } 
,=i l + expiXbeta,) 
(4) 
An approximate 95% CI for equation 2 is then given by: exp(ln(equation 2) ± 2xequation 
(4)) 
For example: a child born in 9602 attending the screening tests at age 9, 10, 11, and 12 
months has X b e t a ^ -0.84 (σ ,= 0.072), Xbeta 2= -0.56 (σ 2 = 0.16), Xbeta,= 0.57 (σ , = 
0.31) and Xbeta4 = 0.92 ( σ 4 = 0.38). These values are provided by the G E N M O D 
procedure in SAS. The natural logarithm of the probability of failing the four hearing tests 
is given by: 
[Xbeta, - ln(l + exptXbeta,))] + + |Xbeta 4 - ln(l + exp(Xbeta4))J (5) 
The variance of [Xbeta,-ln(l + exp(Xbeta1))] is approximated by [σ, /(I + cxp( Xbeta , ) ) ] 2 . 
Here we use the well known approximation for the variance of a function /(X) by 
[/"(£(X)) 2 Xvar(X)] · In our case [/"(X) = X - l n ( 1 + e x p ( X ) ) ] and so the derivative is 
[f'(X) = 1/(1 + exp(X))]- If we assume independence of Xbeta,,...,Xbeta4 equation (4) 
follows immediately. The 95% CI for this child is then given by: 
exp(ln(0.()50) ± 1.96x(0.191))=(0.034 - 0.073). 
The overall prevalence is defined as the mean of the sum of the last column of Table 4. The 
standard error of the overall prevalence can be derived using the vanance of each probability 
in the last column of Table 4: 
, previ+ prev2 + prcv3 + .. . + prevp , _ 1 , . . . . . .. 
var [- — ^ J ^X (var^prevj+var (prev2)+ +var(prev l 2)). 
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The standard deviation of the overall prevalence is then given by: 
Std = —x^(var(prev,) + ... var(prevp) . 
The 95% CI for the overall prevalence is then: 
overall prevalence ± ——χ .^(va^prev,) + ... var(prev,
 2 ) . 
As we have already obtained the variance of In (prev,), we can approximate the vanance of 
prev, by exp(2xprev,)xvarfln(prev ])], again using the approximation of the vanance for a 
function. 
Chapter 3 
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simulation of patient allocation based on a trial of ventilation 
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Abstract 
Objective: A basic issue in randomised controlled trials (RCTs) is whether we can safely 
assume comparability between groups at baseline with respect to all potentially important 
prognostic factors. In other words, did randomisation work sufficiently well? In small trials 
balanced allocation procedures are employed, whereas in large-scale trials simple 
randomisation will do. The question is: When should balancing be considered? 
Methods: We performed a simulation study in which we varied the number of categories in 
the prognostic factors and the number of patients. 
Results: Simulation showed that, in all instances, a balancing procedure almost always led to 
perfect or almost perfect balance, while the imbalance with simple randomisation was larger. 
To study the effect of balanced and random allocation on subgroup analyses in our O M E 
trial, we compared the quotient of the width of the confidence intervals {CA). The widest CI 
in random allocation over the 13 hospitals was on average 13% wider than in balanced 
allocation. 
Conclusion: Investigators should always consider balanced allocation, especially in categories 
with a low number of patients and when subgroup analysis over many categories is requested. 
Introduction 
In randomised controlled trials (RCTs) it is important to achieve comparability between 
groups at baseline on each of the prognostic factors. In general, randomisation will do this job 
adequately in large-scale trials, but in a trial with 100-200 patients or less, substantial 
differences can occur at baseline for one of the prognostic factors. If these differences can be 
measured, they can be corrected in the analysis to some degree. However, if the number of 
patients decreases, or the number of prognostic factors as well as the number of categories 
increases, the resulting imbalance could invalidate the trial results. 
For this reason balancing procedures are advocated for small trials. Balanced allocation 
ensures that imbalance in prognostic factors, occurring after randomisation of the first 
patients, is corrected by placing the next patients to the group that will result in the smallest 
imbalance. 
In our study the question was whether children with otitis media with effusion (OME) 
treated with ventilation tubes do better than the children in the watchful waiting group with 
respect to language development, behaviour, and quality of life. This tnal is an example of 
an intermediate situation because it is not obvious whether balanced allocation was needed, 
especially in view of the large number of participating hospitals (N=13), which was one of 
the prognostic factors taken into account. 
Methodology 
To answer this question, we performed a simulation study in which we varied the 
number of categones in the prognostic factors as well as the number of patients. In addition, 
we analysed the effect of both balanced and random allocation, taking into account the 
overall margins of our O M E trial. 
Methods 
Simulation methods 
T o determine what is the effect of the number of categones on balance when a balanced 
allocation method is used, we employed a simulation program with the following 
charactenstics: 
1,000 simulations for each assignment; 
T w o treatment groups; 
Four prognostic factors with a vanable number of categones (4x2, 4x3,...., 4x8); 
Categones within a prognostic factor were divided evenly; and 
η = 50, 100, 200 or 400 patients 
Tiic balanced allocation (variance) method 
If a, and b, are the number of subjects in treatment groups A and Β that belong to the same 
categones as the new patient, then the assignment of patients to groups occurs on the basis 
of the degree of imbalance between the numbers. The degree of imbalance between two 
treatment groups is defined as the sum of the squared differences between the numbers of 
subjects in the case of two treatments' 4 1 ' ^ 
R = ^[(a+l-b, ) 2 -(arb,- l ) 2 J 
If R < 0: assignment to group A; 
If R > 0. assignment to group B; 
If R = 0: randomisation. 
Definition of imbalance 
Several suggestions have been made to define the degree of imbalance. In this paper we 
present a standardised imbalance (SIB), which is defined as: SIBS = [d s/v(nj], where d^  
denotes the difference between the number of treated and untreated children in the first 
category of the fint prognostic factor in the sth (s=l, 2, 3,..., 1,000) simulation at the end of 
enrollment. N
s
 denotes the total number in the first category of the first prognostic factor at 
the end of enrollment and η denotes the total number of individuals who enter the trial. 
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The value of SIB is not defined if n
s
=(); there is perfect balance if d,=0, and almost perfect 
balance if d
s
<3. 
The 5% and 95% percentiles of SIBS and ds for random and balanced allocation quantify the 
differences in imbalance between the two methods: in random allocation the 5% and 95% 
percentiles of SIB^ are calculated as ±1.645, while the 5% and 95% percentiles of d
s
 are 
calculated as ±1.645 ν η,. In balanced allocation the percentiles of the frequency distribution 
are derived from the simulation of the SIB
s
, which gives SIB,% and SIB9,%. 
The Otitis Media trial results 
It was possible to study the effect of the balanced allocation method in the otitis media mal, 
because patient accrual is complete. First, we looked at the largest difference between 
treatment, with ventilation tubes and watchful waiting in one category. Second, we studied 
the differences that could have occurred after simple randomisation, taking into account the 
overall margins. Third, we analysed the effect of both randomisation and balanced allocation 
on subgroup analyses. 
Results 
Standardised imbalances resulting from simple randomisation and from applying the balancing 
method in the simulation, using 1,000 runs for each trial (50, 100, 200 or 400 patients) 
comprising four prognostic factors and 4x2,4x3, . . . , 4 x 8 categones, are shown in Figure 1. 
As more categones were added in the balancing method, the range became wider but 
remained within the range after randomisation. Even when the number of categories was 
fairly large, the balance remained almost perfect (d,<3). In randomisation, on the other hand, 
the imbalance was often very large (d,>4). 
These results were based on equal distribution of the categones over the four prognostic 
factors. We also performed simulations in which the categories were unequally distributed 
over the four prognostic factors. When an excessive number of categones was loaded onto 
one prognostic factor, which resulted in a sharp reduction in the number of patients per 
category for that factor, the imbalance changed. In the case of one prognostic factor with 
eight categories and dichotomous categones in the other three prognostic factors, the 5% and 
95% percentiles of SIB were equal to the 5% and 95% percentiles of the situation with 4 x 8 
categones. 
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FigurelA. The 5% and 95% percentiles of SIB for balancing and randomisation (N — 50) 
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FigurelB. The 5% and 95% percentiles of SIB for balancing and randomisation (N = 100) 
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Figure IC. The 5% and 95% percentiles of SIB for balancing and randomisation (N=200) 
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Figure ID. The 5% and 95% percentiles of SIB for balancing and randomisation (N=400) 
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Table 1. The results of the balanced allocation in the O M E trial and the 10 simulations with simple randomisation taking into 
the overall margins of column 1. 
Prognostic Factors 
Sex- Male 
Female 
Educational level m o t h e r 
Low 
Middle 
«K'< 
Season* Spring 
Summer 
Autumn 
Winter 
Age· 
< 20 months 
> = 20 months 
Hospital A 
Β 
C 
D 
h 
F 
G 
H 
I 
J 
Κ 
L 
M 
M a x i m a l d. 
M a x i m a l SI13 
|T-C| 
O M E m a l 
Τ C 
55 55 
39 39 
25 24 
45 47 
24 23 
20 23 
23 24 
31 28 
20 19 
72 73 
22 21 
11 12 
9 8 
18 18 
4 6 
7 8 
3 5 
9 11 
2 1 
5 3 
1 3 
2 1 
12 8 
11 10 
4 
1 00 
0 
Sim 1 
Τ C 
59 51 
43 35 
31 18 
47 45 
24 23 
17 26 
25 22 
36 23 
24 15 
80 65 
22 21 
10 13 
12 5 
19 17 
5 5 
7 H 
5 3 
11 9 
1 2 
6 2 
1 3 
2 1 
10 10 
13 8 
15 
1.70 
16 
Sim 2 
Τ C 
45 65 
42 36 
30 19 
42 50 
15 32 
22 21 
24 23 
26 33 
15 24 
66 79 
21 22 
14 9 
9 8 
18 18 
6 4 
7 8 
2 6 
9 11 
0 3 
3 5 
2 2 
0 3 
8 12 
9 12 
20 
1 73 
14 
S im 3 
Τ C 
55 55 
40 38 
19 30 
55 37 
21 26 
20 23 
22 25 
30 29 
23 16 
70 75 
25 18 
7 16 
8 9 
18 18 
7 3 
9 6 
5 3 
10 10 
2 1 
4 4 
1 3 
1 2 
9 11 
14 7 
18 
1 88 
2 
Sim 4 
τ C 
59 51 
40 38 
22 27 
52 40 
25 22 
22 21 
29 18 
29 30 
19 20 
76 69 
23 20 
14 9 
10 7 
22 14 
3 7 
4 11 
2 6 
12 8 
2 1 
4 4 
3 1 
2 1 
10 10 
11 10 
12 
1 41 
10 
Sim 5 
Τ C 
50 60 
40 38 
21 28 
44 48 
25 22 
30 13 
15 32 
27 32 
18 21 
72 73 
18 25 
10 13 
6 11 
16 20 
7 3 
6 9 
6 2 
10 10 
1 2 
3 5 
3 1 
3 0 
1(1 10 
9 12 
13 
1.73 
8 
Sim 6 
Τ C 
57 53 
46 32 
26 23 
55 37 
22 25 
24 19 
25 22 
34 25 
20 19 
75 70 
28 15 
10 13 
8 9 
20 16 
5 5 
12 3 
3 5 
9 11 
1 2 
2 6 
2 2 
1 2 
14 6 
16 5 
18 
2 32 
18 
S i m 7 
Τ C 
47 63 
33 45 
18 31 
42 50 
20 27 
20 23 
26 21 
19 40 
15 24 
60 85 
20 23 
13 10 
7 10 
10 26 
5 5 
7 8 
3 5 
7 13 
2 1 
6 2 
0 4 
3 0 
8 12 
9 12 
25 
2 0 
28 
S m i 8 
Τ C 
57 53 
35 43 
26 23 
40 52 
26 21 
16 27 
26 21 
33 26 
17 22 
71 74 
21 22 
9 14 
11 6 
22 14 
3 7 
9 6 
2 6 
13 7 
2 1 
4 4 
1 3 
1 2 
9 11 
6 15 
12 
1 96 
4 
S i m 9 
Τ C 
54 56 
42 36 
22 27 
48 44 
26 21 
18 25 
26 21 
35 24 
17 22 
72 73 
24 19 
12 11 
10 7 
19 17 
3 7 
7 8 
6 2 
10 10 
2 1 
3 5 
1 3 
2 1 
11 9 
10 11 
12 
1 41 
4 
Sun 10 
Τ C 
60 50 
41 37 
27 22 
49 43 
25 22 
24 19 
24 23 
35 24 
18 21 
78 67 
23 20 
11 12 
9 8 
22 14 
3 7 
9 6 
4 4 
14 6 
2 1 
6 2 
1 3 
2 1 
9 11 
9 12 
12 
1 79 
14 
Β 
Chapter 3 
In the otitis media tnal 188 infants were balanced over five prognostic factors, viz. sex 
(two categones), age (two categones), educational level mother (three categones), season 
(four categones) and 'hospital' (13 categones). Table 1 shows the results ofbalanced allocation 
as well as the possible differences after simulating simple randomisation. The largest imbalance 
was found at hospital L with a difference (dj of four patients between the two groups 
(SIB=d s/vn,=4/v 20=0.89). In the simulations (simple randomisation) the differences appear 
to be larger (the largest ds is at least 12) (Table 1) 
If we are interested in the difference of the means of, for example, language 
development within each hospital, a subgroup analysis over the factor hospital has to be 
performed. In such an analysis we compare the quotient of the width of the confidence 
intervals with balanced and random allocation. 
From the random allocations given in Table 1, we know that in 3 of the 10 simulations 
it was not possible to perform a subgroup analysis, because all the children in one hospital 
were allocated to the same treatment arm (zero cells in one or more hospitals) For the other 
seven random allocations, the width of the CI is on average 2% larger than in balanced 
allocation. However, the worst CI in random allocation over the 13 hospitals was on average 
13% (range, 9%-24%) wider than in balanced allocation. 
Discussion 
This simulation study, using four prognostic factors with 4x2 , 4x3 , . . . , 4x8 categories and 
vanous sample sizes, demonstrated that in all instances, a balancing procedure led to perfect 
or almost perfect balance (d,<3) within each group, while with simple randomisation the 
balance was mostly imperfect (di>3) in at least one category When more categories were 
taken into account, the SIB increased slightly, but the balance in simple randomisation 
remained infenor. This finding, which supports the idea that a balancing method leads to less 
imbalance than simple randomisation alone, is consistent with previous studies ui '42141"1', 
In this study, the balance after using a balanced allocation method only seemed to be 
mildly affected by the number of prognostic factors, and it was also less affected by the 
number of categories than simple randomisation. When more categones were included, the 
balance remained perfect or almost perfect It was only when there was an excessive number 
of categones in one prognostic factor and a very small number of patients that SIB could not 
be defined because ns was null This means that if a balanced allocation method is used in 
studies with a small number of patients, the categones will have to be combined in such a 
way that the expected number of patients in each category is sufficient, say five or more. In 
this case no empty cells are expected 
Methodology 
In the actual trial on ventilation tubes in 188 children with OME, all 13 hospitals can 
be taken into account separately and need not be aggregated into hospital clusters, because 
the number of patients per category will be large enough to achieve good balance. With 
random allocation, on the other hand, there is at least one hospital with very unbalanced 
numbers over the two treatment arms. It is even possible that one of the arms in that hospital 
is empty. In these cases investigators would not be able to perform subgroup analyses. 
In the O M E trial 17 parents gave informed consent straight away, but they changed 
their minds after a few days. If new patients entered the trial in the meantime, a large 
imbalance might have arisen. This imbalance only disappears if a sufficient number of new 
patients entered the trial. For balance, however, the number of patients who change their 
minds should be as small as possible. A few days for consideration to allow the parents to 
make up their mind might therefore be advisable. 
Owing to possible imbalance between groups at baseline as well as the wider confidence 
intervals with random allocation, investigators are advised to make an inventory of the 
number of patients expected, the prognostic factors, and the number of categories to decide 
whether balanced allocation has to be considered. Especially when subgroup analysis over 
many categories is requested and the number of patients in a category is not very large, 
balanced allocation will lead to more precise estimates. 
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Summary 
Background: Before analysing the results of a randomised controlled clinical trial in which 200 
children were balanced over 5 prognostic factors, we liked to know what type of analysis 
leads to the best results regarding validity, precision, and simplicity. 
Methods: A simulation study with 1,000 replications of each assignment was performed for 
both relatively large tnals (N=100) and for small trials (N=20). Four options for the design 
and analysis were studied: (1) simple randomisation with simple univariate analysis, (2) simple 
randomisation with multivariate modelling, (3) balanced allocation with simple univariate 
analysis, and (4) balanced allocation with multivariate modelling. 
Results/Conclusion: The simulations show that, in small tnals, valid and precise treatment 
effects could best be realized if both balanced allocation and multivariate analysis were 
perfonned. In larger tnals (N=100), using multivanate analysis, balanced allocation has no 
additional advantage over simple randomisation . 
Introduction 
For small trials with strong prognostic factors, balanced allocation methods have been 
developed to increase comparability at baseline.14' '"'2 '"^  14 'U9 To this end balancing factors 
must be known in advance and measured at the time of allocation. In addition or 
alternatively, adjustment procedures in the analysis phase can be performed, such as 
multivariate regression modelling including the prognostic factors. Neither balancing nor 
multivariate analysis will take care of prognostic factors not explicitly taken into account. 
However, we may expect that when an unknown prognostic factor is strongly correlated 
with a known prognostic factor, the balanced design will give better estimation results. 
Four options for the design and analysis of randomised controlled tnals present 
themselves: 
(1) simple randomisation with simple univariate analysis of the treatment effect; 
(2) simple randomisation with multivariate modelling including the prognostic factors in 
the model; 
(3) balanced allocation with the prognostic factors as balancing factors and simple analysis 
of the treatment effect afterwards; 
(4) balanced allocation with multivariate modelling including the same prognostic factors 
in the model as used in the balancing procedure. 
Which of these options is the best in tenus of validity, precision, and width of the confidence 
interval depends on the distnbution of the prognostic factors, the number of patients, and the 
strength of the prognostic factors. T o quantify the effects of the 4 options on validity, 
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precision, width of the confidence interval, and to test the hypothesis that the treatment effect 
is 0 in relatively large and small trials, we performed a simulation study. 
The idea for the present study arose from a specific trial on treatment effects of 
ventilation tubes in children with otitis media with effusion (OME). This trial was underway 
by the time these analyses were performed. In this trial 200 children were balanced over 5 
prognostic factors: gender (dichotomous), age (dichotomous), season (4 categones), education 
level of mother (3 categones), and hospital (13 categones). 
Before the results of such a tnal can be analysed one likes to know what type of analysis leads 
to the best results regarding validity, precision, and simplicity. 
Methods 
A simulation study, with 1,000 replications for each assignment in relatively large trials 
(N=1()0) or in small trials (N=20) was performed with presumed effects of the covanables 
on the outcome in the range of 1.0-2.0 and two treatments (A and B). 
When y , i—l,2,...,N and j = 1,2,...,S denote the simulated value for the dependent vanable 
of the Γ individual in the/'simulation. The regression equation used to generate the y is 
given by: 
Y1J=a+ß1X1,J+P2X2B+P1X„J+P4X,1J+e1J 
In this equation CC is the intercept, β,ΐΐιε treatment effect, X, = 0 if treatment A and X, 
= 1 if treatment B, ß2 , ßj ,β.,, the regression coefficients of the dichotomous (0, 1) 
covanables X 2 + X 1 l j + X 4 l j . The probability that X 2 = 1, , X., = 1 are ρ,'Λ' 
respectively where ρ-,-ρ
Λ
 are all 0.5 or 0.1. X 4 is an unknown prognostic factor ( O R 
between X , and X 4 = 4), and e is independently generated from a normal distnbution with 
mean = 0 and standard deviation = 1 (for generating the observations see also Appendix I). 
For balanced allocation we used the variance method of Pocock and Simon 1 4 3 in which 
the imbalance is defined as the sum of squared differences over all prognostic factors both in 
the situation that this patient will be allocated to the treatment group and in relation to the 
reference group. A new patient will be allocated to the treatment with the smallest sum of 
squared differences. For example, in our study with five prognostic factors, two treatment 
groups (T=treated and C=control) and 24 categories, the result of balanced allocation after 
60 allocations is: 
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Prognostic Factors 
Gender 
Male 
Female 
Educational level mother 
low 
middle 
high 
Season 
Spring 
Summer 
Autumn 
Winter 
Age 
< 20 months 
>= 20 months 
Hospital 
A 
Β 
C 
D 
E 
F 
G 
H 
I 
J 
Κ 
L 
M 
Τ 
19 
11 
9 
10 
11 
2 
12 
16 
0 
26 
4 
Ü 
2 
6 
3 
2 
2 
6 
0 
2 
2 
1 
2 
2 
C 
18 
12 
11 
11 
8 
3 
12 
15 
0 
27 
3 
2 
2 
6 
1 
1 
2 
6 
1 
2 
1 
ü 
4 
2 
Suppose, the next patient (number 61) is a young male, with a highly educated mother, 
diagnosed in hospital A in the summer. If this patients enters the treatment group, the total 
imbalance would be 22+42+l2+02+l2= 22, as opposed to 02+22+l2+22+32=18 if untreated. 
Therefore, allocation of this patient to the control group would give best balance. 
The simulation program calculated mean ( $ , ) as a measure of validity, Std( β] ) as a measure 
of precision, and mean[(7| ] as a measure of width of confidence intervals (see also Appendix 
II). 
Methodology 
Table 1. Results of 1000 simulations with Y = Ο.Ο+Ο.δΧ, + Ι.ΟΧ,+ 1.5X3+2.0X4+6, and 
OR=4. 
R A N D O M I S A T I O N 
T-test 
Multiple regression: 
B A L A N C I N G 
T-tcst 
Multiple regression 
X,, 
x„ 
X„ 
X,, 
X,, 
X | 1 
R A N D O M I S A T I O N 
T-test 
Multiple regression: 
B A L A N C I N G 
T-test 
Multiple regression 
X l ' 
Xp 
X| , 
X | , 
X | , 
x
n 
R A N D O M I S A T I O N 
T-test 
Multiple regression 
B A L A N C I N G 
T-test 
Multiple regression 
x,, 
X| , 
X,, 
X l i 
t i . 
X | , 
Χτ. X J 
x. 
, X, 
X2. Χι 
Xl 
X, 
X2. X ! 
x2 
X, 
x , , Xj 
x 2 
. X, 
. X 2 , Xj 
, x. 
X, 
, Xi . Xj 
, Xl 
. Xl 
Ν 
100 
100 
100 
100 
100 
100 
100 
100 
20 
20 
20 
20 
20 
20 
20 
20 
100 
100 
100 
100 
100 
100 
100 
100 
p2-p4 
0 5 
0 5 
0 5 
0 5 
0 5 
0 5 
0 5 
0 5 
0 5 
0 5 
0.5 
0.5 
0 5 
0.5 
0.5 
0.5 
0.1 
0 1 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
mean ( f t ) 
0 5041 
0 4976 
0 4948 
0 5070 
0 4999 
0.4994 
0 4995 
0 4997 
0 5356 
0.5176 
0 5269 
0 5292 
0 4909 
0 5004 
0.4870 
0.5031 
0 4985 
0 5012 
0 4993 
0 5009 
0 5045 
0.5056 
0.5047 
0 5054 
Std(Â) 
0.3756 
0 2803 
0 3651 
0 2975 
0.2783 
0.2758 
0.2785 
0.2758 
0.8628 
0.6868 
0.8630 
0.6933 
0.6320 
0 6104 
0.6357 
0.6128 
0 2693 
0.2353 
0.2627 
0.2414 
0.2388 
0.2355 
0.2378 
0.2361 
meanlCT!) 
0 3648 
0 2784 
0 3531 
0 2944 
0 3638 
0.2740 
0 3502 
0 2915 
0 8293 
0 6688 
0 8226 
0.6874 
0 8170 
0 6167 
0 7909 
0 6520 
0 2658 
0 2356 
0.2603 
0 2418 
0 2647 
0 2321 
0 2580 
0.2394 
power ( ßi 
28 4 
42 4 
29 4 
39 4 
21.1 
43 4 
23.5 
39 4 
8 7 
10 5 
8 6 
10.0 
3 1 
10.1 
4 0 
8 9 
45 4 
56 2 
47.6 
53 1 
47 3 
58 2 
49 0 
55 3 
=0) 
R A N D O M I S A T I O N 
T-test 
Multiple regression' x,, x2, x, 
B A L A N C I N G 
T-test 
Multiple regression* 
20 
20 
20 
20 
20 
20 
20 
20 
0 1 
0 1 
0 1 
0.1 
0.1 
0 1 
0 1 
0 1 
0 5177 
0 5155 
0 5141 
0 5169 
0.4926 
0 4826 
0 4872 
0.4871 
0 5977 
0 5442 
0.5977 
0.5494 
0 5774 
0 5435 
0 5716 
0 5488 
0.5940 
0 5450 
0 5946 
0 5462 
0 5783 
0 5179 
0.5728 
0.5248 
119 
144 
12 0 
14 1 
11.6 
15 1 
12.2 
148 
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Results 
N o difference in validity and precision between the four options can be found if the 
prognostic factors are not prognostic. If ß^O.O the power (β,^Ό or β ^ Ο ) is 5%. 
Table 1 shows the results of the simulations in the situation that the prognostic factors are 
prognostic ( β ^ Ο . 5 , β 2 = 1 , β 1 = 1·5 and β^=2). For relatively large trials (N=100) simple 
randomisation with multivariate modelling and balanced allocation with simple analysis 
afterwards show the same validity and precision for the estimated treatment effect; however 
the mean (O) is smaller in the case of simple randomisation with multivariate modelling 
which means that the confidence intervals are more narrow. N o differences in validity and 
precision can be found if balanced allocation with multivariate analysis afterwards is compared 
with randomisation with multivariate analysis. 
In small trials (N=20) the treatment effect is estimated most precisely and the mean [O] 
is smaller in the case of balanced allocation with multivariate analyses. 
T-test and regression analyses are valid both in the randomised allocation scheme and in the 
balancing design (see Table 1 ). There are relatively large differences in the precision of the 
T-test and regression analyses (with Χ,-Χ,) for the JV=20, Ν=100 and p-,-p4=0.5 or 0.1 in 
designs with randomised allocation. There is only a very small difference in precision between 
the T-test and the regression analysis in the balanced design. For estimating of the treatment 
effect in a balanced design the T-test is quite satisfactory (see Figures 1 and 2). The T-test as 
well as the regression analysis are more precise in the balanced design compared with the 
random design, especially the N=2() designs with p^-p4=0.5. 
When it conies to constructing confidence intervals and hypothesis testing, the T-test 
in the balanced design gives poor results. The confidence intervals are much too wide, 
resulting in a low power compared with the T-test in a randomised design. 
If the O R between X,and X4is 20, the treatment effect is estimated more precisely in designs 
with regression analysis, especially when N = 2 0 . In randomised and balanced allocation Std 
(/?,) decreased respectively to 0.6291 and0.5644, and mean [σ,] decreased to 0.6132 and 
0.5649 when N=2() and p2-pA = 0.5, see also Table 2. 
If the O R between Xjand X4is 1 (Table 3), the T-test in the randomised design gives a more 
precise treatment effect (Std(^31)=().7927) as well as a narrower confidence interval (mean 
[σ, ] = 0.7607) when N=2() and p^-p^ = 0.5. In the balanced design Std(j31) shows no 
difference as compared with a design with O R = 4 . However, mean [σ,] becomes 
Methodology 
Figure 1. Randomisation with 10000 simulations, N=20 and generated from 
Y = 0.0+0.5X, + 1.0X2+l.5X,+2.0X4+e, OR X,and Χ,= 4 
-5 
Τ ' I ' I ' I • I • Γ 
- 2 - 1 0 1 2 3 
Estimates for ft 
Regression analysis: Υ=α+β 1Χ 1 + β2Χ2+β3Χ3+β4Χ4+£ 
T-test: Υ=α+β 1Χ 1+β 2Χ 2+β 1Χ 3+β^Χ 4+€ 
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Figure 2. Balanced allocation with 10000 simulations, N—20 and generated from 
Y = Ο.Ο+Ο.δΧ, + Ι.ΟΧ,+ Ι.δΧ,Η^.ΟΧ,+ε O R X ^ a n d X ^ 4 
τ
-
- 5 
- Γ
-
- 4 - 3 - 2 - 1 0 1 2 
Estimates for β ι 
Regression analysis: Y=a+ß1X ] + ß2X2+ß3X3+ß4X4+e 
T-test: Y=a+ß1X,+ß2X2+ß3X,+ß,X4+e 
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Table 2. Results of 1000 simulations with Y = 0.0+0.5X1 + 1.0X2+1.5X3+2.0X4+6, and 
OR=20. 
R A N D O M I S A T I O N 
T-test 
Multiple regression x,, 
X„ 
X | . 
B A L A N C I N G 
T-test 
Multiple regression: x,, 
X,, 
X 2 , X , 
" 2 
X, 
Xit X\ 
x. 
Ν 
100 
100 
100 
100 
100 
100 
100 
p2-p4 
0 5 
0 5 
0 5 
0 5 
0 5 
0.5 
0.5 
m e a n ( f t ) 
0.5057 
0 5004 
0 4974 
0.5090 
0.5021 
0.5016 
0.5017 
Std(Â) 
0.3999 
0 2578 
0 3190 
0 2762 
0 2595 
0.2564 
0.2599 
mean [ σ ! ] 
0.3886 
0 2554 
0 3779 
0 2732 
0 3878 
0 2513 
0 3750 
power ( ft = 
25.2 
49 2 
26 1 
44 5 
15 9 
49 8 
18 1 
= 0) 
•
 χ
ι 100 0.5 0.5019 0 2563 0 2705 43 7 
RANDOMISATION 
T-test 
Multiple regression- x,. 
X| . 
X,. 
B A L A N C I N G 
T-test 
Multiple regression, x, 
X,. 
. X-» Xi 
. X2 
. " ι 
ι Χι, Xi 
, x. 
20 
20 
20 
20 
20 
20 
20 
0 5 
0 5 
0 5 
0.5 
0.5 
0.5 
0.5 
0 5344 
0 5173 
0 5275 
0 5280 
0.4991 
0 5089 
0.4941 
0 9271 
0 6291 
0 9287 
0 6440 
0 6009 
0 5644 
0.6038 
0 8856 
0 6132 
0 8814 
0 6384 
0 8758 
0 5650 
0 8512 
9 0 
12 6 
8 8 
11 8 
2 3 
13.4 
2.7 
20 0.5 0.5126 0 5703 0 6055 10 1 
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Table3. Results of 1000 simulations with Y = 0.0+0.5X1 + 1.0X2+l.5X,+2.()X4+e, and O R = l . 
Ν p2-p4 mean(ft) Stcl(j9i) mean[<Ji] power ( ft = 0) 
RANDOMISATION 
T-test 
Multiple regression. 
B A L A N C I N G 
T-test 
Multiple regression 
X , 
X , 
X l 
x. 
" l 
X l 
. Χι. Xi 
• ^2 
, x^  
, X,, \ , 
. Xi 
. Xl 
100 
100 
100 
100 
100 
100 
100 
100 
0=5 
0 5 
0 5 
0 5 
0 5 
0 5 
0 5 
0 5 
0 5007 
0 4932 
0 4911 
0 5029 
0 5031 
0 5025 
0 5027 
0 5029 
0 3456 
0 2881 
0 3317 
0 3061 
0 2909 
0 2895 
0.2910 
0.2895 
0 3365 
0 2871 
0.3233 
0 3026 
0 3353 
0 2825 
0 3203 
0 2996 
32.5 
39 5 
33.0 
38.3 
29.7 
42.3 
32 8 
37 8 
RANDOMISATION 
T-test 
Multiple regression 
B A L A N C I N G 
T-test 
Multiple regression-
X , , 
X p 
X , , 
x,, 
X , , 
X l 
Χι. Xi 
X , 
X , 
Χι, Xi 
X l 
I. X l 
20 
20 
20 
20 
20 
20 
20 
20 
0 5 
0 5 
0 5 
0 5 
0 5 
0 5 
0 5 
0 5 
0.5129 
0 4941 
0 5032 
0 5064 
0 5003 
0 5071 
0 4969 
0 5094 
0 7972 
0 6937 
0 7791 
0 7146 
0 6554 
0 6468 
0 6575 
0 6479 
0 7607 
0 6869 
0 7484 
0 7039 
0 7462 
0 6313 
07152 
0 6668 
8 8 
10 1 
9 6 
9 5 
6 9 
12 9 
8 0 
10 2 
smaller (mean [σ,] = 0.7462). O n the other hand, regression analysis shows hardly any 
differences as compared with the designs with O R = 4 . 
Discussion 
This simulation study demonstrated that in small tnals (N=20) the combination of balanced 
allocation and multivariate modelling leads to the most precise and valid treatment effects. In 
larger tnals the advantages of balanced allocation disappear and do not at all outweigh the 
disadvantages of a more labourious allocation procedure. Therefore, balanced allocation is only 
recommended in small randomised controlled trials, but additional multivariate analysis is 
necessary. However, the results of the T-test and regression analysis are only valid in 
homoschedastic linear models. In other important nonlinear regression models treatment 
effects may be biased if one fails to adjust on prognostic variables.13" H 1 
Methodology 
If an investigator can also control Χ,-Χμΐ is attractive to fix X,-X4 (include for example 
only men) for precision and power results in estimating the treatment effect, which can be seen 
from ρ-,-ρι =0.1 , and to perform a T-test for two independent groups. 
Does this mean that we balanced unnecessanly in our O M E mal? Indeed, this would be 
the case if we had to deal with dichotomous prognostic factors. However, in addition to the 
validity and precision of the main effect, the balance of prognostic factors over the treatment 
groups may also be important. In this specific tnal we deal with 13 hospitals, so to be sure that 
we will be able to do sub-analyses in these hospitals a balanced allocation still is preferable. 
In addition, the simulations showed that even in large trials with balanced allocation 
multivariate analysis does improve the quality of constructed confidence intervals. 
APPENDIX I 
Generating the observations 
When the allocation is randomised, X, is generated from a binomial distnbution with success 
probability 0.5 and N = l denoted by Bin(l, 0.5). The generated value of X, is either 0 (no 
treatment) or 1 (treatment). When the allocation is balanced, the first 10 generated values in 
the j * simulation for X, are from Bin(l, 0.5) and the next values for X, are generated 
according to the balanced design. X, is generated from Bin(l,/)-,), wi thp, = 0.5 or p., = 0.1. 
X, and X 4 are simultaneously generated from a multinomial distribution with probability 
p(l(l for the outcome X3 =0 and X 4 =0, pm for the outcome Χ,,,
=0 and X 4 = 1 , pw for the 
outcome Χ , , ^ Ι andX 4 =0, andp,, for the outcome Χ , , ^ Ι andX 4 = 1 . These probabilities 
satisfy the equations: 
Poil + P()l+Plll + Pll = 1 
0 < Po(i < l . 0<p„ 1 <1, 0 < p 1 0 < l and 0 < p l l < l 
T U j j Ψ
 =
P]\xPm _ 
The odds ratio T34^ 4 
Pm XPH) 
The marginal probability that Χ , , ^ Ι is p, = Pm+Pn = 0.5 or 0.1. 
The marginal probability that X 4 l ,
=
 l is p 4 = p 1 0 + p n
 =
 0.5 or 0.1. 
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APPENDIX II 
Analysing the observations 
After the Ν observations in the/ 1 ' simulation are generated a standard regression method is 
applied with covanable X, (treatment yes/no only) as independent vanable and Vas dependent 
vanable. This is equivalent to a T-test for two independent groups. Next a standard regression 
method (least squares) is applied with the covanables Χ,-Χ, as independent vanables and Yas 
dependent variable. X4 is not used in the analysis and can be seen as an unknown factor 
strongly correlated with the known factor X
v
 We expect that when there is an unknown 
factor strongly correlated with a known factor a balanced design will be more advantageous 
than a randomised design The analyses are performed with the R E G procedure of the 
statistical package SAS 
Letj=1,2,.... ,S denote the estimate for the regression coefficient for the Ν observations in the 
/ h simulation for X, can be seen as the estimated treatment effect in the fh simulation 
The validity of the analysis procedure is measured by: 
m e a n l Â ] = [ l Â j / S 
The procedure is more valid (unbiased) the closer this value is to 0.5. Increasing S will give 
a more reliable estimate of the validity 
The precision of the analysis is measured by the standard deviation in the Pij's and is given 
by: 
J103, r"'ca"\ßy-
std(Â) = i^—Ti 
The smaller Std(^1), the closer β,, is to jS, on average. 
Let â{ rj = 1,2, ,S denote the standard error of /Î , , . The standard error of /?,, is provided 
from the R E G procedure. A two-sided 95% CI for ftbased on the Ν observation in t h e / ' 
simulation can be constructed as follows. 
Methodology 
β
ί |±ι97,/(Λτ-2)χσ1 /, where ι.η3/ (Λ' -2) is the 97.5% percentile of a student t-distnbution with 
ΛΓ-2 degrees of freedom. 
The width of the confidence interval is proportional to σ,
 ; . As a measure for precision in 
constructing confidence intervals we use the mean of σ,
 ; : 
meanfà,] = [Σσ, J/S 
7 = 1 
The smaller mean f σ,], the narrower (on average) the CI's are. 
The hypothesis H0: βί =0 is accepted if OejS, /±r,)75r(N-2)W l ) , rejected in favour of the 
alternative β
ι
 >0 ι(0<β
ί ;-ί ι )75/,(Ν-2)χσ1 / ,and rejected in favour of the alternative /J, < 0 if 
0>Ρι/'"ί>)75κ(Ν—2^01,,. The power when β^Ο is given by the number of times the 
hypothesis H(l: β^Ο is rejected in favour of the alternative β,Χλ 
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Abstract 
Objective: To study the similarities and differences between the non-automated labour-
intensive Ewing hearing test and the less labour-intensive automated CAP AS (Compact 
Amsterdam Paedo Audiometncal Screening) hearing test. 
Setting: A multi-centre study in which all the children bom in the Eastern part of the 
Netherlands between 1 January 1996 and 1 April 1997 were routinely screened for heanng 
impairment at nine months of age. 
Methods: Differences and similarities between the two methods were descnbed in terms of the 
proportion of children who failed every test, the percentage of referred children, the yield of 
bilateral and unilateral Otitis Media with Effusion, the positive predictive value of the third 
test result and the yield of persistent O M E after 4-6 months' follow-up at an E N T -
department. Results: 12603 infants were screened with the CAPAS test and 17496 infants with 
the Ewing test. There were differences between the CAPAS test and the Ewing test, 
respectively in the proportions of children lost to follow-up (10.1% vs. 15.2%), the proportions 
of referrals diagnosed with O M E (59% vs. 81%), the yield of bilateral Otitis Media with 
Effusion (2.4% vs. 3.0%) and the yield of persistent O M E after 4-6 months' follow-up (1.1% 
vs. 1.6%). 
Conclusions: The CAPAS test is more practical than the Ewing test, but the non-automated 
Ewing test appears to be more reliable and valid for detecting conductive hearing loss. 
Introduction 
Since 1964, screening for hearing loss in infants has formed part of routine care, because 
deafness in the early years of life can hinder the development of communication.23 2A :i'38 '26 To 
identify affected children in the Netherlands at the earliest possible stage the Dutch Foundation 
for the Deaf and Heanng Impaired Child introduced the Ewing distraction test for the 
screening of heanng in 1965. 
The aim of this screening test is to detect three groups of affected children : (a) children 
with sensorineural hearing loss, (b) children with persistent conductive hearing loss of which 
Otitis Media with Effusion (OME) is the best known and (c) children with both sensonneural 
and conductive (mixed) heanng loss. However, the test cannot differentiate between a 
conductive and sensonneural heanng loss. 
Nowadays, more than 90% of the infants bom in the Netherlands are screened when 
they are mne months old. ^ Children who fail this heanng test are rescreened at one monthly 
intervals. Those who fail three times in succession are normally referred to a GP for further 
evaluation and potential referral to an otolaryngologist or an audiology centre. 
Methodology 
Over the last ten years the emphasis in screening programmes for permanent hearing 
inipairment has switched to the neonatal period in several countnes 1 , and in this context the 
auditory brainstem response and the transient evoked otoacoustic emission have been used 
successfully ^ . Both methods are based upon a response to wide-band clicks presented in the 
ear. This neonatal screenings often replaces the heanng screening programmes in the latter part 
of the first year. It is, however, uncertain what such screening, or any case finding method, 
would contribute to the detection of conductive heanng losses (OME). Secondary prevention 
of auditory/linguistic disability has become the chiefjustification for early surgical intervention 
in O M E the last two decades1'1, but a recent trial showed only a modest effect on language 
development^8. Timing and accuracy of screens will affect the difference between the natural 
and the screened/treated disease coune, therefore both these parameters are of importance to 
the strategy for otological treatment. This raises questions about the efficiency of screens, the 
seventy of the disease and the numbers affected. 
The effectiveness of any screening test depends on the nature of the disorder, the 
screening procedure and the possibility of eventual treatment.'"'''H7 To justify screening as a 
policy the screening procedure must be practical, reliable, valid and reasonably low in cost. 
Moreover, if a disorder is detected, the treatment must be efficacious, available, accessible, and 
early treatment must be more effective than later treatment. 
At present two heanng screening tests are being used in the Netherlands, namely the Ewing 
test and the Compact Amsterdam Paedo Audiometncal Screening (CAPAS) test. The 
technique of these tests is based on expected responses: between 9-13 months the infant will 
be able to localise sounds directly, l5', The Ewing test is fairly labour-intensive: it has to be 
carried out by two persons and the outcome of the measurements wntten on an administration 
form, for processing by a central computer. Moreover, the auditory stimuli are generated 
manually. 
To enhance efficiency and objectivity a new method has been developed, called the 
CAPAS test. The principles of the CAPAS test are the same as those of the Ewing test; but the 
new CAPAS test can be carried out by one person, the data can be stored immediately on a 
computer, and the auditory stimuli are presented digitally. 
This study aimed at comparing the performance of these two screening procedures in 
a field setting. We chose as measures of performance to be compared: (a) the proportion of 
children lost to follow-up; (b) the proportion of children who failed every test; (c) nominal 
OME prevalence; (d) the positive predictive value of the screen and (e) the prevalence of 
persistent cases of O M E among those found after 4-6 months' follow-up at an E N T 
department. 
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Methods 
The hearing tests 
The Ewing hearing screening test is carried out by two persons: an observer, who focuses the 
attention of the childjust before presentation, and a tester who presents the vanous sounds. 
The test has to be performed in a quiet environment in which the parent sits on a chair with 
the child on his/her lap Both the parent and the child have to look in the observer's direction, 
while the tester produces the auditory stimuli behind the parent and child, on the right and 
the left, exactly at one meter distance and at an angle of 45 degrees. The sounds presented are 
a music-box, a rattle, hitting a porcelain cup, banging a metal spoon and a voice or a song 
The frequency of the sounds are between 250 and 8000 Hz, and the intensity of the sound is 
about 35 dB SFL Each sound is presented for 5 seconds, and while the sounds are being 
presented, the observer stops actively drawing the child's attention. If a child does not react 
to one of the sounds, the sound is presented again in another standardised way The total test 
takes about 5 minutes. The test result is adequate if the child reacts correctly to all four sounds 
on the left and right "'" 
If the child fails the screening test, he/she is rescreened one month later. If the child also 
fails this second test, he/she is recalled for a more comprehensive third screening test. Dunng 
this third test the sounds are also presented louder if a child does not react to 35 dB. The aim 
of this is to get an idea about the level of the hearing loss. However, the child will be referred 
if there is no response to sounds at 35 dB. 
In contrast with the Ewing test, the auditory stimuli in the CAPAS test comprise 
digitised natural sounds. The speech frequency spectrum lies between 500 and 6000 Hz and 
the sound level is about 35 dB. Moreover, a computer automatically records the test results."'1 
Study population 
The study population comprised all the infants bom in seven health care regions in the Eastern 
part of the Netherlands between 1 January 1996 and 1 April 1997, who were screened for 
hearing impairment at nine months of age. Children who failed the screen were referred to 
one of the 13 participating ENT outpatient clinics for tympanometry and otoscopy 
In four of the seven regions, 17,496 children were screened with the Ewing screen, while in 
the other three regions the CAPAS screen was used for 12,603 children. 
Evaluation cntcna 
Differences and simdanties between the two screens were evaluated in tenns of the proportion 
of children lost to follow-up, the proportion of children who failed every screening test, the 
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proportion of referred children diagnosed with O M E , the prevalence of bilateral and unilateral 
otitis media with effusion and the positive predictive value of the third screening 
The proportion of infants lost to follow-up was determined by counting (a) the number 
of children who never participate in the screening programme (also called the non-attendance 
rate); (b) the number of children who failed one test but did not return for the next test; and 
(c) the number of children who failed three times in succession but did not visit an E N T 
department for diagnosis. 
The proportion of children who failed every test was computed as the ratio between the 
number of children who failed the test and the total number of children tested. 
The proportion of children referred was calculated as the number of children who failed the 
screen divided by all the children who participated in the first screening test 
The yield of O M E was calculated by dividing the number of children diagnosed with bilateral 
O M E by the total number of children who participated in the first test. 
The positive predictive value of the third test was calculated as the number of children 
diagnosed with bilateral O M E as a proportion of the total number of children who were 
diagnosed at an E N T department. 
The yield of persistent O M E (that is O M E dunng the 4-6 months' follow-up at an E N T 
department) was calculated by dividing the number of children with bilateral O M E at three 
of the four E N T visits by the number of children who participated in the first test 
To diagnose OME, the otorhinolaryngologists used the classification algorithm descnbed 
by Cantekin"'2 and the M O M E S study"' , and summansed in Figure 1. In this algorithm, 
OME is indicated by a type Β tympanogram or a type C2 tympanogram Where 
tympanometry was not possible, O M E had to be diagnosed by otoscopy 
In addition, a list was made of all the children in the study population diagnosed with 
sensorineural hearing loss at the six audiology centres in the Eastern part of the Netherlands. 
These data were used to estimate the detection rates of sensorineural hearing loss using the 
Ewing screen and the CAPAS screen. 
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Figure 1. Algorithm used to diagnose O M E 
Type i 
ι ympaiiometry 
Type C2, or not measured 
Glue 
Otitis Media with Effusion 
OtOicopy 
Not clear 
Doubt 
Type A, C I 
N o glue 
N o Otitis Media 
Type A' compliance >— 0 2 ml, pressure > -100 daPa 
Type Β compliance < 0 2 ml, pressure < 200 daPa 
Type CI compliance > = 0 2 ml, -100 daPa < = pressure< -200 daPa 
Type C.2 compliance > = 0 2 ml, pressure < = -200 daPa 
Results 
Figure 2 shows the breakdown for the C APAS screen; 12603 children were bom between 1 
January 1996 and 1 Apnl 1997; 721 (5.7%) of them did not respond to the invitation for 
screening; 3812 out ofthe 11882 (32.1%) infants failed the first test; 1301 (36.6%) out ofthe 
3552 subsequent participants failed the second test; and 591 (53.6%) out ofthe 1102 children 
who participated in the third test failed. 
Figure 3 shows the breakdown for the Ewing screen ; 17496 children were bom between 
1 January 1996 and 1 April 1997; 1736 (9.9%) of them did not respond to the invitation for 
screening; 4662 (29.6%) out ofthe 15760 infants failed the first test; 1665 (39.7%) out ofthe 
4197 subsequent participating infants failed the second test; and 774 (55.4%) out ofthe 1397 
children who participated in the third test failed. 
Tables 1 and 2 show the differences and similarities between the CAPAS and Ewing 
screens. Differences were found in: (a) the attendance rate (94% vs. 90%); (b) the proportions 
of children lost to follow-up (10.1% vs. 15.2%); (c) the proportion of referrals diagnosed with 
O M E (59% vs. 81%); (d) the positive predictive value (58% vs. 80%); (e) the yield ofbilateral 
O M E (2.4% vs. 3.0%); (f) the yield of persistent O M E after 4-6 months' follow-up at an E N T 
department (1.1% vs. 1.6%). 
Methodology 
The proportion of children diagnosed with bilateral O M E vaned from 53% to 93% 
between 13 hospitals. At the hospitals in which the 'CARAS patients' were diagnosed, the 
percentage vaned from 53% to 74%. At the Ewing hospitals, this percentage vaned from 73% 
to 93%. 
Table 1. Differences and similarities between the CAPAS test and the Ewing test 
Parameter 
Attendance rate 
Loss to follow-up 
Referrals 
Predictive value 
Yield of OME 
Yield of persistent OME 
CAPAS/Ewing 
CAPAS 
Ewing 
CAPAS 
Ewing 
CAPAS 
Ewing 
CAPAS 
Ewing 
CAPAS 
Ewing 
CAPAS 
Ewing 
Proportion 
11882/12603 = 94% 
15760/17496 = 90% 
1274/12603= 10.1% 
2657/17496= 15.2%, 
591/11882= 5 0%, 
774/15760 = 4.9% 
289/497 = 58% 
466/586 = 80% 
289/11882 = 2 4% 
466/15760 = 3 0% 
134/11882 = 1.1% 
251/15760= 1 6% 
95%, CI 
94 -
90 -
9 .6 -
147 
4 6 -
4 . 6 -
54 -
76 -
2 2 -
2 . 7 -
1.0-
1 4 -
95 
91 
106 
- 1 5 7 
5 4 
5.2 
62 
83 
2 7 
3.2 
1.3 
1 7 
Table 2. Diagnoses of the children referred to an E N T department 
Method 
CAPAS 
Ewing 
Number of, 
screened 
11882 
15760 
children Diagnosis 
289 (59%) bilateral OME 
347 (71%) bilateral+umlateral OME 
150 (30%) no OME 
466 (81%) bilateral OME 
499 (86%) bilateral+umlateral OME 
87 (15%) no OME 
Prevalence 
(95% C.I.) 
2 4 (2.2 - 2.7) 
2.9 (2.6 - 3.2) 
3 0 (2.7 - 3.2) 
3.2 (2.9 - 3.4) 
During the study period five children in the Ewing region were diagnosed with sensonneural 
hearing: one child had never been screened, two had been referred for more sensitive testing 
after failing the second screening test, and two had failed three times. One of the infants had 
been referred to an audiology centre immediately after the third test; the other child had been 
referred to a GP, who referred the child to an audiology centre. In the CAPAS region, 9 
children were diagnosed with sensorineural hearing loss: 3 infants had never been screened, 
3 had been referred for more sensitive testing after failing the first test, one had been referred 
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Figure 2. Results of infant heanng screening with the CAP AS test 
12ί)(Π born between 1 January 1996 and 
1 April 1997 
721 non-attendance 
11882 participants in the first screening 
38 Ρ failed 
26(1 lost to lollow-up 
3552 participants in the second screening 
13U1 failed 
199 lost to follow-tip 
1102 participants in the third screening 
591 failed 
94 non-referrals 
497 infants were referred to an E N T Department 
- > 289 had bilateral O M E 
Figure 3. Results of infant heanng screening with the Ewing test 
17496 bom between 1 January 1996 and 
1 April 1997 
173o non-attendance 
15760 participants the first screening 
4662 failed 
465 lost to follow-up 
4197 participants in the second screening 
1665 failed 
26H lost to follow-up 
1397 participants in the third screening 
774 failed 
188 non-referrals 
586 infants were referred to an E N T department 
- > 466 had bilateral O M E 
Methodology 
after failing the second test, and two children had been referred to an E N T department where 
sensorineural hearing loss was suspected. 
Discussion 
The proportion of children lost to follow-up (10.1%) versus 15.2%), and the proportion of 
children diagnosed with persistent bilateral O M E (59% versus 81%) differed between the 
CAPAS and Ewing tests. The apparent differences in the yield of bilateral O M E (CAPAS 
2.4% versus 3.0% Ewing) could in fact be due to this. When the denominator was adjusted 
for loss to follow-up, the yield was 466/17496 = 2.7% and 289/12603 = 2.3% for the Ewing 
test and the CAPAS test, respectively. Another difference was found in the predictive value 
(CAPAS 58% versus Ewing 80%). In contrast with yield this parameter is less sensitive for loss 
to follow-up: only if the tested children are a selective sample will the predictive value be 
influenced. N o differences were found in the proportion of children who failed every 
screening test and in the proportion infants referred to an E N T department for diagnosis. 
There is no epidemiological reason to believe that the very small demographic and 
climatic differences between the regions would lead to differences in prevalence of OME. The 
differences in performance (particularly the differences in predictive values) between the two 
tests were therefore probably due to the procedures themselves. 
A possible explanation for some of the differences in the yield of O M E might be regional 
differences in diagnostic skills or stringency of critena between the different regions or 
otorhinolaryngologists. The proportion of children diagnosed with bilateral OME varied from 
53% to 93% between the 13 hospitals, while the percentages of children diagnosed according 
to the algorithm varied from 89% to 98% between hospitals. However, tympanometry was 
not performed in 38% of all diagnosis (34% and 43% in the Ewing and the CAPAS region, 
respectively). Nine percent more children failed tympanometry in the CAPAS region. If they 
had otherwise been diagnosed with bilateral OME, 331 (instead of 289) children would have 
had bilateral OME. In this case the yield would have been 331/11882 = 2.8%. However, it 
is unlikely that all the extra tympanometry failures were due to differences in true proportions 
having bilateral OME. Differences in diagnosis can therefore also partly explain the differences 
in yield. 
A third possible explanation is that there were differences in the time interval between 
the third screening test and the moment of diagnosis at an E N T department, or in the ages 
of the children (that is, differences in the duration of the total Ewing and CAPAS screening 
programmes). Analysis of the time intervals between the third screening test and the moment 
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of diagnosis, as well as the ages of the infants, did not reveal any differences: 0.7 versus 0.8 
month and 13.8 versus 13.7 months for the Ewing test and the CAPAS test, respectively. 
The question then arises: to what in the test themselves are the differences chiefly due? 
For example, the auditory stimuli differ, the Ewing test is not automated and the auditory 
stimuli of the CAPAS test are known to be a little louder. The latter would result in a lower 
proportion of children who fail the test. The CAPAS screen also uses more frequency specific 
stimuli. 
To analyse the differences between the CAPAS and the Ewmg methods more fully, it 
would be necessary for all the children to undergo E N T evaluation after screening. Then it 
would be possible to calculate the sensitivity and specificity of each test. As in many studies 
of screening, we could only calculate the positive predictive value of the screen, because the 
children who passed the screening were not referred for ENT evaluation. It should also be 
noted that the infants were diagnosed 1 -4 weeks after failing the screening; this assumes that 
children with persistent hearing loss were detected and that they were persistent for that 
penod. This situation also applies to clinical practice, because the moment of diagnosis will 
always be at least 2-4 weeks after referral. 
It should be noted that the detection rate of sensorineural hearing loss, at 0.()4%o, was 
lower than the expected prevalence of 1 per 1000. The Ewing test traced five children with 
sensonneural heanng loss, while the CAPAS test traced 9 children with sensonneural hearing 
loss. The CAPAS test seems to be at least as effective in detecting children with sensorineural 
heanng loss, either because the test method was more sensitive, or because the loss to follow-
up was lower. However, the numbers of cases with a sensorineural heanng loss are too few 
to draw firm conclusions about the methods. 
A screening programme has to be practical, reliable, valid and reasonably low in 
cost.1'6 ' ^ The CAPAS test is more practical than the Ewing test. However, the Ewing test 
appeared to be more reliable and valid for detecting persistent OME, and hence a better tool 
in daily practice. 
As we have not performed a randomised study we cannot claim to have produced 
unbiased estimates of differences in screen vanables. However, it is not likely that differences 
in epidemiology or diagnosis between the two health distnets cancelled a genuine difference 
between the tests. We therefore conclude that so long as these screens remain in place and 
have as one of their aims the early detection of conductive loss, both types of test are 
acceptable options. To prompt a finn policy recommendation in favour of one or other test 
stronger evidence, for example of hann to undetected and untreated cases is required. A 
decision can therefore be made on cost-effectiveness. 
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Abstract 
Not all general hospitals have audiometry test sets and special test rooms that are suitable for 
testing young children. In studies on otitis media with effusion (OME), hearing thresholds are 
important measures. In our multi-centre tnal, we therefore made use of a portable VRA 
(Visual Reinforcement Audiometry) set; measurements took place at the hospitals in relatively 
quiet normal rooms. 
In this paper we describe some details of this set-up, the influence of room acoustics and we 
compare results obtained with the portable and a standard VRA set in a special sound-treated 
test room. 
In most of the test rooms the noise floor for the frequencies 0.5, 1, 2 and 4 kHz was 20 dB 
A or better. After correction for differences in calibration procedures, a systematic difference 
of 1 to 7 dB remained between the portable and the standard VRA, which was ascnbed to 
differences in the sound stimuli used. 
For clinical trials on the effect of surgical treatment for O M E in children the ambulant 
procedure appears to be a good alternative to referring all children to an Audiological Centre. 
Introduction 
In 1996 a multi-centre trial was started on the effect of early screening and treatment with 
ventilation tubes on hearing sensitivity, language development and quality of life in infants 
with Otitis Media with Effusion (OME). In most longitudinal studies on OME in young 
infants, O M E is documented by performing tympanometry. Other studies have shown that 
the relation between tympanometric findings and hearing sensitivity are not straight 
forward.' ' As not the presence of O M E but rather the presence of an O M E associated 
hearing loss has an effect on the child's development, hearing sensitivity should be studied 
instead of or in addition to tympanometry. Performing hearing tests in young children is 
difficult, especially when special equipment and sound treated test rooms are not available. 
The present study comprised measurements in quiet test rooms in 13 hospitals and the 
question therefore is whether it is possible to measure hearing sensitivity reliable with a 
portable VRA set in these quiet rooms, not specially equipped for sound-field measurements. 
In infants older than 7 months, visual reinforcement audiometry or VRA is the first 
option to determine hearing sensitivity.164 "" VRA is a well-validated, reliable diagnostic 
technique based on a child's natural tendency to onent towards a sound source. One major 
advantage of VRA over the more objective auditory brainstem response (ABR), is that 
sedation is not needed and that in contrast with click-evoked ABR, VRA provides frequency-
specific data. 
Methodology 
Generally, young children respond adequately to auditory stimuli. '" However, without 
reinforcement, the child's responses (head turning) may diminish rapidly. With appropnate 
reinforcement (e.g. with a lighted colourful picture) the child's attention can be maintained 
for quite some time. With appropnate reinforcement, habituation does not occur in one-year-
old and two-year-old children until they have turned their heads up 30 and 15 times, 
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respectively. 
VRA measurements are taken in the sound field. However, VRA can be adapted to ear 
specific and bone conducted test-signals for children who accept earphones or the bone 
conduction transducer. In addition, high demands are made on the test room (ambient noise 
level and to a lesser extent room acoustics). Even in low reverberant rooms (e.g. audiometrie 
tests rooms, the critical distance (which is the distance measured from the sound source were 
the direct sounds and reflected sounds arc equally loud) is limited to about 60-80 cm. 6 This 
means that even in most audiometrie test booths, threshold testing in the sound field implies 
testing in the reverberant field. It is even less practical to perform measurements in the direct 
field, because head movements can lead to changes in hearing thresholds. "sl< 
The ISO 8253, part 1 (1989) specifies acceptable noise levels in one third octave wide 
frequency bands for audiometrie sound booths when normal hearing thresholds are measured. 
The overall just acceptable noise level is slightly below 20 dB A. If measured frequency-
specific ambient noise levels are higher than the specified levels, they will have a masking 
effect on hearing thresholds. Thus, for each test room, the noise floor (level of the ambient 
noise as a function of frequency) has to be determined. A noise level of below 20 dB A is not 
easy to achieve; in normal quiet rooms, levels are between 30 and 40 dB A."'9 
Portable VRA test equipment is worthwhile in studies in which the measurements have 
to be performed on different locations where a standard VRA set is not available. For our 
multi-centre trial we therefore used a portable VRA set (no standard VRA set was available 
at most of the participating hospitals). The set was specially assembled for the study and the 
validity and accuracy of measurements with this portable set as compared to the standard VRA 
set have been studied. Validity and accuracy might depend on technical performance, as well 
as on the room acoustics in the different test rooms at the hospitals. In this paper we: 1) 
desenbe some details of this portable VRA set; 2) we describe the room acoustics in the 
different test rooms and their effects on the VRA outcomes and 3) we compare the results 
obtained with the portable set and a standard VRA set used in the same group of OME-prone 
children. 
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Material and methods 
Tlie portable VRA set 
The portable VRA set is shown in Figure 1. The audiometer was software driven (Carnea; 
Audiological Devices Hoensbroek, the Netherlands). The free-field amplifier with 
loudspeakers was copied from the so-called CAFAS test equipment which is a portable test 
set used in the Netherlands to screen hearing in 9-nionth-old children (computerised version 
of the Ewing test ' ). The amplifier and loudspeakers were mounted as one unit with the 
loudspeakers on arms at the height of the child's head, 70 cm to the right and left at + 80 
from the mid-line. This distance was in accordance with the recommendations made by 
Magnusson et al. 
As stimuli, narrow band noise was used with a bandwidth of 1 /3-octave and centre 
frequencies of 0.5,1,2 and 4 kHz. The presentation level was variable between 0 and 70 dB. 
The visual reinforcer comprised a dot matrix display (11 x 11 cm) consisting of 225 red LED 
lights. It was mounted in the same small box as the loudspeakers. This option was chosen 
because of its dimensions. It might be less attractive than a lighted moving object or a video 
picture (as normally used in standard sets). The reinforcer of the portable set used in this study, 
however, could display twelve different figures, for example a clown's face, a train, a moon. 
Figure 1. The portable system 
Methodology 
Measurement procedure 
Standard audiometry testing was used to obtain sound field thresholds from the children 
The child sat on the parent's lap between the loudspeakers. The parent was instructed not to 
react when a sound was presented. Two expencnced examiners were present; one examiner 
attempted to hold the child's attention in the midline using toys, while the other operated the 
equipment Auditory stimuli were presented as soon as the child was quiet and his/her 
attention was directed towards the mid-position Reinforcement was provided when the child 
showed a response, which is not necessarily had to be an accurate orientation A response in 
the shape of an eye-movement or an other outwardly reaction was enough to provide 
reinforcement. 
The starting presentation level was 40 dB; the duration of the sounds was about 3 
seconds. If there was no response, the level was raised to 60 dB. After a good response, the 
level was decreased in steps of 10 and 5 dB, respectively To determine the threshold a child 
had to show at least two obvious responses. In the case of lack of clarity (including the 
possibility that the child's response was due to chance) about the response even more 
responses had to be obtained. Thresholds were measured at 0 5, 1 ,2 and 4 kHz All 
measurements were performed by highly experienced staffmemebers of the Audiological 
Assessment Centre Nijmegen. 
Room acoustics 
For sound field testing a quiet and convenient room was selected at each hospital. The rooms 
chosen vaned from special audiometrie test booths to rooms with no special acoustic 
treatment. 
To quantify room acoustics, the dimensions of each room and the type of covering on 
the walls, ceiling and floor were determined. The critical distance was calculated using this 
information and known sound absorption coefficients for the vanous types of coverings. '' 
Calculations were performed for the frequencies 0.5, 1, 2 and 4 kHz. The overall value was 
taken as the average value. 
Ambient noise 
Ambient noise levels were studied in two ways: First, noise levels were measured with a sound 
level meter. Second, the potential elevation of sound field thresholds was assessed by 
measuring sound field thresholds in normal hearing adult critical listenen. The ambient noise 
level was measured with a Bruel and Kjaer 2121 frequency analyser. The microphone was 
placed in the same position as the children's head during testing. Measurements were taken 
after the portable VRA equipment had been set-up and switched on. Readings were in dB 
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A and the slow reading mode was used Next, hearing thresholds were determined of two 
expenenced listeners who had normal hearing sensitivity. Their sound-field thresholds were 
measured in all the test rooms. Their average sound field threshold as a function of frequency 
was considered as the "noise floor" for sound field threshold testing The hearing thresholds 
of the two listeners were 10 dB HL or better from 125 Hz to 8 kHz. 
Calibration 
For calibration purposes, a microphone, the Bruel and Kjaer 4145, was connected to the 
Bruel and Kjaer 2121 frequency analyser and placed in the same position as the children's 
heads during testing. It was decided not to calibrate the system with known reference values, 
because such values depend on room acoustics l72 m As was suggested by Beynon and 
Munro172, calibration was performed in dB A; this calibration procedure is independent of 
room acoustics Therefore, hearing thresholds are expressed in dB A instead of dB HL It 
should be noted that dB A readings are somewhat higher than dB HL readings at most 
frequencies: in the order of 3 to 5 dB. 
Comparison study 
The results obtained with the portable VRA were compared to those obtained with the 
standard VRA system from our Audiology Assessment department. The latter system 
comprised an AC40 audiometer (Interacoustics, Vaerlose, Denmark) and, as reinforcer, the 
VERA 103 system (Madsen, Copenhagen, Denmark) Calibration of this set-up was 
performed in accordance with Stream and Dirks.171 The reinforcing system comprised 
coloured animated pictures on a video monitor The portable system was always applied first, 
because the reinforcement from the standard VRA system was expected to be more appealing 
to most of the children. 
The same measurement procedure was used dunng testing with the portable and 
standard sets, and all the tests were performed by the same personnel in similar test booths 
(double walled special treated rooms with the same dimensions) In between the two 
measurements was a short break. A random sample of 21 OME-prone children aged between 
25 and 33 months (mean age: 30 months) participated in this companson study. 
Methodology 
Results 
Room acoustics 
Ambient noise levels, the main selection criterion for the test rooms, varied between 22 and 
33 dl3 A, with a mean of 29 dB A. This is about 10 dB higher than the ISO 8253 nomi. The 
calculated critical distance varied between 30 and 80 cm, with an average of 55 cm. In two 
of the test rooms, the critical distance was slightly further than the 70 cm between the child 
and loudspeaker: 75 cm and 80 cm, respectively. Therefore, measurements were performed 
in the reverberant field or in the transition area between the direct field and the reverberant 
field. 
The mean noise floor per test room varied from 8.8 dB A to 19.1 dB A. In Figure 2, 
noise floors are plotted as a function of the ambient noise level. As expected, a one-to-one 
relation was found between the ambient noise level and the average noise floor. Per test room 
and per frequency, the calculated noise floor was re-expressed as the next higher multiple of 
5 dB from the calculated value. In eleven test rooms, the noise floor at all four test frequencies 
was 20 dB A or better. In the remaining two test rooms, there was a 25 dB A noise floor only 
at 1 kHz. 
Figure 2. The noise floor as obtained with threshold measurements in two subjects with 
normal hearing in each of the test rooms as a function the overall ambient noise level 
measured with a sound level meter 
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Companion study 
Twenty-one children (42 ears) were tested twice in audiometrie test rooms at the 
AudiologicaJ Assessment Centre. The children were first tested with the portable set followed 
by the standard VRA set. Thresholds were compared per frequency. To minimise the 
influence of the noise floor, only ears with a hearing threshold of 20 dB HL or worse (as 
determined with the standard VRA) were included. Table 1 shows the results. The thresholds 
obtained with 
Table 1. Difference in thresholds obtained with the standard VRA set minus those obtained 
with the portable set presented as a function of test frequency 
Frequency 
(kHz) 
0 5 
1 
2 
4 
n (ears) 
32 
29 
31 
31 
mean difference 
(dB A) 
-7 5 
-7.4 
-6 1 
-4 4 
correcte 
(dB A) 
-5.5 
-2 4 
-1 1 
-7.4 
d difference SD 
(dB A) 
5.2 
5.3 
4.0 
6.4 
the portable set (in dB A) were systematically poorer than those obtained with the standard 
set (in dB HL). Part of this difference can be ascribed to the different dBs (dB A versus dB 
HL). The difference between the adjusted levels in dB HL (audiometer readings) and 
measured dB A in the audiometrie test booth was -2, -5 , -5 and +3 dB for 0.5, 1, 2 and 4 
kHz, respectively. These figures were used to calculate corrected values, which are also 
presented in Table 1. After correction, a systematic difference of 1 to 7 dB remained with a 
standard deviation of 4 to 6.5 dB. 
Discussion 
We found that if certain precautions are taken, it is feasible to perform sound-field threshold 
measurements adequately at different locations, even in rooms with no special facilities for 
sound- field testing. Ambient noise levels should be low and the frequency-specific noise floor 
must be established accurately. Under these circumstances information on hearing sensitivity 
can be obtained from children, as long as the thresholds are above the noise level. Hearing 
thresholds better than the noise floor (typically 15 dB A) were not detectable. For clinical trials 
on hearing sensitivity in OME-prone children such noise floors are acceptable. Because of 
efficiency, the noise floor was established by testing two expenenced adult listeners instead 
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of a larger number of children. Due to the expenence of the two adults it is assumed that the 
established noise floor is adequate. 
Thresholds obtained with the portable VRA were poorer than those obtained with the 
standard VRA, even after correcting for the different types of dBs used to express the 
threshold values. This is explained by the different stimuli applied: a narrow band noise for 
the portable set and warble tones for the standard VRA. In a well-designed experiment using 
head phones, Orchick and Rintelmann174 found systematically 3 to 5 dB better thresholds 
with warble-tones than with narrow-band noises in the youngest group of children tested (3.5 
years of age). Thus it can be suggested that the difference in thresholds between the two VRA 
sets was mainly caused by technical factors. However, the visual reinforccr (more striking for 
the standard VRA) might have also played a role, by influencing the concentration of the 
children as well as their willingness to co-operate. Insufficient concentration can lead to about 
5 dB poorer thresholds. ^ Due to the more complex reinforccr in the standard set, this set was 
always used after testing with the portable set. This non-random order of testing might have 
biased the results, though the expenenced audiologist, who tested the children, did not notice 
a tiredness or unwillingness to co-operate in these tested children. 
The mean age of the children in the comparison study was 30 months (range 25-33), 
which is over the range of 6-24 months that is considered most appropriate for the 
conditioned head turn response. '' By 30 months, the majority of children are ready for a 
conditional play audiometry. In between 24 and 30 months both techniques are applied. The 
age range of the children in this study seems not optimal. However, in practice the co-
operation of all the children in both tests was assessed as adequate by the testers. 
In the companson study, only ears with hearing thresholds of 20 dB HL or more were 
included to be sure that the noise floor did not play a role. 
Individual differences in thresholds were small (SD 4 to 6 dB, see Table 1) and comparable 
with test-retest sound-field thresholds in adults (SD 3 to 5 dB177). In our study the repeated 
measurements can be seen as a test-retest situation, because the two sets gave comparable 
results and these results appeared to be reliable. This suggests that the reliability of sound-field 
testing in children was comparable with literature values obtained in adults. 
In the Netherlands, hearing sensitivity in infants is chiefly assessed at specialised 
Audiological Centres. Most regular hospitals do not have audiometry sets or test rooms that 
are suitable for testing young children. For a multi-centre trial, the portable VRA proved to 
be a good alternative to referring all the children to the nearest Audiological Centre. It 
decreased the burden for the parents and hence increased the accrual rate. 
Instead of sound-field measurements, VRA testing with insert earphones, which are 
readily accepted by most children, might further improve the reliability of future research. 
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Earphones reduce the effects of ambient noise and room acoustics, but variability is introduced 
by unknown acoustics in individual ears.I78 Thus any advantage regarding reliability remains 
to be demonstrated. 
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Introduction 
Otitis Media with Effusion (OME) can have consequences on early language development, 
cognitive development, behaviour, and on the quality of life. A number of randomised trials 
of surgical treatments for O M E have already been performed and reviewed However, 
heterogeneity in both the populations studied, plus heterogeneity in the outcome 
measurements has made firm overall conclusions by meta analysis impossible. In meta-
analysis, homogeneity of samples, and outcome measurements is required in order to use 
multiple trials as a means of achieving higher precision, but heterogeneity among tnals, 
especially if systematic rather than arbitrary, can also be used for purpose of studying 
generalisation 
Ventilation tubes are shown to be effective in improving hearing levels ", but there 
is no evidence as to whether these improvements work through to influence other outcome 
measurements 9 In current trials, the effect of treatment with ventilation tubes in infants with 
O M E on language development are therefore being studied. One particular area of interest 
is the intervention strategy for children detected early with case finding methods and screens 
more sensitive than those of 20 years ago. ^ Two trials are currently addressing cognitive and 
behaviour outcomes in these young children. 
The randomised controlled trial is the accepted method for comparing treatment effects, 
because in a well designed trial, internal validity is virtually ensured, i.e. any bias in the 
assignment of treatments to included children is specifically ruled out. However, the impact 
of such a trial upon practice depends also on its external validity. This external validity refers 
to whether or not the design and sample permit interpretation and generalization of results 
to practice; from the actual study to the abstract, with no particular reference to type of 
patient, selection path, healthcare system, place, or time. 
Sederberg-Olsen et al181 have recently noted the threat to generalisation in the 
randomised trials of antibiotics in O M E ansing from the low proportion of clinical cases being 
included. We will draw the necessary distinction between reasonable inclusion criteria for 
seventy/persistence and more alarming failures of representativeness. We compare two 
current O M E tnals in which the authors are principal investigators The two have rather 
different characteristics, but illustrate the different ways in which external validity can be 
addressed, including the documentation of background characteristics on included versus 
excluded cases. W e propose a framework forjudging and augmenting external validity and 
pemntting inference from studies in Otitis Media with Effusion. 
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Descriptive features of the two trials 
The KNOOP-3 (Netherlands) OME surgical trial 
The source population of K N O O P - 3 consists of: 
all children born in the Eastern part of the Netherlands between 1 January 1996 and 1 
April 1997 (N=30,099) 
who were screened for heanng impairment at 9 months of age 
who failed this hearing screening three times 
who were subsequently diagnosed with bilateral O M E for 4-6 months 
Finally, the children for whom informed consent was obtained were randomly allocated to 
two groups: Group A was treated with ventilation tubes, while Group Β underwent watchful 
waiting. Both groups were followed for one year. The outcome measurements are heanng 
levels, language development, quality of life, behaviour, and parent child interaction. The 
main purpose is to estimate the clinical appropnateness of the early intervention policies that 
have developed in the last two decades. 
Tltc TARGET (U.K.) OME surgical trial 
The source population of T A R G E T comprises: 
4282 children aged 3.25 — 6.75 years referred with suspected ear/heanng problems 
who were diagnosed with persistent (3 months) bilateral O M E 
whose heanng loss was between 20 to 40 dB 
These children were randomized into three groups: 1) treatment with ventilation tubes, 2) 
treatment with both ventilation tubes and adenoidectomy, and 3) medical 
management/watchful waiting. The outcome measurements reported here are heanng levels, 
specific and non-specific health scores, behaviour and quality of life. The chief purpose of the 
trial is to determine, whether the current treatments for O M E are cost-effective, and to issue 
more precise guidelines about who should be treated so as to reduce the wider variation in 
intervention rates. 
Methods to compare the two trials 
External validity of both surgical trials described above is studied along three lines: 
(1) comparing the demographic charactenstics of the tnal population with the source 
population; (2) studying the possible effect modifiers (variables for which the intervention 
might differ over the strata within the trial population); (3) stratifying on the seventy of the 
disease. 
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Comparing the tnal samples 
Figure 1 shows the patient flow into the K N O O P - 3 (Netherlands) and T A R G E T (UK) 
O M E trials. The chief limitation upon extensive compansons is a practical one; the cost and 
the motivation of clinical collaborators to acquire even outline data on children that are not 
included for either of the two main classes of reason: unwilling to give consent for 
randomisation or considerable seventy to be a pnme candidate for the treatment. Nevertheless 
both trials have provided data on external validity. 
Differences and similarities between the two trials 
Companson of similarities and differences between the two trials is informative: Firstly, the 
age of the children in the two trials is different, because they address different aspects of the 
clinical effectiveness question. This might result in different effect magnitude and different 
effect modifiers. Secondly, for the K N O O P - 3 trial we know the total source population. In 
the T A R G E T trial there is not a determinate cohort; we can only estimate the population 
covered from the age profiles and the hospital catchments. This suggest a virtual cohort 
around about 45,000 children. Thirdly, the selection of the tnal population in the KNOOP-S 
trial involves a more extended 'funnel'; only those children who failed the screening three 
times and who were diagnosed with persistent bilateral O M E at the E N T department, were 
eligible to participate. Fourthly, in relation to the differences in design the inclusion cntena 
differ slightly: in TARGET the children had to have evidence ofbilateral OME for 3 months, 
confirmed by at least a B+C2 tympanogram and a hearing threshold of more than 20 dB in 
the better ear. In K N O O P - 3 the child had to be diagnosed with bilateral O M E (a bilateral 
C2 tympanogram confirmed by otoscopie diagnosed glue) over at least 4 months. Fifthly, the 
follow-up intervals differ; the total follow-up time in TARGET is 2 years with measurements 
in between at 3 ,6,12, and 18 months after randomisation, while the children in K N O O P - 3 
are followed for 1 year with measurements at 3, 6, 9 and 12 months. Sixthly, there are 
similanties and differences in the set of outcome measurements. Both tnals perform 
audiometry, tympanometry, otoscopy, and measure quality of life and behaviour of the child, 
but the instruments for the latter two differ between the trials. Moreover, TARGET also 
measures the general health and an OME specific symptom score, while K N O O P - 3 measures 
both comprehensive and expressive language as well as the parent child interaction. 
Despite these differences the external validity issues in trials can be juxtaposed 
compared, because they have other important charactenstics in common. Firstly, both studies 
only included children with persistent bilateral OME. Secondly, they measured the 
Figure 1. Flow chart of the KNOOP-3 (Netherlands) and TARGET (UK) OME trials 
3(X>99 inlanls born between I January 
1996 and 1 Apr i l 1997 
2457 non-atlcndancc 
27642 pariicipanis in the first screening 
725 lost to fo l low-up 
7749 pariicipanis in the second screening 
467 lost lo lo l low-up 
2499 pariicipanis in ihe Ihird screening 
282 non-referrals 
1083 mlani.s were referred lo an ENT 
dcpartmcni 
201 lost lo lo l low-up 
386 children were el igible lo participale 
in the ina i 
66 lost lo lo l low-up 
187 children in the ina i 133 children in the 'shadow' group 
42KI children aged between 3 25 and 
6.75 were selected lor visit 1 
1059 mei ihe inclusion 
criteria + 40 O T T 
3182 children were excluded 
90 loM lo lo l low-up 
969 attended visu 2 
452 children included aller 
visit 2 
5 17 children were excluded 
31 children w i ih a 
hearing 
loss ol > 40dQ 
384 children were randomised 
52 lost lo fo l low-up 
+ 
21 were el igible lo 
part iupalc in the Inai 
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same effect modifiers. Thirdly, some of the outcome measurements are the same, and fourthly, 
the follow-up intervals in the first year overlap for 3 measurements. 
Results 
General comparison of the trial populations with the source population 
No differences could be found for month ofbirth (KNOOP-3), age (TARGET), and gender 
(TARGET), respectively. Although the differences between the districts in KNOOP-S are 
not significant, there appear to be slight differences in selection with respect to these districts. 
This could be due to the different screening procedures (automatic CAPAS test versus the 
non-automatic Ewing test) in these districts, or could be due to the differences between 
clinicians, for example in convincing the parents to give informed consent. Moreover, in 
K N O O P - 3 the selection process gives more males than females (59% versus 41%); this is 
probably due to the fact that the rate of persistence/recurrence is higher in males in a 
longitudinal cohort. 
(Possible) effect modifiers 
In Tables 1 and 2 the differences between the included and excluded patients are shown in 
respect of the possible effect modifiers. During the selections before arriving at the final trial 
population, we found that in the K N O O P - 3 trial the children lost to follow-up during the 
visits at the E N T department differed from the children followed in the number of upper 
respiratory infections (URTIs); the children lost to follow-up had more URTIs. In TARGET 
the children excluded at visit 1 but who despite satisfying the inclusion criteria were about 
three months younger than the included children. 
In the K N O O P - 3 trial, the children who participate in the trial have less educated 
mothers, more often older siblings, and attend day care less often than the children who did 
not participate. In T A R G E T more of the children that end up participating in the trial had 
parents from the manual worker group. 
Overall the differences mentioned above are all small and few of them are significant. 
Some of the investigated vanables (URTIs and AOM) are directly related to the seventy of 
the disease, and differences in these variables refer therefore to the selection of the persistent 
cases, which both trials would like to include, rather than to a problem of external validity. 
On the other hand, other factors not measured might be important for external validity and 
the challenge of dealing with generalisation lies in tracing such variables. 
Table 1. Compansons of the possible effect modifiers from source population to tnal population in TARGET 
Age (months) 
(icnder 
Mak 
Femati 
Social class (PC) 
1 (itrujmlnig) 
2 (asptmiii) 
1 (tstahhslud) 
4 ((Inubinç) 
' (pro-ptnmi) 
Season 
Winter 
Spmni 
Summer 
Autumn 
Ethnic group 
Wlute - i'K/Europian 
Afro (,anbbcan 
Indian/Pakiitam 
Othir 
Other siblings 
Vis 
So 
A O M 
>=6 
< 6 
URTIs 
>0tUi'/ ί moiitlis 
/i>S ()/f('fI 
Attending day care 
y<> 
\o 
Manna] group 
\oH-MtWHal 
Uiwual 
Hearing level 
Indudcd Visit 
1 (N = 1()S9) 
s ' j y n o 6i 
SI H% 
48 2% 
49 (1% 
9 4% 
IH 5% 
Κ 8% 
14 2% 
31 8% 
28 2% 
IS 8% 
24 2% 
94 4% 
(1 7% 
2 9% 
1 1% 
ST 1% 
16 7% 
4 8% 
9 S 1% 
19 9% 
8(1 1%, 
99 VA, 
(I 7%~ 
17 6% 
62 4%, 
12 9 (6 2) 
Excluded visit 1-
tympanometry or 
audiometry 
(N=2666) 
61 (1(11 1) 
S4 7%, 
4 S VA, 
44 9% 
8 0% 
19 8%, 
12 2% 
IS 1%, 
21 2%, 
2 S 2%, 
28 6% 
21 0% 
— 
— 
— 
— 
— 
— 
— 
— 
— 
-
— 
-
--
— 
IH(i f7 η 
Other 
excluded 
Visit 1 
(N=.1()9) 
Ï 6 2 Î I I (!) 
S4 4% 
4 S 6% 
49 2%, 
118%, 
14 2%, 
12 S% 
Id 8%, 
29 4%, 
10 4%, 
18 8%, 
21 4%, 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
--
— 
__ 
14 1 (7 1) 
Rdusals visit 
1 (N=96) 
S9 2(1()1) 
46 9% 
SI 1% 
S8 1%, 
2 8% 
18 1%, 
6 9% 
119%, 
14 8% 
19 6%, 
17 4%, 
28 1%, 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
--
— 
— 
12 8 (6 7) 
Tnal children 
(N=184) 
61 1 (10 1) 
SO 1%, 
49 7%, 
S 2 9%, 
12 S% 
16 6%, 
7 1% 
10 8%, 
11 0% 
11 1% 
20 8% 
16 9% 
96 1%, 
0 S% 
2 9% 
0 S%, 
84 S% 
15 5% 
4 9% 
9 S 1% 
18 1% 
81 9% 
99 7%, 
0 3% 
14% 
66 0%, 
12 5 (6 1) 
Excluded visit 2 
audiometry or 
tympanometry 
(N=410) 
614 (10 8) 
51 7%, 
46 3% 
44 5%, 
6 2%, 
22 7% 
11 2% 
1 S 1%, 
18 1%, 
2 S 6% 
19 1%, 
17 2%, 
95 8% 
0 9%, 
2 1% 
1 1%, 
82 6%, 
17 4%, 
5 1%, 
94 7%, 
22 5%, 
77 5%, 
99 8%, 
0 2%, 
41 4%, 
56 6%, 
18 1 (6 2) 
Other 
excluded visit 
2 
(N=68) 
64 2(11 2) 
SS 9% 
44 1% 
40 4% 
7 0%, 
19 1%, 
17 5% 
1 5 8% 
27 9%, 
15 1%, 
21 5% 
11 2% 
91 2% 
0 0%, 
7 4%, 
1 5%, 
84 6% 
15 4%, 
1 5% 
98 5%, 
14 9%, 
HS 1% 
100%, 
0%, 
42 4%, 
57 6% 
12 8 (7 9) 
Refusals visit 2 
(N = S0) 
62 0 (11 8) 
46 0% 
54 0% 
51 1% 
1 5 6%, 
8 9% 
2 2%, 
22 2%, 
28 0%, 
16 0%, 
22 (1%, 
14 0%, 
91 8%, 
2 0% 
4 1%, 
2 0% 
81 1%, 
16 7%, 
6 1% 
91 8% 
8 1%, 
91 7%, 
94 0%, 
6 0%, 
16 0% 
64 0% 
14 5 (ft 1) 
Table 2. Compansons of the possible effect modifiers over the different selections from cohort to tnal population in K N O O P - 3 . 
C o h o r t Followed at the E N T 
(Ν=Λ(),Ι)99) department (N=882) 
Lost to follow-up at 
the E N T department 
(N=2()1) 
Tnal population 
(N=1H7) 
'Shadow' group 
(N=m) 
Lost to follow-up at 
randomisation 
(N=66) 
C ïender 
Mah 
I vmak 
District 
ƒ 
2 
4 
Season of birth 
Wmier 96 
Summer 
Autumn 
Wtutcr 97 
Other treatments 
Adiuo/TotHil 
Som 
Older siblings 
Vo 
So 
History of A O M 
Vii 
So 
U R T I s 
Yes 
So 
Attending day care 
Yes 
So 
Low education level mother 
Average hearing level in dB (SO) 
i l 4% 
48 6% 
10 5% 
S4 2% 
12 6% 
22 7% 
20 (1% 
20 8% 
21 1% 
20 4% 
17 i % 
.. 
-
„ 
--
.. 
--
__ 
--
— 
— 
S7 6% 
42 4% 
9 <J% 
SI 1% 
21 S% 
1 5 1% 
21 4% 
26 S% 
17 1% 
14 7% 
18 1% 
S 9% 
94 1% 
7 τ 9% 
24 1% 
34 7% 
6 ϊ VX, 
Ϊ 4 6% 
ϊ ϊ 4% 
24 8% 
75 2% 
21 1% 
60 9% 
TO 1% 
8 5% 
58 2% 
16 9% 
16 4%, 
24 6% 
24 6%, 
12 1%. 
11 6% 
27 1%, 
8 0%, 
92 0% 
76 4% 
23 6% 
39 4%, 
60 6% 
71 8% 
28,2% 
29 0%, 
71 0%, 
24 0% 
58 9%, 
41 1%, 
5 9%, 
66 8%, 
1 3 4%, 
1 3 4%, 
22 0% 
26 9% 
15 1%, 
18 3% 
17 7%, 
9 6% 
90 4%, 
83 2% 
16 8%, 
31 8% 
68 2%, 
62 2%, 
37 8%, 
26 1% 
73 9%, 
26 4% 
37 (1 (11 4) 
56 8%, 
43 2%, 
10 5%, 
64 7%, 
12 8%, 
12 0%, 
22 6%, 
27 1%, 
18 8%, 
14 3%, 
17 3%, 
9 0%, 
91 0%, 
74 1% 
25 9%, 
37 1%, 
62 9%, 
65 1%, 
34 9%, 
42 4% 
57,6%, 
14 8% 
36 3 ( 1 1 2 ) 
60 0%, 
40 0% 
12 9%, 
62 9%, 
15 7%, 
8 6% 
22 8% 
27 7% 
17 3% 
13 9% 
18 3%, 
9 m, 
91 0%, 
72 9% 
27 1% 
38 7% 
61 3% 
59 4%, 
40 6%, 
40 0%, 
60 0%, 
13 4% 
— 
Underl ined percentages denote were subgroups differ from the trial population 
Methodolog)' 
Severity of the disease 
The average hearing threshold in the T A R G E T trial ranged from 20 to 50 dB with a mean 
of 32.5 dB (SD=6.3), while the hearing thresholds in the K N O O P - 3 trial ranged from 5 to 
60 dB with a mean of 37 dB (SD=11.3). 
Discussion 
Differences between the included and excluded children 
For neither K N O O P - 3 and T A R G E T were significant differences found for any of the 
demographic variables. Sederberg-Olsen et al.181 who also studied the demographic 
comparability of included and excluded patients in a mal on children with Otitis Media found 
the same. 
On the other hand, some of the possible effect modifiers were unequally distributed 
over the included and excluded children in the trials. Firstly, in T A R G E T differences were 
found for season and hearing level between the included and excluded children who did not 
satisfy the inclusion criteria for both visit 1 and visit 2. This is what we would have expected 
because persistence O M E is related to season and hearing levels and does not underpin the 
external validity, because the aim of the tnal was to include the persistent cases. Secondly, in 
K N O O P - 3 we also found that the children lost to follow-up during the visits at the E N T 
department before the randomisation were more often diagnosed with URTIs , while in 
T A R G E T we found a difference in age between the children included and excluded at visit 
1. Thirdly, during the final stage of selection of the trial population some differences were 
found. In TARGET: social class; In K N O O P - 3 : educational level mother, attending day care, 
and the number of older siblings. This is in agreement with the findings of Harth and 
Thong184 who also found that volunteenng parents were less well educated. Parents of higher 
social class might be more sensitive to other concerns and might therefore prefer a treatment 
or might make the clinician more aware of these concerns. We did not find a difference for 
day care and older siblings in T A R G E T , while such a difference was found in K N O O P - 3 . 
Almost all children in T A R G E T attended a form of day care, so the power to detect a 
difference if one exists will be too low. In respect of siblings the differences in age range 
between the trials might be the most important reason for not finding a difference in 
TARGET. 
The question then anses whether the above mentioned variables indeed modify the 
effect magnitude. Neither of the tnals have yet been analysed on an unblinded basis, so we 
are not sure if these factors will really modify the outcome effect. Subgroup analysis in both 
tnals will be underpowered to identify an effect modifier (type II error). For this reason we 
raise a pnori for informed debate a short list of vanables expected to modify the effect 
Chapter 3 
magnitude. It is to be expected that factors such as URTIs , other treatments and A O M will 
be related to the persistence/seventy and might also have an influence on the efficacy of the 
intervention and will therefore have the greatest impact on the effect magnitude. The more 
social factors as day care, social class, and the number of siblings might modify particular 
outcome measurements such as language development, behaviour and quality of life. Such 
modification might be less, because the influence on the efficacy of the intervention will 
probably be smaller. 
In K N O O P - 3 we found differences in the number of URTIs between the children 
followed at the E N T department and the children lost to follow-up. The children lost to 
follow-up might therefore be the more severe cases. On the other hand, we did not find a 
difference in other treatments such as e.g. adenoidectomy, while if the children indeed were 
more severely affected such a difference is expected as well. Moreover, we found small 
differences in attending day care, educational level of the mother, the number of older siblings 
(KNOOP-3) and the social group (TARGET) Attending day care and the number of siblings 
are certainly nsk factors for OME, but whether they also modify the effect magnitude within 
the different treatment groups can be doubted. The social group/educational level of the 
mother appears to be a more important factor for both language development and behaviour: 
Earlier studies ^ suggested that the number of years of parents' education, and especially that 
of the mother was the best predictor for child health status. Although the power might be to 
low to show a significant difference, both trials should take into account the social 
group/educational level of the mother in the analysis and present potential differences within 
the strata of this variable. 
Another plausible way of determining what variables are effect modifiers would be to 
perform a meta-analysis with both trials to enlarge the power of subgroup-analysis, but we 
believe that the power of such a meta-analysis will still be too low. The only way to obtain 
sufficient power is to perform trials within a framework permitting a meta-analysis in future 
Recommendations /or/HfHre· OME tnaU· 
Because the impact of a trial upon policy and practice depends on generalised interpretation 
we recommend that all future O M E trials should: 1 ) describe every step from source in tnal 
population up to randomised sample; 2) obtain at least some demographic data on all cases not 
included at early stage, 3) measure for every step all plausible effect modifiers, 4) describe all 
inclusion and exclusion critena precisely; and 5) describe all possible effect modifiers over the 
included and excluded children. Only when the above mentioned factors are described and 
a valid result has been obtained, can a judgement of the generahsability be made. 
Methodology 
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Abstract 
Objective: To study the effect of ventilation tubes in children aged 1-2 years with 
screening-detected, bilateral Otitis Media with Effusion (OME) persisting for 4-6 months, 
as compared to watchful waiting. 
Design: Multi-centre randomised controlled tnal (n=187) with two treatment arms: 
ventilation tubes versus watchful waiting. Infants underwent auditory screening; those with 
persistent (4-6 months) bilateral O M E were recruited. 
Results: The mean duration of effusion over one-year follow-up was 142 days (36%) in the 
ventilation tube (VT) group versus 277 days (70%) in the watchful waiting (WW) group. 
After 6 months of follow-up, the pure tone average (FT A) in the VT group was 5.6 dB A 
better than that in the W W group. After 12 months, most of the advantage in the VT 
group had disappeared. After the insertion of ventilation tubes, the children with greater 
hearing deficits at randomisation appeared to have improved more than the children with 
lower thresholds. The greatest contrast was found between the children in the VT group 
whose ventilation tubes remained in situ and the children in the W W group. In the VT 
children with recurrent OME, the hearing deficits increased again, but remained slightly 
lower than those in the infants with persistent O M E in the W W group. 
Conclusions: Ventilation tubes have a beneficial effect on hearing in the short run (6 
months); this effect largely disappears however in the long run (12 months). This is 
probably due to partial recurrent OME in the VT group and to partial spontaneous 
recovery in the W W group. 
Introduction 
The adverse effects of Otitis Media with Effusion (OME) on cognitive and linguistic 
development are generally considered to be the result of conductive hearing loss associated 
with OME. Persistent hearing loss of 25-30 dB HL for more than 3 months has been 
suggested as an indication for treatment.'' The most common treatment for OME is still 
the insertion of ventilation tubes, introduced by Armstrong in 1954.'" 
Studies on the effectiveness of ventilation tubes for persistent OME showed that 
short-term improvement in hearing can be attained. '" The average hearing levels 6 
months after the insertion of ventilation tubes were in the order of 15-20 dB HL, with a 
mean improvement of 5-15 dB compared to baseline (pre-treatment) measurement. After 
12 months or longer, however, hearing levels in treatment groups equalised to those in the 
control groups of non-treated OME, probably due to spontaneous recovery in the controls 
and recurrent O M E in the treated children.18''188 '*'' Only the study by Gates181 provided 
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information on the mean time spent with effusion: 35% and 49% of the time during a 
follow-up of 12 months, in the treatment and the control group, respectively. 
It should be noted that there was wide variation between the previous studies 
regarding design and population characteristics, such as the mean duration of O M E before 
randomisation, inclusion and exclusion criteria, treatment protocol, types of referent 
treatment and outcome measures (other than the mean hearing level). Moreover, all these 
studies were performed on children of between 4-8 years of age.18' '"''18tt ,HC, As O M E also 
occurs frequently in younger children, many of them will receive ventilation tubes. An 
important rationale for this treatment is to reduce the time with bilateral hearing loss at an 
age, which is critical for speech- language development. This presents the opportunity and 
need to study the effect of ventilation tubes on hearing levels in infants of 1 -2 years of age, 
and to find out whether the conclusions drawn from studies on older children are valid in 
younger children. 
W e performed a multi-centre randomised controlled tnal in which infants with 
persistent O M E were assigned to either early insertion of ventilation tubes or a watchful 
waiting period. Data were obtained on aspects such as language development, quality of 
life, and hearing sensitivity. In addition, we examined the hearing levels over the different 
distinguishable periods in these randomised children, namely a) before assignment to the 
VT or W W group; b) during the period that the tubes were in situ and functioning; c) 
during the penod that the tubes were extruded and the child remained OME free and d) 
during the period that a child in the VT group was diagnosed with recurrent OME. The 
research questions related to these periods were: 1) How large was the hearing deficit due 
to OME? 2) Did hearing levels return to normal after treatment with ventilation tubes? 3) 
Did hearing levels remain normal or at least better than those in the W W group after the 
tubes had been extruded? 
Patients and methods 
Patients 
The trial population was embedded in a cohort, which included 30,099 children born in 
the Eastern part of the Netherlands between 1 January 1996 and 1 April 1997. All these 
children were invited for a routine behavioural heanng screening at the age of 9 months. 
For the purpose of the study, those who failed three times were referred to one of the 13 
participating E N T outpatient clinics in the region for diagnosis and follow-up (n=1081). 
The parents of infants diagnosed with persistent (4-6 months) bilateral O M E (confirmed 
by tympanometry and otoscopy) in subsequent visits to the E N T surgeon (n=386) were 
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asked whether they would give consent for their child to participate in the randomised 
controlled trial. Children with Down's syndrome, sensorineural hearing loss, cystic fibrosis, 
asthma and schisis were excluded. The children for whom informed consent was obtained 
(n=187) were randomly allocated to one of two groups: either treatment with ventilation 
tubes (n=93) (Bevel Bobbins'), or watchful waiting (n=94). The two groups were 
followed for one year with three monthly tympanometry and otoscopy measurements, and 
audiometry every 6 months. 
Information on prognostic factors, such as common colds since birth, attending day care, 
etc., was obtained using a questionnaire that was filled in by the parents during the first 
visit to the E N T clinic.'"1 Information on other clinical symptoms, such as adenoidectomy 
before randomisation was obtained by means of a questionnaire that was filled in by the 
E N T surgeon. 
We obtained approval for this study from the Ethical Committees at the 13 participating 
hospitals. 
Methods 
To increase comparability at baseline, a balanced allocation procedure was employed with 
5 balancing factors: sex, age, season at randomisation, educational level of the mother and 
hospital. 
During the trial, tympanometry and audiometry were performed by experienced 
audiologists; otoscopy was performed by the E N T surgeon. The tympanograms were 
classified according to Jerger191, while O M E was defined according to the MOMES 
protocol"^, see also Figure 1. Hearing assessment was performed in standard rooms in the 
13 participating hospitals. If no special audiometrie test booth was available, a quiet and 
convenient room was selected. A portable visual reinforcement audiometry set was used, 
calibrated according to the substitution method in dB A1'" and advocated by Beynon et 
al..'72 The noise floor in the test rooms was assessed by measuring soundfield hearing 
thresholds in adults with normal hearing (thresholds of between -5 and +10 dB HL). 
Averaged over the 4 frequencies (500, 1000, 2000 and 4000 Hz), the noise level varied per 
test room from 8.8 dB A to 19.1 dB A, with an average of 13.0 dB A.1 '2 Moreover, one 
should bear in mind that a visual reinforcement audiometry set in fact measures a minimal 
response level instead of a real mean hearing level. 
To study the (natural) course of O M E during the trial we examined the mean time 
spent with O M E as well as the mean duration that the children had hearing thresholds of 
equal to or smaller than 35 dB A. If a child had O M E (hearing thresholds of equal to or 
smaller than 35 dB A) at two successive measurements, the days between these 
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measurements were counted as days with effusion (low heanng thresholds). If on the other 
hand a child had O M E at the first measurement but not at the second, only half of the 
days were counted as days with effusion. 
To study the efficacy of the ventilation tubes, we distinguished three different situations' a) 
ventilation tubes in situ and functioning; b) extruded ventilation tubes and no bilateral 
O M E , and c) extruded ventilation tubes, but bilateral effusion. 
To compare the extrusion rate of the tubes with those reported in the literature, we also 
studied the percentage of tubes that were in situ at 3, 6, 9 and 12 months of follow-up 
Statistical analysis 
All the analyses were performed according to the intention to treat principle Mean 
differences in heanng thresholds in the best ear (at 500, 1000, 2000 and 4000 Hz) at 0, 6 
and 12 months of follow-up between the VT group and W W group were tested with the 
Student t-test for independent groups. The choice of the best ear was motivated by the 
etiological model of this tnal: to study the effect of treatment with ventilation tubes on 
developmental outcomes mediated by the conductive heanng deficit in the best ear. 
Figure 1. Algonthm to diagnose O M E (MOMES protocol) 
T o adjust for potential confounders and to explore possible effect modifiers with 
Type Β 
Type C2. 
Glue 
Otitis Media with EfFusion 
:>r not measured 
Otoscopy 
N o t clear 
Doubt 
Type A, C I 
N o glue 
N o Otitis Media 
Type A compliance > = 0 2 ml, pressure > -100 dal'a 
Type Β compliance < 0 2 ml, pressure < 200 dal'a 
Type C I compliance > = 0 2 ml, -100 daPa < = pressure< -200 daPa 
Type C2 compliance > = 0 2 ml, pressure < = -200 daPa 
Chapter 4 
treatment, we performed regression analyses. 
O u r a p n o n model was: 
M(heanng level at T12 — hearing level at TO) = β,, + ß^ t rea tment + ßjXconfounders 
+ ß^xtreatmentXeffect modifiers + €, 
Potential confounders and/or effect modifiers were: age at randomisation (<20 
months />=20 months), adenoidectomy before randomisation (yes/no), hospital (1-13), 
season at randomisation (1-4), number of upper respiratory tract infections since birth 
(>4/<=4) and hearing loss at baseline (dB A). 
We also designed a logistic model with the same parameters to analyse the effect of 
ventilation tubes on the probability that children would improve by more than 1 5 dB. To 
study the modifying effect of treatment for specific clinical complaints such as upper 
respiratory tract problems, clusters of children were fomied by means of a pnncipal 
component analysis with two principal components using the following information from 
the medical history: a) adenoidectomy, b) number of common colds, c) persistence of 
O M E before randomisation, d) penods of earache and/or fever indicating acute otitis 
media. Three clusters were fomied: 1) children without complaints (n=67), 2) children 
with some complaints (n=57) and 3) children with freqeunt complaints (n=55), see also 
Table 1. 
Results 
The children in the trial 
A total of the 187 children were randomised' 93 children entered the ventilation tube 
(VT) group and 94 children entered the watchful waiting (WW) group. During the trial 
period, 11 children dropped-out (3 children from the VT group and 8 from the W W 
group) In addition, 10 children in the W W group received treatment with ventilation 
tubes. Eight children in the VT group underwent surgery for ventilation tube insertion 
twice, because the ventilation tubes were extruded before six months follow-up. 
The mean age of the children at randomisation was 19.5 months (SE=1.7) in the VT 
group and 19.4 months (SE=1.9) in the W W group. 
Patient characteristics and mean hearing levels during follow-up are shown in Table 2 
Trial results 
Table 1. Description of the 3 clusters formed by means of pnncipal component analysis 
(explained variation = 57%) 
Treatment group 
VTgroup 
WW group 
Sex 
Male 
Female 
Adcnoidectomy 
Yes 
No 
Fever 
Yes 
No 
Earache 
Yes 
No 
Mean number of visits with 
common colds 
Hearing level at T=0 
Cluster 1 
(no 
31 
36 
36 
31 
Ü 
67 
0 
67 
0 
67 
complaints) 
(46.3%) 
(53 7%) 
(53.7%) 
(46.3%) 
(0%) 
(100%) 
(0%) 
(100%) 
(0%) 
(100%) 
0 6 
44.4 
Chi ster 2 
(some complaints) 
31 
26 
33 
24 
5 
52 
8 
49 
31 
26 
(54.4%) 
(45.6%) 
(57.9%) 
(42.1%) 
(8.8%,) 
(91.2%) 
(14 0%) 
(86 0%) 
(54.4%) 
(45.6%.) 
0.7 
44.9 
Cluster 3 
(fre 
28 
27 
35 
20 
11 
44 
49 
6 
55 
0 
quent complaints) 
(50.9%) 
(49 1%) 
(63.6%) 
(36.4%) 
(20.0%,) 
(80 0%,) 
(89.1%,) 
(10.9%) 
(100%,) 
(0%) 
0.7 
45.4 
Tympanometry and otoscopy 
At 3 months follow-up, 13 (15%) of the children in the VT group were diagnosed as 
having bilateral OME. At 6, 9 and 12 months follow-up, 29, 27 and 27% of the children 
in the VT group were diagnosed as having bilateral OME, respectively. In the WW group, 
the percentages were 77, 66, 57 and 53% at 3, 6, 9 and 12 months of follow-up, 
respectively; see also Figure 2. 
In the WW group, 25 (27%) children were diagnosed as having bilateral OME at 
all visits, while 10 (11%) were diagnosed as having bilateral OME only once. In the VT 
group, three children (3%) were diagnosed as having bilateral OME at all visits, while 44 
(47%) of the children were diagnosed as having bilateral OME only at randomisation. 
The estimated mean number of days with bilateral OME in the VT group was 142 days 
(36%) versus 277 days (70%) in the WW group. 
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Audiometry 
Figure 3 shows the changes in mean heanng loss in the best ear. The mean heanng levels 
improved in the two groups, but the VT group improved more, especially dunng the first 
6 months. The improvement at 6 months follow-up in the VT group was 10.2 dB (95% 
Confidence Interval (CI) 7.3 - 13.1 dB) versus 4 6 dB (95% CI 2.0 - 7.3 dB) in the W W 
group (p=0.()06). At 12 months follow-up, the improvements were 13.1 dB (95% CI 
10.42 - 15.8 dB) and 8.5 dB (95% CI 5.5 - 11.5 dB), respectively (p=0.03). 
The mean heanng deficit in the VT group decreased from about 45 dB A to about 
35 dB A; the estimated mean duration with a heanng deficit of equal to or smaller than 35 
dB A were 50% and 40% in the VT group and the W W group, respectively. 
The results changed very little when the measurements at 4000 Hz were omitted. 
Efficacy analyses 
Table 3 shows the results of the efficacy analyses. The largest difference in mean heanng 
thresholds was found between the children with functioning tubes and the children in the 
W W group In the latter the mean hearing thresholds were 38.7 dB A and 34.7 dB A at 6 
and 12 months of follow-up; the difference was about 5 dB (p=0.0001 and 0.0003 
respectively). Heanng loss between 6 and 12 months follow-up in the children with 
recurrent O M E in the VT group increased, but remained slightly lower (2-3 dB, p=0.3 
and 0 07 respectively) than in the W W group. When these heanng levels were compared 
to those in children in the W W group who did not recover spontaneously the differences 
became larger: heanng loss in these children was 41.1 dB A (SE=1.2) and 38.7 dB A 
(SE=1.1) after 6 and 12 months follow-up, respectively. The heanng losses in the W W 
children who recovered spontaneously were almost identical to those in the children with 
functional tubes: 33.6 dB A (SE=1.3) and 30 1 dB A (SE=() 8) after 6 and 12 months 
follow-up, respectively 
At 3, 6, 9 and 12 months of follow-up, 92%, 76%, 56% and 30% of the tubes were still in 
situ, respectively. 
Table 2. Patient charactenstics and mean hearing levels in the best ear dunng follow-up 
Treatment Group 
VT group 
WW group 
Sex 
Male 
Female 
Educational level 
mother 
High 
Middle 
Low 
Season at 
randomisation 
Spring 
Summer 
Autumn 
Winter 
Age at 
randomisation 
<20 months 
>20 months 
District 
/ 
2 
3 
4 
Number 
93 
94 
110 
77 
46 
92 
49 
43 
47 
59 
38 
145 
42 
11 
125 
25 
26 
Ventilation 
tubes 
93 
— 
55 
38 
23 
45 
25 
20 
23 
31 
19 
72 
21 
7 
62 
13 
11 
Watchful 
waiting 
— 
94 
55 
39 
23 
47 
24 
23 
24 
28 
19 
73 
21 
4 
63 
12 
15 
Mean (dli) at 
T = 0 
46 4 
43.4 
43 8 
46 2 
43.5 
46 8 
42.7 
45 9 
41.4 
45.2 
47.4 
44.2 
47.2 
45.5 
43.3 
47.4 
50.2 
Mean (dB) at 
T = 6 
35.8 
38 7 
37.1 
37.5 
38.8 
37.1 
36 2 
38 2 
37 6 
37.6 
35 3 
37 6 
36 2 
38 6 
37 2 
34.2 
40 1 
Mean (dB) at 
T=12 
33 2 
34.7 
34.2 
33 6 
35.3 
33.6 
33.0 
31.7 
35.2 
34.4 
34.2 
34.5 
31.7 
32.8 
33.9 
34.4 
34.1 
Δ6 (dB) 
10.2* 
4 6 
6 7 
8.4 
5 7 
9.1 
5.8 
8.3 
2.5. 
7.2 
12 3 
6 4 
11 1 
6.8 
6 1 
12.9 
9.2 
Δ ΐ 2 (dB) 
13 1 
8.5 
9 5 
12.8 
8 7 
13 0 
8.9 
147 
5.2 
10.9 
13.0 
9 6 
15.4 
14 1 
9 6 
12.0 
15 4 
' The underlined différence scores were statistically significant (p<().05) 
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Figure 2. Percentage of children with bilateral OME during follow-up 
100 
DVT group 
• WW group 
Figure 3. The Pure Tone Average (PTA) in the best ear at 0, 6 and 12 months follow-up 
- WW group 
- VT group 
12 
Follow-up in months 
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T a b l e 3 . T h e efficacy of the venti lat ion tubes in t he V T g r o u p 
Months of 
follow-up 
6 
12 
VTin 
Yes 
No 
No 
Yes 
No 
No 
situ Bilateral OME 
No 
No 
Yes 
No 
No 
Yes 
Number of 
children" 
49 
-
8 
26 
7 
5 
Mean 
deficit 
32 5 
-
36.1 
29 9 
32.5 
32.9 
heanng 
(dB A) 
SE (dB A) 
0.8 
-
2 8 
0.8 
2.9 
2 1 
For reference at 6 and 12 months follow-up, heanng deficits in the W W group were 38.7 dB A (SE— 1.0) 
and 34.7 dB A (SE=0.8), respectively 
* The total number was lower than the 94 due to missing values for tympanograms and/or otoscopy. 
Regression analyses 
In the univariate analysis with hearing improvement at 6 months as dependent variable, 
season and hearing level at randomisation appeared to be confounders. In the multivariate 
analysis, only heanng level at randomisation was a confounder (disturbing the relation 
between treatment and hearing level) and an effect modifier (children with a higher deficit 
at randomisation improved more than children with a lower level at baseline). The final 
linear model is shown in Table 4A. From this model it was possible to calculate the 
improvement in heanng levels in the two groups over various categories of heanng 
thresholds at randomisation. For example, when the hearing loss at randomisation was 50 
dB, a child in the VT group improved 15.9 dB, while a similar child in the W W group 
improved 11.4 dB. 
Table 4A. The final model with Ahearing level in the best ear as dependent vanablc at 6 
months follow-up (N=166, with 82 children in the W W group and 84 in the VT group) 
Co-vanable Estimate SE p-value 
Intercept (OC) 39.1 4.7 
Group 
Watchful waiting -10.5 6 0 0.084 
Ventilation tubes (rcf) 
Heanng at T0 (dB) -1 .1 0.1 0 0001 
Interaction 
(Groupxheanng TJ 0.3 0 1 0 023 
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In the umvanate analysis with improvement at 12 months as dependent variable, heanng 
level at randomisation, season and age at randomisation appeared to be important co-
vanables. In the multivanate linear model, heanng level and age at randomisation acted as 
confounders (see Table 4B). The difference in heanng improvement at 12 months follow-
up between the VT group and W W group, adjusted for the heanng level and age at 
randomisation, was 1.6 dB (95% CI -0.6 - 3.6). 
Table 4B. The final model with Aheanng level in the best ear as dependent vanable at 12 
months follow-up (N=166, with 80 children in the W W group and 86 in the VT group) 
Co-vanable 
Intercept (OC)Group 
Watdilul waiting 
Ventilation Tubes (ref) 
Heanng at T,, (dB) 
Age at T,, 
<20 months 
>20 months (refi 
Estimate 
32 7 
- 1 6 
— 
- 1 0 
2 6 
— 
SE 
2 9 
1 1 
— 
0 1 
1 4 
-
p-value 
0 16 
— 
0 0001 
0 06 
— 
Logistic regression 
The final logistic model is desenbed by: 
Logit P(>15 dB A) = 0 . 3 9 - 1.11 Χ treatment. Thus the chance of 15 dB improvement was 
0.40 (95% CI 0.31- 0.51) and 0.18 (95% CI 0.11- 0.28) in the VT group and W W group, 
respectively. In other words, the children in the VT group were 2.2 times more likely to 
improve 15 dB than the children in the W W group. 
Principal component analyses 
The subgroup of children with some complaints appeared to benefit more from treatment 
with ventilation tubes (improvement 8.5 dB) than the children with no complaints or 
frequent complaints It should be noted that 11 children in the latter cluster had 
undergone adenoidectomy before randomisation. As these young children probably 
underwent adenoidectomy because illness, the results suggest a positive effect of 
adenoidectomy on hearing improvement dunng the mal penod. A principal component 
analysis without the adenoidectomies revealed no differences between the clusters. 
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Maximal contrast 
Spontaneous resolution and recurrence of O M E in the W W group obscured the contrast 
in underlying disease between the VT group and the W W group. To test our etiological 
model (effusion causes heanng deficits) we compared the children with effusion during the 
whole follow-up period (N=28) to the children who were effusion-free during follow-up 
(N=54); note that in this analysis, the original intervention contrast was disregarded. 
After adjustment for hearing level at randomisation, the mean hearing level in the children 
who were diagnosed as having bilateral effusion only at randomisation showed 6.8 dB 
more improvement than that in the children with effusion during the whole follow-up 
(p=0.007). The absolute heanng levels in the children who were effusion-free during 
foUow-up were 34.1 dB A (SE=1.0) and 30.8 dB A (SE=0.7) at 6 and 12 months foUow-
up, respectively. In the children with bilateral effusion dunng the entire follow-up these 
heanng levels were 40.8 dB A (SE=1.7) and 39.3 dB A (SE=1.5), respectively. 
Discussion 
Some aspects of the findings in this study confirm those reported in other randomised 
controlled studies on surgery for O M E in older children.181 18'',88 '"'' The effect of 
ventilation tubes on group average heanng levels was evident at 6 months foUow-up, but 
most of the advantage had disappeared by one year follow-up. In accordance with the 
results of the study by Gates'81 effusion was present for about one third of the follow-up 
period in the VT group. The percentages of tubes that remained in situ (92%, 76%, 56% 
and 30% at 3, 6, 9 and 12 months follow-up, respectively) are in agreement with the 
findings of Gibb & Mackenzie19 who studied Reuter Bobbins®. 
It should be emphasised that the children in our study were much younger than 
those in previous trials. The mean age at randomisation in our study was 19 months 
compared to 4 yean and older in all the other studies was. Therefore, comparisons with 
the literature might not always be meaningful. 
The children in our study were referred to an E N T department after they had 
failed a population based auditory screening test (thus without any obvious complaints), 
whereas in other studies the children were recruited by means of referral by GPs, speech 
and hearing centres or other hospital departments because of heanng problems and/or 
behaviour problems. 
This might imply that the children in the present study had milder hearing loss than those 
in previous studies. 
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In contrast with other studies reported in the literature, we found that the 
magnitude of hearing loss was an effect modifier: after the insertion of ventilation tubes, 
children with greater hearing loss at randomisation improved more than those with a 
better hearing level. 
It is also of interest that the group mean hearing loss decreased in the children in the W W 
group who did not recover spontaneously from O M E (from 45.4 dB A to 38.7 dB A). 
This may have been due to an age-effect as indicated by Orchik and Rintelman174. 
However, in our trial the two groups of children were of equal age, thus this age-effect 
will not have confounded the effect estimates. 
Unexpectedly, there was a difference of 3 dB in mean hearing levels between the 
VT group and the W W group at baseline, despite the balanced randomisation procedure. 
This may have partly been due to the fact that immediately after finding out the result of 
balanced randomisation, the parents of 19 children who had given informed consent 
withdrew their child from the study. These children were not included in the analysis; 15 
had been randomised to the VT group and 4 to the W W group. Audiometry data on these 
children showed that the 4 children randomised to the W W group had poorer hearing 
levels than the remaining children in the W W group. To adjust for this baseline difference, 
hearing level at randomisation was added as a co-variable in the analyses. 
In addition, 10 children in the W W group received treatment with ventilation 
tubes during follow-up. These children differed from the remaining children in the W W 
group with respect to sex (more girls) and age (older) and mean hearing deficit at 
randomisation (higher) (42.9 versus 47.6 dB A, respectively). At the last measurement 
before receiving ventilation tubes, 6 out of the 10 children had a hearing threshold of 
equal to or larger than 45 dB A. A sensitivity analysis (those 10 children were analysed as 
treated, or not analysed at all) showed that these differences could not account for the 
effects in the intention-to-treat analysis. A further 11 children dropped-out in the trial 
penod (8 from the W W group and 3 from the VT group). There was a difference in mean 
hearing level at randomisation in the three children withdrawn from the VT group (mean 
hearing level of 59.2 dB A). However, these three children will have little impact on the 
overall results. 
In conclusion, this study showed that ventilation tubes improved the hearing levels 
in infants with persistent bilateral OME. The magnitude and duration of this effect, 
however, was limited. Whether this provides sufficient justification for treatment in this 
age group also depends on other effects, such as possible improvement in language 
development or in quality of life. These effects need to be studied before conclusions can 
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be drawn about the (cost) effectiveness of treatment with ventilation tubes in infants who 
are diagnosed as having persistent O M E after referral from a screening programme 
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Abstract 
Objective To study the effectiveness of ventilation tubes on the language development in 
infants with persistent otitis media with effusion (OME) All existing studies addressed 
children of 3 years or older. Nowadays O M E is detected and treated with ventilation tubes 
at a younger age. Because of the critical relationship between age, hearing and language 
development, we conducted a study of the effects of ventilation tubes on language 
development in infants with persistent O M E , aged 1-2 years. 
Design A multi-centre randomised controlled tnal (embedded in a cohort) with two 
treatment arms A) ventilation tubes (N=93) and B) watchful waiting (N=94) Hearing 
loss, expressive and comprehensive language were assessed every six months, while 
tympanometry and otoscopy were performed every three months 
Remiti. N o relevant differences were found in expressive or comprehensive language 
between the two groups after adjustment for educational level of the mother, IQ of the 
child and differences at baseline However, there were delays in expressive language in 
both groups compared to their age expected values Disregarding the intervention contrast, 
improvements in hearing appeared to be related to improvements in language 
development, especially in verbal comprehension. 
Coiichnioiii,. In the total group of infants with persistent OME, ventilation tubes did not 
have any incremental effect on language development. Beneficial effect of treatment in 
individual patients or subgroups of patients can however not be excluded 
Introduction 
Otitis Media with Effusion (OME) is one of the most common diseases in early childhood, 
it is associated with mild to moderate conductive heanng loss " V'A This hearing loss is 
presumed to have an adverse effect on language development , The aim of the 
insertion of ventilation tubes is to restore hearing to normal levels and to prevent potential 
developmental problems. 
Evidence of an association between O M E during very early childhood and (later) 
language developmental problems, however, remains elusive, because of conflicting results 
from previous studies " ^ Some authors found an association between otitis media and 
language development " ', whereas others did not " . The conflicting findings may be 
caused by methodological limitations "• ^4 i ' VH Some studies failed to confirm the duration 
and the seventy of O M E or did not measure heanng levels. Other studies used a 
retrospective design, included only a few cases and/or only a specific group of children. 
None of the studies accounted for other factors that might contnbute to a child's language 
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perfonnance, such as the educational level of the mother or other demographic 
characteristics. 
A focus on young children is necessary because the essence and rates of language 
development in infants are different for infants and pre-school children First, speech and 
language develop more rapidly during the first 2 years of life than in subsequent years 
Second, it has been argued that (intermittent) hearing loss because of OME has different 
effects on early and later language development""', because one-to-one interaction typically 
for early childhood contrasted with communication in noise at later ages. 
Adequately designed prospective studies on the effects of O M E on development 
are only few in number. ' Nowadays, O M E is detected and treated with ventilation tubes 
at a younger age4', so there is need for well designed studies among young children. 
Non-randomised studies on children of younger than 3 years found mixed or 
contradictory results Wnght et al. did not find an association between O M E and speech 
and language scores in children of 2 years. Fnel-Patti and Finizo21 found effects on 
receptive language in one-year old children and effect on expressive language in 1.5 years 
old children; however, there were no effects during the other periods, i.e. between 1-2 
years. Vernon-Feagans et al ^ and Roberts et al." found an association between O M E 
and language development, but their analyses suggested that this association was probably 
confounded by the environment of the child (e.g. educational level of the mother) 
The accepted way to deal with such (unknown) confounding is to perfomi a randomised 
controlled trial. Maw et al.4N recently performed such a trial on 186 children of 3-4 years 
old. At 9 months follow-up, marginally significant differences were found in 
comprehensive and expressive language between children in the surgery group and the 
watchful waiting group However, 18 months after randomisation 85% of the children in 
the watchful waiting group had undergone surgery and the groups no longer differed. So 
far, no trials have been performed on children of younger than 3 years of age. 
W e performed a randomized controlled tnal on the effect of treatment for O M E 
on language development in infants of 16-24 months Treatment with ventilation tubes 
was compared to watchful waiting in infants with persistent OME. Language development 
was tested at 6 and 12 months follow-up. 
Patients and methods 
Patients 
The tnal is embedded in a cohort, which includes 30,099 children bom in the Eastern part 
of the Netherlands between 1 January 1996 and 1 April 1997 These children were invited 
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for routine heanng screening at the age of 9 months. For the purpose of the trial, those 
who failed three successive tests were referred to one of the 13 participating E N T 
outpatient clinics for diagnosis and follow up (n=1081). The parents of infants found to be 
suffering from persistent (4-6 months) bilateral O M E (confimied by tympanometry and 
otoscopy) by the E N T surgeon in subsequent observations were invited to enter their 
child into our randomised controlled trial (N=386). Exclusion cntena were. Down's 
syndrome, schisis, asthma, cystic fibrosis, and sensonneural heanng loss. The children for 
whom informed consent was obtained were randomly allocated to one of two groups. VT 
group (N=93): treatment with ventilation tubes (Bevel Bobbins®), or W W group 
(N=94)· a penod of watchful waiting The two groups were followed for one year with 
language tests within 2 weeks after randomisation (before treatment) and at 6 and 12 
months after randomisation 
Information on prognostic factors, such as educational level of the mother, 
attending day care and the number of siblings, was obtained using a questionnaire that was 
filled in by the parents dunng the first visit to the E N T clinic 1'"1 Information on other 
clinical symptoms, such as adenoidectomy before randomisation was obtained by means of 
a questionnaire that was filled in by the E N T surgeon. 
We obtained approval from the Ethical Committees of all 13 participating hospitals. 
Methods 
A balanced allocation procedure was employed to increase the comparability at baseline. In 
this trial, 187 children were balanced over 5 prognostic factors: sex, age, season at 
randomisation, educational level of the mother and hospital. 
The Reynell test19'' was used to measure comprehensive language development, 
while the Schhchting test1'' was used for the expressive language development. These tests 
were administered by a speech therapist Scores were obtained as age-standardised and 
equivalent age. We also used the Lexi test for the expressive language development. 
This test consists of words that appear in normal language; the parents are asked to mark 
the words that their child speaks spontaneously. 
Heanng was assessed with a portable visual reinforcement audiometry set, which 
was developed especially for this study and has been desenbed in detail elsewhere.1'" 
Otoscopy was performed by the E N T surgeon. Tympanometry was classified according to 
Jerger191, while O M E was classified according to the MOMES protocol."'1 
A test for intellectual development (IQ), Bayleys developmental scales (BOS)198, 
was included, because IQ interacts with language development. 
Trial results 
Other factors with potential influence on language development were also 
included: adenoidectomy before randomisation, hospital, attending day care, sex, age at 
randomisation, educational level of the mother, upper respiratory infections, native 
country of the parents, and older siblings. 
The trial was designed to allow for the detection of a mean difference in language 
development of 3 months or more between children allocated to the treatment group and 
watchful waiting group as measured by the Reynell-test at 12 months of follow-up. 
Statistical analysis 
All the analyses were done on the basis of intention to treat. Language development was 
expressed as the difference between equivalent age in months and real age in months. 
Differences in language development at 0, 6 and 12 months as well as the difference 
between 12 and 0 months follow up between groups were tested with the Student t-test 
for independent groups. 
T o adjust for potential confounders as well as to study possible effect modifiers, we 
performed regression analysis with the following basis model: 
M (Alanguage after 12 months follow-up) = ßo + ßi x treatment+ß2 x confounders 
+ ß 1 xtreatmentx effect modifiers 
Potential confounders and/or effect modifiers were: adenoidectomy before randomisation 
(yes/no), hearing loss at baseline (dB), IQ of the child at baseline (low/middle/high), day 
care (yes/no), hospital (1-13), sex (male/female), age at randomisation (>=20/<20) , 
educational level mother (low/middle/high), season at randomisation (winter/ 
spring/summer/autumn), common colds since birth (<=4/>4) , older siblings (yes/no), 
native country of the parents (the Netherlands/other). 
The models were built in two directions: (1) starting with univariate analysis followed by a 
multivariate model with the relevant factors; (2) starting with a model with all potential 
confounders plus all possible effect modifiers, and then deletion of the irrelevant factors. 
W e also made logistic models to analyse the probability that a child would improve 
more than 3 months, 4 months and 170 words on the Reynell, Schhchting and Lexi tests, 
respectively. The dichotomisation of improvements was based on the P75. The models 
can be described by: 
logit ( P ) = a + ß l xtreatment+ß2xconfounders+ß3xtreatmentXefrect modifiers. 
To reduce the number of variables in subgroup analyses we performed principal 
component analysis: a model with two components summarising several clinical factors 
(adenoidectomy before randomisation, frequent common colds, OME before 
randomisation and fever and/or earache as indications of acute otitis media); a model 
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Table 1. Two clusters formed by means of a principal component analysis with two 
components (explained variation=5%) 
Group 
Ventilation tube·: 
Watchjiil watting 
Sex 
Male 
remale 
Adenoidec tomy 
Ya 
No 
Fever 
Ya 
\o 
Earache 
Yes, 
So 
Common colds 
Hearing level at T=() (tIB) 
Cluster 1 
'no/some complaints' 
62 
62 
69 
55 
3 
119 
8 
116 
31 
93 
3 8 
44 f 
(50.0%) 
(50.0%.) 
(55.7%,) 
(44.4%.) 
(4 0%) 
(96 0%) 
(6.5%) 
(93 6%) 
(25.0%,) 
(75.0%,) 
) 
Cluster 2 
'frequent complaints' 
49 
28 
35 
20 
11 
44 
49 
6 
55 
0 
4 7 
4 5 ' 
(49 1%) 
(50 9%) 
(63.6%) 
(36 4%) 
(20 0%) 
(80 0%) 
(89 1%) 
(10.9%) 
(100%,) 
(0%,) 
+ 
Table 2. Two clusters formed by means of a pnncipal component analysis with two 
components (explained variation=8%) 
Cluster 1 Cluster 2 
'low change' 'high change' 
20 (47.6%,) 
22 (52.4%,) 
19 (45.2%) 
23 (54.8%) 
36 (85.7%) 
6 (14.3%) 
27 (64 3%,) 
15 (35.7%,) 
0 (0%) 
14 (33 3%) 
28 (66.7%) 
3 (7.7%) 
11 (28 2%) 
25 (64 1%) 
Group 
Ventilation tuba 
Walclijnl waiting 
Sex 
Male 
heimle 
Day care 
Yes 
\o 
Older siblings 
Ye·. 
\o 
Educational level mo the r 
Loir 
Middle 
High 
1Q of the child 
Low 
Middle 
Hwh 
70 
68 
86 
52 
11 
127 
122 
16 
47 
74 
17 
61 
49 
31 
(50.7%,) 
(49.3%,) 
(62 3%) 
(37 7%) 
(8 0%) 
(92.0%,) 
(88.4%,) 
(11 6%,) 
(34.1%,) 
(53.6%) 
(12.3%) 
(43.3%) 
(34.8%,) 
(22.0%,) 
Trial results 
indicating the degree of auditive stimulation (educational level of the mother, older 
siblings, attending day care and the intellectual development of the child). Two clinical 
components occur (see also Table 1): 1) children with no or some complaints and 2) 
children with frequent complaints. Two clusters were also apparent for the predisposing 
factors (see also Table 2): 1) the 'low chance' children (children with a lower IQ and 
mothers with a low educational level and 2) the 'high chance' children (children with a 
higher IQ and mothers with a high educational level). 
Results 
A total of 187 children were randomised: 93 children to the ventilation tube (VT) group 
and 94 to the watchful waiting (WW) group. Mean language development and patient 
charactenstics are shown in Table 3. The parents of 19 infants withdrew immediately after 
randomisation. During the trial period, a further 11 children dropped-out: 8 children from 
the W W group and 3 from the VT group. Furthermore, 10 children in the W W group 
were treated with ventilation tubes. 
The mean age of the children at randomisation was 19.5 months (SE=1.7) in the 
VT group and 19.4 months (SE=1.9) in the W W group. 
The mean hearing levels (measured over 500, 1 ()()(), 2000 and 4000 Hz) in the best ear at 
randomisation were 46.4 dB A (SE=1.1) in the VT group and 43.4 dB A (SE=1.2) in the 
W W group. 
At 6 months follow-up the improvement in hearing levels in the VT group was 
10.2 dB versus 4.6 dB in the W W group; at 12 months follow-up, these values were 13.1 
dB and 8.5 dB, respectively. 
At 3, 6, 9 and 12 months follow-up, 14.6%, 29.3%, 26.9% and 26.6% of the 
children in the VT group were diagnosed with bilateral OME, respectively. In the W W 
group, these percentages were 77.2%, 65.9%, 57.3% and 53.2%, respectively. In the W W 
group 25 (26.6%) children were diagnosed as having bilateral O M E at all visits, while 10 
(10.7%) children only had one episode of bilateral OME. In the VT group, three (3%) 
children were diagnosed as having bilateral O M E at all visits, while 44 (47.3%) were only 
diagnosed as having bilateral O M E before insertion of the tubes. 
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Verbal comprehension 
Figure 1 shows the children's comprehensive language development. Language 
development in the VT group increased more than that in the W W group, but there was 
also a baseline difference. At baseline the W W group had a language development that was 
0.3 month (95% CI -0.3 - 0.95) behind their age score, while the VT group score was 0.9 
month (95% CI 0.35 - 1.5) behind their age score. At 6 and 12 months follow-up, both 
group scores were better than the age scores. At 12 months follow-up, the children in the 
W W group had improved 0.8 month (95% CI -0.1 - 1.6), while the children in the VT 
group had improved 1.8 months (95% CI 1.0 - 2.6). 
Multivariate analysis showed that educational level of the mother, IQ of the child 
and language development at baseline were confounders. In Table 4A, the estimates of this 
model are shown. After adjustment for these factors, the children in the VT group 
improved 0.7 month (95 % CI -0.3 - 1.7) more than the children in the W W group 
(p=0.18). 
In Table 413, the estimates of the logistic model are shown. In this model, the 
probability to improve more than 3 months in the VT group was 0.48 (95% CI 0.29 -
0.68) for children with highly educated mothers versus 0.09 (95% CI 0.02 - 0.30) whose 
mothers had a low educational level. In the W W group, these chances were 0.30 (95% CI 
0.14 - 0.53) and 0.14 (95% CI 0.04 - 0.35), respectively. 
The principal component analyses with two components showed that in the VT 
group, the children with frequent complaints (cluster 2, Table 1) improved 1.6 months 
more than those with no or some complaints (p=0.20). However, the VT group children 
with favourable language stimulation (cluster 2, Table 2) did not improve more than the 
children with less favourable stimulation (p=0.4). 
Table 3. Mean language development in months (equivalent age - real age) and patient characteristics 
G r o u p 
Vaitiliition tube* 
Watchlul 
Sex 
Male 
Female 
Education 
Lo ir 
Middle 
High 
Season at ' 
Spnug 
Summer 
Aiitimui 
Winter 
waiting 
m o t h e r 
T = 0 
Age at T = ( ) 
<20 inotith* 
>20 montlis 
Distr ict 
/ 
2 
3 
4 
IQ' 
Uni' 
Middle 
High 
N u m b e r 
93 
94 
110 
77 
46 
92 
49 
43 
47 
59 
38 
145 
42 
11 
125 
25 
2f> 
66 
62 
58 
Vent i la t ion 
tubes 
93 
— 
55 
38 
23 
45 
25 
20 
23 
31 
19 
72 
21 
7 
62 
13 
11 
35 
29 
28 
W a t c h f u l 
w a i t i n g 
— 
94 
55 
39 
23 
47 
24 
23 
24 
28 
19 
73 
21 
4 
63 
12 
15 
31 
33 
30 
R e y n e l l 
T = 0 
-0 91 
-0 31 
-0.94 
-0.14 
-1 77 
-0 45 
0 26 
-1 19 
-1 21 
0 27 
-0 61 
-0 46 
-1 14 
0 09 
-0 69 
-0 84 
-0 35 
-2 68 
-0 68 
1 81 
R e y n e l l 
T = 6 
0 11 
0 51 
0 01 
0 72 
-1 93 
0 52 
2.14 
0 38 
-0 49 
0 25 
1 27 
0.74 
-1 18 
1 91 
0 23 
0 52 
-0.16 
-2 47 
0 58 
3 21 
Reynel l 
T = 1 2 
0 87 
0 59 
0 36 
1 2.3 
-2 14 
1 19 
2 77 
-0 48 
0 27 
1 52 
1.50 
0 88 
0 22 
1 73 
0 92 
-0.38 
0 45 
-2 48 
1 73 
3 35 
Reynel l 
Δ 1 2 
1.78 
0 77 
1 28 
1 27 
-0.43 
1 56 
2 47 
0 71 
1 56 
0 96 
2 08 
1 29 
1 22 
1 64 
1.50 
0 33 
0 95 
0 24 
2 29 
1 42 
Schl icht ing 
T = 0 
-2 49 
-1 97 
-2 52 
-1 79 
-3 07 
-1 85 
-2 16 
-2 44 
-2 60 
-1 71 
-2 39 
-2 02 
-2 90 
-1.45 
-2 15 
-2 43 
-2 69 
-4 30 
-2 16 
-0 03 
Schl icht ing 
T = 6 
-2 13 
-1 06 
-2 30 
-0 58 
-3 79 
-1 31 
-0 02 
-1 98 
-2 05 
-1 11 
-1 32 
-1 21 
-2 90 
-1 45 
-2 15 
-2 43 
-2 69 
-4 30 
-2.16 
-0 03 
Schl icht ing 
T = 1 2 
-1 27 
-0 16 
-1 39 
0 17 
-3.95 
-0 48 
1 91 
-1 93 
-1.95 
0 31 
0 47 
-0 81 
-0 33 
-0 10 
-0 24 
-2 75 
-1 18 
- 4 27 
-0 36 
2 53 
Schl icht ing 
Δ 1 2 
1 35 
1 88 
1 24 
2 12 
-1 06 
1 55 
4 02 
0 51 
1 34 
1 85 
2.76 
1 .34 
2 69 
0 80 
2 14 
-0 23 
1 32 
0 21 
2 1 8 
2 45 
The l.ingujßi scores OMT the subgroups ol the idiu..moii.iI kvd of the inothir AS well JS ovtr the subgroups ot tin. IQ ol tin. child wen signifiiam (ρ« · OS) tor ill mcisurumnts 
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Figure 1. Comprehensive language development (equivalent age - real age in months) 
- · — Reynell (Ventilation tubes) 
- • - Reynell (Watchful waiting) 
12 
months of follow-up 
Table 4A. Final linear model with development of verbal comprehension (Reynell) as 
dependent vanable at 12 months follow-up (N=173; 86 children in the WW group and 
87 in the VT group) 
Co-vamble 
Intercept 
Treatment effect 
Watchful waiting 
Ventilation 
Language at T = 0 
tubes (refi 
Educational level mother 
Η,χΙ, 
Middle(rel) 
LAW 
IQ of the child 
High 
Middle 
Low (refi 
Estimate 
-0.19 
-0 71 
— 
-0.53 
0 86 
— 
-2.10 
2.92 
2 86 
— 
SE 
0 67 
0 53 
— 
0 11 
0 65 
— 
0 65 
0.83 
0 68 
— 
p-valuc 
0 18 
— 
0.0001 
0.19 
— 
0.002 
0.0006 
0 0001 
— 
Trial results 
Table 4B. Logistic model with an improvement of more than 3 months (Reynell) as 
dependent variable (N=173; 86 children in the W W group and 87 in the VT group) 
Co-varuble 
Intercept 
Treatment effect 
Watchful waitnif· 
Ventilation tube': (refi 
Educational level mother 
Higfi 
Middle (refi 
Low 
Treatmentx Educational level 
Watchful wattntgxhigh 
Watchful waitmgxlow 
Othm (ref) 
Estimate 
- 0.59 
- 0 51 
— 
0.50 
— 
-1.72 
-0.25 
0.97 
--
SE 
0.32 
0 47 
— 
0 53 
— 
0.81 
0.80 
1.08 
-
p-value 
0.28 
0.34 
— 
0 03 
0.75 
0 37 
--
Figure 2. Expressive language development (equivalent age - real age in months) 
o 
E, 
o 
w 
O) 
en 
< 
- Schlichtmg (Ventilation tubes) 
- Schlichtmg (Watchful waiting) 
12 
months of follow-up 
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Expressive language 
Figure 2 shows expressive language development. During the whole follow-up period, the 
two groups had scores that were behind their age scores. The overall increases in 
expressive language were 1.9 (95% CI 0.65 - 3.1) and 1.4 (95% CI 0.2 - 2.5) months in 
the W W and VT group, respectively. 
Again, language development at baseline, educational level of the mother and IQ, 
were confounders in the multivariate analysis. The estimates of this model are shown in 
Table 5A. After adjustment for the confounding factors, the children in the W W group 
improved one month more than those in the VT group (p=().17). 
Table 5A. Final model with development of verbal expression (Schlichting) as dependent 
variable at 12 months follow-up (N=158; 78 children in the W W and 80 in the VT 
group) 
Co-vanablc 
Intercept 
Treatment efFett 
Watciijul waiting 
Ventilation li 
Language at T=0 
ibes (ret) 
Educational level mother 
High 
Middle (refi 
Low 
IQ of the child 
High 
Middle 
Low (rej) 
Estimate 
-3 5Ï 
0 96 
— 
-0.88 
1.80 
— 
-2 26 
5 21 
3 47 
— 
SE 
0 98 
071 
— 
0.13 
0.86 
— 
0.91 
1 06 
0 94 
— 
p-value 
0 0004 
0 18 
— 
0 0001 
0.04 
— 
0 01 
0 0001 
0 0003 
— 
Table 5B. Logistic model with an improvement of more than 4 months (Schlichting) as 
dependent variable (N=158; 78 children in the W W group and 80 in the VT group) 
Co-vanable 
Intercept 
Treatment effect 
Watchful waiting 
Ventilation tnbn (ref) 
Educational level mother 
High 
Middle (ref) 
Low 
Treatment x Educational level 
Watchful waitingy-higli 
Watchful wattingxlow 
Otiten (ref) 
Estimate 
-1 71 
1 16 
— 
1 79 
— 
-1 13 
-1.56 
-0 40 
— 
SE 
0 44 
0 55 
— 
0.61 
— 
1.12 
0.83 
1.39 
— 
p-value 
0 4 
— 
0 0003 
— 
0 31 
0 06 
0 77 
— 
Trial results 
In Table 5B the estimates of the logistic model are shown. In this model, the 
probability of an improvement of 4 months or more in the VT group was 0 52 (95% CI 
0.32 - 0.71) for children with highly educated mothers versus 0 06 (95% CI 0.01 - 0 31) 
for children whose mothers had a low education In the W W group, these chances were 
0.42 (95% CI 0.23 - 0 64) and 0.11 (95% CI 0 03 - 0.35), respectively. 
No differences were found between the vanous clusters (Table 1 and 2) 
The children in the W W group improved from 60 to 267 words on the Lexi test, 
versus an improvement from 55 to 253 words in the VT group (p=0.66). After adjustment 
for educational level of the mother, IQ of the child and language development at baseline, 
the children in the W W group improved 8 words more than the children in the VT group 
(p=0.32). The probability of achieving considerable improvement on the Lexi test (i.e. 
more than 170 words) was equal within the two groups and within the vanous subgroups 
Maximum contrast 
Spontaneous resolution and recurrence of O M E obscured the contrast between the two 
groups to some extent. To test our etiological model (hearing loss due to O M E influences 
language development) we compared the children with effusion during the entire follow-
up period (N=28) to the children who were effusion-free during follow-up (N=54). The 
comprehensive language of children who were effusion-free during follow-up improved 
1.5 months (95% CI -0 .2 - 3 2) more than that of the children who had persistent 
effusion. N o differences were found for expressive language development. 
Hearing level 
As mentioned above, the etiological model of this study was that effusion results in hearing 
loss, which was expected to influence language development. I3y comparing the language 
development of the children in the VT group to that in the children in the W W group, 
we only studied the effect of O M E on language development To study the effect of 
heanng levels on language development, we made another linear model with the 
improvement in hearing at 12 months follow-up as independent variable. After correction 
for the language difference at baseline, the educational level of the mother and the IQ of 
the child, the children with the greatest improvement in hearing had the best 
comprehensive language development: ß=-0.()5 (SE=() 02, p=().()l), which means that 
with every dB improvement in hearing, comprehensive language development improved 
0.05 month. For expressive language, the p-estimate was also -0.05 (SE—0.03), but this 
estimate could not be distinguished from chance (p = 0 10). 
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It should be noted that the original intervention contrast was disregarded in this analysis 
and the maximum contrast analysis. 
Discussion 
In this trial, there was no difference in language development between young children 
who received ventilation tubes and those who underwent watchful waiting. This is 
dissimilar to the study by Maw4N who reported a marginal effect of otitis media treatment 
on language development. This might be due some differences between the trials. First, 
the children in the Bristol trial were older (3 years versus 19 months in our study). Second, 
the children in our tnal were selected on the basis of failing the E wing screening and had 
no obvious complaints, while the children in Maw's trial were included because of 
disruptions in speech, language, learning or behaviour. Third, Maw did not adjust for 
important co-variables such as educational level of the mother and IQ of the child. As 
Roberts and Vernon-Feagans suggested in their papers29 ^ 47 ," ' w , it is important to account 
for any factors that might contribute to a child's language performance and therefore might 
interact with the treatment effect. 
Verbal comprehension improved from below standard to about the standard level 
during the trial. The children with ventilation tubes did not improve substantially more 
than those in the W W group. Verbal expression, however, remained below standard, 
which is in agreement with the findings of Maw.48 It should be noted that it takes a child 
about 5 months to produce the words once he/she comprehended them.""" The follow-up 
period in our study might have been too short to demonstrate an effect on verbal 
expression in the core analyses as well as in analysing the maximal contrast. 
In this study we used the Reynell, Schlichting and Lexi tests to study the relation 
between early persistent O M E and language development. These tests are directly related 
to normal language, widely accepted and validated. It cannot be ruled out that more 
specific measures, such as auditory perception tests, would have produced more differences 
between groups, but the focus was on general language development. 
Surprisingly, despite balanced randomisation there was a difference in language 
development between the VT group and the W W group at baseline. This difference can 
partly be explained by 19 parents who had given informed consent, but withdraw their 
child immediately after hearing the result of the balanced randomisation procedure. These 
children were excluded from the analyses; 15 had originally been randomised to the VT 
group and 4 to the W W group. Audiometry data on these 19 children showed that the 4 
children randomised to the W W waiting group had poorer mean hearing levels than the 
Trial results 
remaining children in the W W group To adjust for this baseline difference, language 
development at randomisation was taken into account in the analysis. 
The educational level of the mother appeared to be an important co-variable in our 
model, despite the balanced allocation procedure over this factor. This can be explained on 
the basis of the children who were withdrawn immediately after randomisation Although 
the resulting imbalance was small, we had to adjust for this factor in our multivariate 
model 
A total of 10 children in the W W group received treatment with ventilation tubes 
during follow-up. A further 11 children dropped-out during the trial period. If these 
children differed from the other children, the intention-to-treat analysis would have lead 
to an underestimation of the effect. However, no differences in language development 
were found at baseline between the 10 children who received ventilation tubes during 
follow-up and those who remained in the W W group, or between the 11 children who 
dropped-out and those who completed the trial. In sensitivity analyses, the 10 children 
who received ventilation tubes were not analysed at all or they were analysed as treated, 
the results did not change. 
In conclusion, ventilation tubes did not have a substantial incremental effect on 
language development m the total group of infants with persistent O M E In agreement 
with the language model of Roberts and Vernon-Feagans46, hearing improvement 
appeared to have an incremental effect on language development. In this model, hearing 
loss was the causal vanable, but there were also moderating variables, such as the 
educational level of the mother, parental sensitivity, child IQ and child temperament. It is 
possible that the parents of children with persistent OME and hearing loss compensate for 
negative effects of impaired hearing on language development In our study we tned to 
find such subgroups, but no relevant differences were found. As this might be due to a 
power problem, a meta-analysis is advocated on data-sets of trials that adequately 
documented the potential modifiers. 
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Abstract 
Objective To study the effect of a treatment with ventilation tubes on quality of life in 
children aged 1-2 years with persistent OME, as compared to watchful waiting. 
Design· A multi-centre randomised controlled trial (n=187) with two treatment amis: 
ventilation tubes and watchful waiting. Children were detected by auditory screening at 
the age of 9-12 months, and were subsequently diagnosed as having persistent (4-6 
months) bilateral O M E . Quality of life (TAIQOL and Enckson scales) was measured at 0, 
6 and 12 months follow-up 
Remiti On almost all subdomains of the TAIQOL, except for aggression, the children 
with ventilation tubes showed greater improvement in quality of life, or less increase in the 
number of complaints. On the Enckson scales, only 2 out of the 10 subdomains 
(compliance and hostility) showed a slight difference in favour of the children with 
ventilation tubes However, none of these differences were statistically significant. 
Conclihion Ventilation tubes did not have a substantial incremental effect on the quality of 
life of infants aged 1-2 years with uncomplicated persistent bilateral OME. 
Introduction 
Otitis Media with Effusion (OME), one of the most common diseases in childhood, is 
usually associated with mild to moderate hearing loss. Over the past three decades, much 
research has been done into the effects of O M E on children's development ^ Several 
studies demonstrated impaired developmental outcomes due to OME, but other studies 
failed to show such associations.,:>"t',2"' Variety in results may be due to limitations in 
design, methodology or selected study populations. Only a few adequately designed 
prospective studies have been published on the effect of O M E on development.""' 
Treatment with ventilation tubes (grommets) improves hearing impairment in 
children with O M E ' l 8 ' ' "* and might therefore prevent developmental problems. Most 
studies on the effect of ventilation tubes addressed speech development, language 
development, cognitive development or behaviour, which were measured with 
standardised tests. In contrast, quality of life (QoL) focused on parents' subjective 
perception of their children's health status, was mostly ignored, while on theoretical 
grounds it might be assumed that an impaired development will be related to the general 
health status (QoL). QoL broadly includes aspects of physical, psychological and social 
functioning The lack of a clear definition is reflected in the many instruments that have 
been proposed to measure QoL, each of them based on a different quality of life 
concept." '" QoL instruments either focus on general health measurement or on disease-
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specific well-being. Specific well-being may be more sensitive to the effect of disease, 
while generic tests are more suitable for making compansons with other diseases."' 
Clinicians who deal with O M E frequently encounter spontaneous comments from 
parents after their child has received ventilation tubes. They record remarkable differences: 
improved sleep patterns, improved awareness, and a less irntability and much happier 
child.""'1 In a study of Rosenfeld""3, parents reported fewer physical symptoms and less 
emotional distress in their children. A limitation of these studies, however, is that they 
lacked a control group for comparison. Another problem is that only children of 3 years or 
older were included. Nowadays, O M E is detected at an earlier age and ventilation tubes 
are being inserted at a younger age."^ 
This presents the rationale to study the effect of treatment with ventilation tubes on 
the quality of life of infants (1-2 years of age) with persistent bilateral OME. We 
performed a multi-centre randomised controlled tnal in which we compared treatment 
with ventilation tubes to a period of watchful waiting. 
Patients and methods 
Patients 
The trial is embedded in a cohort, which includes 30,099 children born in the Eastern part 
of the Netherlands between 1 January 1996 and 1 April 1997. These children were invited 
for routine heanng screening at the age of 9 months. For the purpose of the trial, those 
who failed three successive tests were referred to one of the 13 participating E N T 
outpatient clinics for diagnosis and follow-up (N=1081). The parents of infants diagnosed 
with persistent (4-6 months) bilateral O M E (confirmed by tympanometry and otoscopy) 
by the E N T surgeon in subsequent observations (N=386) were invited to enter their child 
into our randomised controlled trial. The children for whom informed consent was 
obtained were randomly allocated to one of two groups: VT group (N=93): treatment 
with ventilation tubes, or W W group (N=94): a period of watchful waiting. QoL was 
measured at baseline and at 6 and 12 months follow-up by means of questionnaires and 
scoring of standard video recordings. 
We obtained approval from all the Ethical Committees of the 13 participating hospitals. 
Methods 
To measure quality of life, we used the T A I Q O L (TNO-AZL Infant Quality of Life) 
questionnaire"1"'. As parent-child interaction can be seen as a domain specific part of quality 
of life, we also measured this interaction by means of the Enckson scales.2"7 The TAIQOL 
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questionnaire was developed for children of 1-4 years and it is filled in by one of the 
parents The questionnaire contains 46 items, covenng 13 domains (i.e. lungs, stomach, 
skin, sleeping, appetite, eating problems, aggressive behaviour, positive emotions, 
emotions of panic, vitality, social behaviour, motoric problems, and communication). In 
19 out of the 46 items, only the occurrence of specific complaints is assessed, while the 
other 27 items form a combination of the occurrence of specific complaints and the 
emotional response of the parents to the complaint. In the analysis, we separated the two 
sets of items; the emotional response was only studied when a difference in occurrence was 
found. 
Parent-child interaction was measured with the Enckson scales Each parent-child 
pair was videotaped in a structured play setting for 13 minutes in a room at the hospital. 
Three toys were placed in the room, representing intellectual, physical and social areas of 
development At 0, 6 and 12 months follow-up, different toys were used" set A consisted 
of a jig-saw puzzle with 5 pieces, a Bo-peep farm set and three different books, set Β 
consisted of ajig-saw puzzle with 14 pieces, a feed-the-animal game and three different 
books; set C consisted of ajig-saw puzzle with 14 pieces, a surpnse-key car game and 
three different books. The parents were told that the investigator was interested in how 
the parent and child played together The parents were asked to start playing with the jig­
saw puzzle (for 3 minutes), followed by the game (for 5 minutes) and the books (for 5 
minutes). The investigator then left the room and knocked on the door after 3, 5 and 5 
minutes to let the parents know when to change toys. 
From the tapes 5 child scales (negativism, compliance, affection for the mother, 
avoidance of the mother and reliance on the mother) and 5 parent scales (supportive 
presence, respects autonomy, structure and limits, quality of instruction and hostility) were 
scored on a 7-point scale ( l=low interaction to 7=high interaction) ""7 
O M E was defined according to the M O M E S protocol"' , which is pnmanly based 
on tympanometry If tympanometry could not be performed, or if the tympanograms 
were doubtful (type C2), otoscopy was used to make the diagnosis. 
Heanng was assessed with a portable visual reinforcement audiometry set. It 
appeared to be a good alternative for the standard visual reinforcement audiometry in 
multi-centre trials A more extensive descnption is given in a separate paper.1 9 2 
Statistical analysis 
All analyses were done according to the intention-to-treat principle. Differences in 
domains at 0, 6 and 12 months of follow-up between the groups were tested with the 
Wilcoxon test as the scores were not normally distributed. To adjust for potential baseline 
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differences we also studied differences in scores between 6 months follow-up and baseline, 
as well as differences between 12 months follow-up and baseline 
To adjust for potential confounders and to study possible effect modifiers, we 
constructed logistic models, with the dichotomised scores based on improvement (children 
who improved versus the others) at 6 months and at 12 months follow-up as dependent 
vanable. 
Potential confounders were, educational level of the mother (high/middle/low), older 
siblings (yes/no), attending day care (yes/no), sex (female/male), adenoidectomy before 
randomisation (yes/no). These variables were also included as potential effect modifiers. In 
addition hearing level at randomisation (dB) was tested for interaction with treatment 
A multivariate analysis of vanante (MANOVA) was performed to detect a 
treatment effect for all domains combined; for this analysis we modelled the improvement 
scores at 6 and 12 months follow-up. 
Results 
A total of 187 children were randomised: 93 children to the ventilation tube (VT) group 
and 94 children to the watchful waiting (WW) group. Between randomisation and 12 
months of follow-up, 11 children dropped-out: 8 children from the W W group and 3 
from the VT group. In addition, 10 children from the watchful waiting group received 
treatment with ventilation tubes during the tnal period 
The mean age of the children at randomisation was 19.5 months (SE=1 7) in the VT 
group and 19.4 months (SE=1.9) in the W W group 
The mean hearing loss (measured over 500, 1000, 2000 and 4000 Hz) in the best ear at 
randomisation was 46.4 dB (SE=1 1) in the VT group and 43.4 dB (SE=1 2) in the W W 
group. 
At 6 and 12 months follow-up, the hearing levels in the VT group had improved more 
than those in the W W group (10.2 and 13.1 dB versus 4.6 and 8.5 dB, respectively). 
At 3, 6, 9 and 12 months follow-up, 14.6%, 29.3%, 26.9% and 26.6% of the children in 
the VT group were diagnosed as having bilateral OME, respectively. In the W W group, 
these percentages were 77.2%, 65.9%, 57.3% and 53.2%, respectively 
Ue TAIQOL 
Figure 1 shows the difference scores between 12 and 0 months follow-up. Quality of life 
improved in 6 subdomains, whereas the number of complaints concerning appetite, 
anxiety and aggression increased. Except for anxiety, the VT group showed greater 
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improvement or less detenoration than the W W group However, the differences were 
not statistically significant From baseline to 6 months and from at 6 to 12 months follow-
up the mean scores did not favour treatment with ventilation tubes 
In the logistic models on the probability of improving in a specific domain at 6 or 
12 months, we were able to adjust for possible tonfounders and to identify effect 
modifiers N o significant effect of treatment was found In most domains only the score at 
baseline was a confounder that needed to be adjusted for 
The M A N O V A on all the domains combined did not show any difference in 
treatment effect between the VT group and the W W group at 6 months or at 12 months 
follow-up (p=0 22 and p=() 94 with the Hotelling-Lavvley Trace test) 
Figure 1. Difference scores on the subdomains of the TAIQOL between 12 and 0 
months follow-up 
Vitality 
Apetite 
Communication 
Motoric* 
Social 
Anxiety 
Aggression" 
Eating 
Sleeping 
• Watchful waiting 
D Ventilation tubes 
-1 0 1 
Difference scores between 12 and 0 months follow-up* 
* Due to deviation in this scile (rruMmum score 16 instcid of 12), we adjusted this difference score 
according to the other scales 
** Due to deviation of this scale (nia\iinum score 21 instead of 12), we adjusted this difference score 
according to the other scales 
*** A positive difference indicates an increase in complaints, a negative difference indicates a decrease 
Trial results 
Enckson scales 
Figure 2A and 2B show the differences in child and parent scores on the Enckson scales 
between 12 and 0 months follow-up. Some slight differences were found in favour of the 
W W group in most domains, but there was a slight difference in compliance and hostility 
in favour of the children VT group. None of these differences could be distinguished from 
chance. However, when the absolute mean scores at 6 and 12 months follow-up were 
compared some slight but significant differences were found in favour of the W W group, 
especially on the parent scales. 
The logistic models on the probability of improving enabled confoundcr 
adjustment and a search for effect modification. We did not find any differences between 
the two groups No association was found between improvement on all the domains 
combined and treatment (MANOVA) at 6 or 12 months follow-up (p=().19 and p=().38 
for the child scales, versus p=0.21 and 0.95 for the parent scales, respectively). 
Figure 2A. Mean difference scores on the Enckson (child) scales between 12 and 0 
months follow-up 
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A positive difFercnce indicates improvement in parent-child interaction, a negative difTerence 
indicates deterioration. 
r 
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Figure 2B. Mean difference scores on the Enckson (parent) scales between 12 and 0 
months follow-up 
Quality 
Supportive 
Respect 
Hostility 
Structure 
- 2 - 1 0 1 2 
Difference scores between 12 and 0 months follow-up* 
* A positive difFcrence indicates improvement: in p.irent-child interaction a negative difference 
indicates deterioration 
Maximuni contrast 
Spontaneous resolution of O M E in the W W group and recurrence of O M E in the VT 
group might have obscured the contrast between the two groups To test our etiological 
model (hearing loss due to O M E impairs quality of life, while functional ventilation tubes 
improve quality of life) we also compared the children with effusion during the whole 
follow-up period (N=28) to those who were effusion-free during follow-up (N=54) We 
did not find any difference in the 13 domains of the TAIQOL, while on the Enckson 
scales, there was a difference in only one (negativism) out of the 10 domains For 
negativism, we found greater increases in parent-child interaction in the children without 
effusion dunng follow-up (these children showed less anger, dislike, or hostility towards 
their mother) 
5 
• Watchful waiting 
D Ventilation tubes 
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Discussion 
In contrast with earlier studies""4 """', our results did not demonstrate that ventilation tubes 
improve the quality of life of young children with persistent O M E 
It should be realised that previous studies reported so far were uncontrolled, hospital-based 
and focused on older children, whereas our study was controlled, population-based and 
the children were 1-2 years of age In addition, we used a generic QoL test, while 
Pacione" ' and Rosenfeld""1 asked OME-specific questions. Although disease-specific QoL 
tests might be more sensitive" , several domains of the TAIQOL and Enckson scales 
(sleeping pattern, eating problems, avoidance) were a priori relevant for OME. 
Formally, the Enckson scales do not measure quality of life test, but parent-child 
interaction can be seen as a domain-specific part of quality of life. The Enckson scales are 
well validated and more objective than the self completed questionnaires and are therefore 
suitable as an additional test. 
So far, no population norm is available for the TAIQOL. Therefore, mean scores 
cannot be compared to the equivalent scores of children without persistent O M E . Some 
compansons are possible with the Enckson scales. In our study, the parent-child 
interaction scores in the children with persistent O M E were slightly poorer than those 
reported by Drenthen ik Ricksen-Walraven" in children without disease 
It is possible that O M E does not have any great impact on QoL. we did not find 
substantial differences between the children with effusion dunng the whole follow-up and 
those who were effusion-free during this period. 
Despite the balanced randomisation procedure, differences in the T A I Q O L and 
Enckson scores were found between the VT group and the W W group at baseline. These 
differences can partly be explained by the fact that 19 parents who had given informed 
consent withdrew their child immediately after heanng the result of the randomisation 
procedure, 15 children had been randomised to the VT group and 4 to the W W group. 
Audiometry data showed that the mean heanng levels in the 4 children who had been 
randomised to the W W group were poorer than those in the remaining W W children. To 
compare the effect of ventilation tubes to the effect of watchful waiting, we had to use 
difference scores or had to adjust for these differences at baseline in our analyses. 
Some bias may have arisen because 10 children in the W W group received 
ventilation tubes during the study penod. These children were older and there were more 
girls compared to the remaining W W children. Sensitivity analyses in which these children 
were omitted or analysed as treated, did not change the outcome of this study 
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A further 11 children dropped-out dunng follow-up (8 from the W W group and 3 from 
the VT group). Their prognostic factors were similar to those in the children who 
completed the trial. Therefore, no bias is expected from these drop-outs 
In conclusion, this randomised controlled trial indicates that treatment with 
ventilation tubes for uncomplicated persistent O M E in infants should not be motivated on 
the basis of its effect of improving quality of life However, further research is needed to 
investigate OME-specific questionnaires that can signal small but relevant effects. It is 
possible that specific subgroups of children will benefit from treatment with ventilation 
tubes, but this study was too small to detect (small) subgroup effects 
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Abstract 
Objcctwc To study the generalisability of mal results by comparing randomised patients to 
eligible but non-randomised patients who received the same management 
Implementation of trial results is onlyjustifiable when the results can be generalised to the 
total domain population 
Design A multi-centre randomised controlled trial on the effect of early screening and 
treatment with ventilation tubes on infants with otitis media with effusion Randomised 
(N=187) and non-randomised eligible patients (N = 133) were followed-up The study 
population comprised children who were detected by auditory screening at the age of 9-
12 months and who were subsequently diagnosed with persistent bilateral otitis media with 
effusion for 4-6 months 
Remits A slight difference was found in the distribution of some prognostic factors more 
randomised children had older siblings, did not attend day care and had mothers with a 
lower educational level than the non-randomised children These factors, however, did 
not modify the outcome No differences were found in mean outcome measures between 
the randomised and non-randomised children 
Conclusoli The results of the randomised and non-randomised patients were comparable 
Therefore, the results of this trial appear to be generahsable to the total domain population 
and might therefore be implemented 
Introduction 
Randomised clinical trials are widely accepted as the unbiased method for quantifying the 
magnitude of treatment effects In well-designed trials, internal validity is ensured 
However, to implement the results of a trial in practice, they must be generahsable to the 
total domain population, which are the instances of illness for which the study is designed 
and for which the results are applicable "'" 
For a variety of reasons, such as treatment preferences and selection, patients who enter a 
trial are often only a proportion of those who satisfy the entry cntena -"'-" In a survey of 
41 trials, Charlson and Horwitz"12 noted 21 tnals that recorded data on the patients who 
were eligible, but who did not enter the study The loss of eligible subjects was attributable 
to refusals by patients in 25% and refusals by physicians in 29% Moreover, the patients 
who did not participate were similar demographically, but differed clinically from those 
enrolled 
Most methodological studies that refer to generalisability of clinical trial results 
emphasise one or two major factors demographic representativeness of the participants 
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and their (treatment) preferences."1 """' Preferences and demographic representativeness 
only affect external validity if they are directly related to nsk factors that modify the effect 
magnitude. If such effect modifiers differ between the trial and domain population, the 
estimate of treatment benefit is not directly generahsable to this domain population. To 
study generalisabihty over such a modifier, tnallists might investigate whether the results 
over the strata of such a modifier differ between the randomised and non-randomised 
patients. 
Recently, we have performed a trial on the effect of ventilation tubes on hearing, 
language development and quality of life in infants with Otitis Media with Effusion 
(OME). At the start, there was some concern that differences between randomised and 
non-randomised patients might affect the outcome and therefore invalidate the 
generalisabihty of the trial results. For example, parents who have complaints about the 
hearing of their child might prefer treatment with ventilation tubes and therefore not 
consent to randomisation. These children might benefit more. Likewise, participation 
might be related to various factors, such as the educational level of the mother or attending 
a day care centre, for which relations with speech- and language development have been 
established. 1" To study this potential generalisabihty problem, hearing levels during 
follow-up were compared between the randomised and non-randomised children. In 
addition, information about potential effect modifiers was collected. 
O M E is one of the most common diseases in childhood, which is frequently treated 
with ventilation tubes . However, evidence of an association between O M E and language 
and behaviour problems and therefore of the utility of treatment with ventilation tubes is 
still inconclusive. The results of this trial might therefore have a substantial impact on 
practice. Before implementing the tnal results, it is important to establish external validity, 
i.e. the extent to which the results can be generalised to the total domain population. 
This study addresses the possible differences in outcome measures (audiometry) as 
well as in the distribution of personal characteristics between the randomised and eligible 
but non-randomised children. 
Patients and methods 
Patients 
The tnal is embedded in a cohort, which includes 30,099 children born in the Eastern part 
of the Netherlands between I January 1996 and I Apnl 1997. These children were invited 
for routine hearing screening at the age of 9 months. For the purpose of the trial, those 
who failed three successive screenings were referred to one of the 13 participating E N T 
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outpatient clinics for diagnosis and follow up (N=1081). The parents of infants found to 
be suffenng from persistent (4-6 months) bilateral O M E (confirmed by tympanometry and 
otoscopy) by the E N T surgeon were invited to participate in the randomised controlled 
trial (N=386). Children for whom infonned consent was obtained were randomly 
allocated to one of two groups. Group A (N=93), treated with ventilation tubes (VT 
group) or group Β (N=94), watchful waiting (WW group). The parents of 199 children 
did not agree to randomisation; 66 of them also disagreed with any form of follow-up. 
The remaining 133 parents who refused randomisation gave consent for follow-up after 
entering their child for the treatment of their (or the E N T surgeon's) preference. 97 
preferred watchful waiting, while 36 preferred treatment with ventilation tubes All these 
children were followed-up for one year with three monthly tympanometry and otoscopy, 
and 6 monthly audiometry 
We obtained approval for this study from the Ethical Committees of all 13 participating 
hospitals 
Metiwdi 
Tympanometry and audiometry were performed by audiologists. Otoscopy was performed 
by the E N T surgeon. The tympanograms were classified according to Jerger1 9 1, while 
O M E was defined according to the M O M E S protocol."' Hearing was assessed by a free 
field portable audiometry set, which appeared to be a good alternative for the standard 
visual reinforcement audiometry in multi-centre trials; this technique is desenbed in a 
separate paper. " All tests were perfonned in standard rooms at the 13 participating 
hospitals, the rooms were calibrated for our audiometry set. 
(Statistical) analysis 
Statistical analysis was performed in several steps. First, differences in mean hearing levels 
in the best ear (over 500, 1000, 2000 and 4000 Hz) between the randomised children in 
the VT and W W groups were tested with the independent Student t-test at 0, 6 and 12 
months follow-up 
Hearing improvement was entered into generalised linear models to adjust for baseline 
differences and potential confounders as well as to study possible effect modifiers O u r a 
p n o n model was. 
M(hearing level at T6/12 - hearing level at TO) = 
ßu+ßiXtreatment+ ßjXconfounders+ßkXtreatmentXeffect modifiers + €, 
Trial results 
Potential confounders and effect modifiers were, age before randomisation (<20 
months />=20 months), adenoidectomy before randomisation (yes/no), hospital (1-13), 
season at randomisation (1-4), number of respiratory tract infections (>4 /<=4) , hearing 
loss at baseline (dB). 
Second, the non-randomised children m the VT and W W groups were analysed m 
the same way By comparing the treatment effects observed in the randomised VT and 
W W groups to those observed in the non-randomised VT and W W groups, we were able 
to study the generahsabihty of the tnal results. 
In addition, the distribution of prognostic factors was investigated in the various 
groups. Confounder effects were adjusted for. Differences in the outcomes between the 
randomised VT children versus non-randomised VT children, and between the 
randomised W W children versus non-randomised W W children reflected the presence of 
hidden bias due to unobserved covanates " 
If a factor (also) acted as an effect modifier, we investigated whether the results over 
these strata differed between the randomised and non-randomised groups 
Results 
Informed consent to participate in the trial was obtained from 187 out of the 386 eligible 
children; 93 children were allocated to the VT group, while 94 were allocated to the W W 
group. The parents of another 133 children did not consent to randomisation, but agreed 
to active follow-up measurements (non-randomised group); 97 children opted for 
watchful waiting, while 36 opted for treatment with ventilation tubes. The parents of the 
remaining 66 children refused randomisation and active follow-up 
Randomised children: 11 children (8 in the W W group and 3 in the VT group) 
were withdrawn between randomisation and 12 months follow-up. Another 10 children 
in the W W group later received ventilation tubes 
Non-randomised children 27 children (19 in the W W waiting group and 8 in the 
VT group) were withdrawn between 0 and 12 months follow-up. Another 15 children 
who had first opted for watchful waiting received ventilation tubes dunng follow-up (see 
also Figure 1). 
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Figure 1. Flow chart of the children eligible for participation in the trial 
386 children eligible for participation in the tna 
66 lost to follow- up 
Informed consent from 187 parents 
93 ventilation tubes 
No consent from 133 parents, 
but agreeable to follow-up for 12 months 
94 watchiul waiting 
3 lost to follou-up 
90 children lollowed 
up 12 months 
36 ventilation tube: 
8 lost to follow -up 
86 children followed 
up 12 months* 
* 10 children received 
ν entilation tubes 
97 watchful waiting 
8 lost to follow-up 
28 thildren followed 
up 12 months 
19 lost to 
follow-up 
78 children followed 
up 12 months** 
* * IS children received 
ventilation tubes 
Pwgnostic factors 
Table 1 shows the distribution of prognostic factors among all the children. There were 
slight imbalances between the randomised and non-randomised children: more of the 
randomised children had older siblings, fewer attended day care and more of the mothers 
had a low educational level. N o differences were found between the non-randomised 
children and the children whose parents refused randomisation and active follow-up. 
Trial results 
Table 1. Distribution of the prognostic factors in the randomised trial population, the 
non-randomised children and the children lost to follow-up at randomisation 
Trul population (N = 187) Non-randomised 
children (N = 133) 
Children lost to follow -
up at randomisation 
(N=66) 
Sex 
Male 
Female 
Season of birth 
Wmter Ì996 
Spnng 
Summer 
Autumn 
Winter 97 
Adenoidectomv 
Ya, 
Ko 
Older siblings 
Yes 
Ko 
History of AOM 
Yd 
So 
Attending day care 
Yfî 
Ko 
Low educational level 
mother 
58.9% 
41.1% 
22.0%, 
26.9%, 
15.1%, 
18.3%, 
17 7%, 
9.6% 
90.4% 
83 2%, 
16.8%, 
31 8% 
68 2%, 
26 1%, 
73.9% 
26 4%, 
56.8%, 
43.2%, 
22.6%, 
27.1%, 
18.8%, 
14 3%, 
17.3%, 
9 0%, 
91 0%, 
74 1% 
25.9% 
37 1%, 
62 9%, 
42 4%, 
57 6% 
14 8% 13 4%, 
60 0%, 
40.0%, 
22.8% 
27.7%, 
17 3%, 
13.9%, 
18.3%, 
9 0%, 
91 0%, 
72 9%, 
27 1% 
38 7% 
61 3% 
40.0%, 
60 0%, 
Underlined values denote where the randomised children differed from the non-randomised children 
Tympanometr)' and otoscopy 
Figure 2 shows the percentages of randomised and non-randomised children diagnosed 
with bilateral O M E dunng the trial period. A small difference between the randomised 
VT children and the non-randomised VT children was found only at 3 and 6 months 
follow-up. 
The mean duration of effusion was 70% (95% CI 66 - 75%), 36%, (95% CI 31 - 40%), 71% 
(95% CI 66 - 75%) and 30% (95% CI 26 - 35%) in the randomised W W group, 
randomised VT group, non-randomised W W group and non-randomised VT group, 
respectively. 
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Figure 2. Proportions of randomised and non-randomised children with bilateral O M E 
during the trial period 
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Figure 3. The pure tone averages (PTA) in the best ear in the randomised and non-
randomised children 
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Trial results 
Audwmetr]' 
Figure 3 shows the pure tone averages (PTA) in the best ear in the randomised and non-
randomised children. There were similarities between the patterns in the randomised and 
non-randomised children in the VT groups and between the patterns m the randomised 
and non-randomised children in the W W groups In the randomised children, 
improvement at 6 months follow-up was 10.2 dB (95% CI 7 3 - 13.1 du) in the VT 
group and 4.6 dl3 (95% CI 2.0 - 7 3 dB) in the W^W group. In the non-randomised 
children, these rates were 14 1 dB (85% Cl 10.2 - 18.0 dB) and 3.3 dB (95% CI 0 2 - 6.7 
dB) in the VT group and W W group, respectively. After 12 months follow-up, the 
improvements were 13 1 dB (95% CI 10.4 - 15 8 dB) and 8 5 dB (95%. CT 5.5 - 11.5 dB) 
in the randomised children and 16.8 dB (95%. CI 12.5 - 2 1 . 1 dB) and 6.9 dB (95%, CI 3 8 
— 10.0 dB) in the non-randomised children 
In the multivariate linear models, the hearing level at randomisation appeared to be 
a confoundcr in the randomised and non-randomised children. After correction for this 
factor the mean extra improvement with ventilation tubes after 6 months follow-up was 3 
dB (95% CI 0.3 - 5.8 dB) and 4.5 dB (95% CI 0.4 - 8.7 dB) in the randomised and non-
randomised children, respectively. In the randomised children, there was some suggestion 
of effect modification by the hearing level at randomisation (p=0.023): the VT group 
children with a higher hearing deficit at randomisation showed more improvement than 
the children with a lower deficit In the non-randomised children, we did not find any 
modifying effect of hearing level at randomisation. 
A sensitivity analysis in which the children in the W W group who received 
ventilation tubes were analysed as treated or were not analysed at all, showed that these 
children did not influence the outcome in the randomised children or in the non-
randomised children 
Discussion 
Patients who do not consent to randomisation are not usually followed-up in clinical trials 
This leaves room for doubt about the external validity of the trial results. In this study, we 
addressed external validity by comparing randomised to non-randomised children in a trial 
on the effect of ventilation tubes versus watchful waiting on hearing, language 
development and quality of life in infants. Randomised children were compared to non-
randomised children with regard to differences in the distribution of prognostic factors 
(possible effect modifiers) and, more importantly, differences in treatment effects. 
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We found blight differences in the distribution of some prognostic factors: older 
siblings, attending day care and educational level of the mother. The latter is in agreement 
with the findings of Hart and Thong who found that parents who volunteered were less 
well-educated. Parents from higher social classes might be more explicit in their treatment 
preferences. In our trial, however, these factors did not modify the outcome (mean 
hearing level) and were therefore no threat to external validity. 
We found that the hearing level at randomisation modified the effect of 
improvement in hearing level in the randomised children, but not m the non-randomised 
children. As only 36 of the non-randomised children were treated with ventilation tubes, 
the power to detect an effect modifier in this group was small. 
The proportion of randomised children in the VT group with bilateral O M E at 3 
months follow-up was lower than the proportion in the non-randomised VT group 
children, while at 6 months the proportion of children with bilateral O M E was higher in 
the randomised VT group than in the non-randomised VT group. Randomised children 
were treated with ventilation tubes according to the trial protocol within 3 months, while 
waiting lists (typically 0-4 months) determined the time of ventilation tube insertion in the 
non-randomised children. The differences in the measurements at 9 and 12 months 
follow-up as well as in the mean hearing levels at 0, 6 and 12 months follow-up between 
the randomised and non-randomised children could not be distinguished from chance. 
Parents' preferences in our trial therefore did not appear to have had any influence on the 
final results. 
More children in the non-randomised group dropped-out or changed group during 
follow-up. This may have been because the physicians and our trial management team put 
less effort into convincing the parents of these non-randomised children to complete 
follow-up. 
The randomised W W group children who received ventilation tubes during follow-up 
differed from the children who did not with respect to age and sex. Moreover, their mean 
hearing deficit at randomisation was larger andjust before receiving ventilation tubes 6 out 
of the 10 children had a hearing threshold of equal to or larger than 45 dB. The children 
in the non-randomised W W group that were treated with ventilation dunng follow-up 
tubes were similar to those who did not with respect to prognostic factors and mean 
hearing deficit at randomisation. In this group, 8 out of the 15 children had a hearing 
threshold of equal to or larger than 45 dB just before the ventilation tubes were inserted. 
Sensitivity analysis showed that these children did not modify the outcome. 
A total of 11 randomised children dropped-out. A difference in mean hearing level at 
randomisation was only present in the three children withdrawn from the VT group. 
Trial results 
These three children did not have a large impact on the overall results. In the 27 non-
randomised children who dropped-out, we did not find a difference in mean hearing level 
at randomisation (in the VT group or in the WW group) 
The 66 children whose parents refused randomisation and active follow-up might 
have differed from the non-randomised and/or randomised children. The prognostic 
factors of these children were not found to differ from those of the non-randomised 
children, but they differed in the same way as the randomised children differed from the 
non-randomised children. It therefore appears that the children who dropped-out were 
not a selective sample and would not have changed the overall results if they had been 
followed-up 
The results of our trial on the effects of ventilation tubes on infants appear to be 
generalisable to the total domain population (infants of 1-2 years with persistent bilateral 
O M E diagnosed after screening). These results are therefore suitable for implementation 
As the results of the randomised and non-randomised children were comparable, it was 
even possible to increase the power of subgroup analysis and/or to calculate a more precise 
estimate by combining the relevant groups in one analysis. 
This procedure of following-up randomised and non-randomised patients is 
recommended when there is concern about selective participation and reduced 
generahsabihty. It should be noted that generalisation to populations outside the domain 
(i.e. older children, children with frequent complaints, etc.) cannot be justified and may 
even be misleading. 
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Abstract 
Obiectipc' To determine differences in effects and costs of treatment with ventilation tubes 
compared to watchful waiting in patients with persistent Otitis Media with Effusion 
(OME). 
Metlwds 187 young children (17-21 months old) with persistent bilateral O M E were 
randomly allocated to treatment with ventilation tubes or to watchful waiting The time 
without effusion, language development, and the costs were measured using a societal 
perspective during one year follow up. 
Rffii/f.«. The mean duration of effusion was 9.2 months m the watchful waiting group 
(WW) and 4 7 months in the ventilation tubes group (VT). The language development 
was comparable in both groups (0 7 months improvement difference (95% C.I. -0.3 - 1.7), 
after correction for confounding variables) The mean costs per child during one year 
follow up were $454 ($1= DFL 1.98) in the VT group and SI 20 in the W W group. The 
costs-effectiveness analysis revealed that the VT group needed an mean additional 
investment of $334 per child to yield 4 5 extra months without effusion. 
Conclusion Due to on the one hand the small differences in time without effusion, no 
differences in language development, and on the other hand the higher costs, treatment 
with ventilation tubes is not recommended as standard treatment m all young patients with 
persistent O M E from an economical point of view. 
Introduction 
Otitis Media with Effusion (OME) is one of the most common diseases in childhood. The 
term O M E refers to an accumulation of fluid in the middle ear cavity behind an intact 
membrane without the signs and symptoms of an acute infection.' " By 2 years of age, 70% 
of the children have had O M E at least once; at 4 years of age this percentage is 80%.M 14 
The most common surgical intervention for O M E is the insertion of ventilation 
tubes , a technique introduced by Armstrong m 1954 " The aim of treatment with 
ventilation tubes is to resolve the effusion, to restore the hearing level, and to prevent 
potential language developmental problems. Ventilation tubes may also prevent irreversible 
changes to the middle ear structure, like tympanosclerosis. 
The reported estimated costs of tube insertion ranges from $957 to $2,174 per 
treatment." " The annual costs for chronic O M E are approximately $2 billion for the 
U.S.""1 These cost studies are based on theoretical models which estimate, rather than 
directly measure, the different components of OME-related costs 2"<22" l n addition, 
previous studies did not adequately measure travel expenses and lost parental wages. 
Trial resulti 
Moreover, the costs for O M E are never viewed in the light of clinical outcomes 
other than time without effusion, while the magnitude and duration of time without 
effusion due to the insertion of tubes was limited.18' The question whether treatment with 
ventilation tubes is justifiable, therefore, also depends on other effects such as a possible 
improvement in language development. This effect need to be studied before conclusions 
can be drawn about the effectiveness of treatment with ventilation tubes in infant with 
persistent OME. 
In this paper we descnbe a cost-effectiveness analysis of treatment with ventilation 
tubes versus watchful waiting using a societal perspective and a analytic time honzon of 
one year. The analysis is based on a large multi-centre randomised tnal into the effect of 
treatment with ventilation tubes on time without effusion, hearing level, language 
development, and quality of life in infants, compared to watchful waiting. 
Methods 
Patients 
The randomised tnal was embedded in a cohort, which includes children born in the 
Eastern part of the Netherlands between 1 January 1996 and 1 Apnl 1997 These children 
were invited for routine heanng screening at the age of 9 months. For the purpose of the 
trial, those who failed three successive tests were referred to one of the 13 participating 
ear, nose, and throat (ENT) outpatient clinics for diagnosis and follow up The parents of 
infants found to be suffenng from persistent (4-6 months) bilateral O M E by the E N T 
surgeon in subsequent observations were invited to enter their child into our randomised 
controlled tnal. Exclusion cntena were' Down's syndrome, schisis, asthma, cystic fibrosis, 
and sensonneural heanng loss. The children for whom informed consent was obtained 
were randomly allocated to one of two groups: VT group treatment with ventilation 
tubes (Bevel Bobbins®), or W W group, a period of watchful waiting. The follow up was 
one year. We obtained approval from the Ethical Committees of all 13 participating 
hospitals. 
Outcome measures 
Two outcome measures were used in the cost-effectiveness analysis: the time without 
effusion and the language development. The language development was considered the 
most important outcome measure and the time without effusion was used as a disease 
specific outcome measure, which has also been used in other studies Heanng level and 
quality of life were not reported in this paper. O M E was defined according to the 
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M O M E S protocol ' , which is primarily based on tympanometry If tympanometry could 
not be performed, or if the tympanograms were doubtful (type C2), otoscopy was used to 
reach a diagnosis Both otoscopy and tympanometry were performed every three months 
The mean time spent with O M E was calculated on the basis of these three monthly 
measurements If a child had O M E at two successive measurements, the days between 
these measurements were counted as days with effusion If, on the other hand, a child had 
O M E at the first measurement but not at the second, only half of the days were counted as 
days with effusion The Reynell test'"' and the Schlichting test" 7 were used to measure 
comprehensive language development and expressive language development, respectively 
These tests were administered by a trained speech therapist Scores were obtained as age-
standardized and equivalent age Both language tests were performed at baseline, and every 
six months 
Using a societal perspective in the economic evaluation meant that both medical and non­
medical costs were determined Costs were calculated on the basis of real costs rather than 
charges 
Quantities 
The quantities were measured with diaries, which covered a period of four weeks The 
parents of the children were asked to document all outpatient visits Research protocol 
dnven costs were not included in the analysis ""' In normal clinical practice, all children 
who receive ventilation tubes are seen by the E N T surgeon shortly after surgery and 6 and 
12 months after tube insertion Thus, the costs of ventilation tubes included these three 
control visits to the E N T surgeon 
Other outpatient visits to the E N T surgeon and visits to a general practitioner were 
divided in O M E related visits and non O M E related visits, based on the given reason for 
the visit Only O M E related outpatient E N T visits and G Ρ visits were included in the cost 
analysis The parents documented the names of medication used on prescription, standard 
doses for each week were used 
Cost prices 
The costs per patient were calculated by multiplying prospectively measured quantities per 
patient with a fixed cost pnee and converted to American dollars ($1= DFL 1 98) The 
cost prices were calculated according to guidelines for economic evaluation in health care 
research " "" All prices were based on the price level of 1998 Older pnees were adjusted 
Trial results 
to the price level of 1998. Real cost prices were calculated for the following items: 
insertion of tubes, hospital stay (day care), and outpatient visit to an E N T surgeon. Integral 
cost prices were calculated, which included employee costs, costs for materials, 
depreciation costs for inventory, and overhead costs. The costs of the ENT surgeon in the 
teaching hospital were based on the wage classification. The costs of the ENT surgeon in 
the general hospital were based on guidelines. The overhead costs included housing, 
cleaning, and the costs of non-productive departments in a hospital. These prices were 
calculated in both a teaching hospital and a general hospital. In the general hospital, no 
overhead costs could be calculated. The prices were adjusted using the percent overhead 
costs of each pnce in the teaching hospital. A weighted mean pnce was calculated using 
the ratio of the national number of outpatient visits in general hospitals and teaching 
hospitals.""4 
The pnce of adenoidectomy was based on charges. For the medication, the costs of 
a standard dose in each week were calculated. In case more than one cost price was 
available, the lowest pnce was chosen. The costs of visits to a general practitioner and the 
cost price per kilometre were valued according to guidelines.""" The distance to a general 
practitioner or the hospital was noted in the diaries. The other non-medical costs were 
directly noted in monetary unit in the dairies. 
Categories 
The medical costs were classified in costs of tube insertion, adenoidectomy, E N T 
outpatient visits, visits to the general practitioner, medication on prescription, and other 
medical costs related to OME. The costs of tube insertion consisted of costs for surgery 
(tube insertion), hospital stay (day care), and the three control visits to the E N T surgeon. 
Non-medical costs were divided in travelling costs, costs of medication not on 
prescription, costs of extra help (baby sitter, family), and other expenses related to O M E . 
Dianes were corrected for missing periods using the patient-year-approach.""1 The 
missing penods were filled with the mean quantities and expenses in the preceding penod. 
Patients with more than 50 percent of the diaries missing, were not included in the cost-
effectiveness analysis. After correction, the mean, median, and inter-quartile range of the 
costs were calculated. 
Analysis 
Differences in the time without effusion, the language development, and the costs were 
compared between the VT group and the W W group. Differences in time without 
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effusion were tested with the chi-square test. Differences in language development at 0, 6, 
and 12 months of follow-up as well as differences between 12 and 0 months follow-up 
between the groups were tested with the Student t-test for independent groups. To adjust 
for potential confounders as well as to study possible effect modifiers, a regression analysis 
was performed The Wilcoxon test was used to test the differente in the mean total costs 
between the VT group and the W W group. 
Two incremental cost-effectiveness ratios (ICERs) were calculated. In the first 
ratio, differences in the mean total costs per patient were compared with differences in the 
mean time without effusion between the groups In the second ratio, differences in the 
mean total tosts per patient were compared with differences in language development 
A sensitivity analysis was performed to examine the robustness of the findings. The 
prices of the surgery (ventilation tubes), hospital stay (day care), and visits to an E N T 
surgeon were varied Besides the baseline estimate, for each of these pntes, three values 
were available the charge, the taltulation in a teaching hospital, and the calculation in a 
general hospital. The lowest and the highest values of these three prices were intluded in 
the sensitivity analyses 
Results 
Between 1 January 1996 and 1 April 1997 30,099 thildren were born. A total of 1,081 
children failed three successive screening tests and were referred to an E N T clinic The 
parents of 386 children were invited to enter their child in the trial. A total of 187 children 
were randomised. 93 children to the ventilation tube (VT) group and 94 to the watchful 
waiting (WW) group. Of these 187 children, 13 completed less than 50% of all diaries and 
were therefore excluded from the cost-effectiveness analysis, which resulted in 88 children 
in the VT group and 86 in the W W group 
Effectivctic^ 
The mean duration of effusion over one-year follow-up was 142 days (36%) in the VT 
group versus 277 days (70%) in the W W group. No relevant differences were found in 
expressive or comprehensive language between the two groups. At 12 months follow-up 
the children in the W W group had improved 0.8 month (95%> C.I -0.1 - 1.6), while the 
children in the VT group had improved 1.8 month (95% C.I. 1.0 - 2.6). After adjustment 
for educational level of the mother, IQ of the child, and language development at baseline 
the children in the VT group improved 0 7 month (95% C.I. -0.3 - 1.7) more than the 
thildren in the W W group. Only the data of thildren with information on both 
Trial resulti 
effectiveness and cost are used to calculate the cost-effectiveness, so that the mean time 
with effusion in this analysis slightly differed from the overall trial results (see also Table 1). 
Table 1. Time without effusion for the children included in the cost-effectiveness analysis 
(N=174) 
number of days with OME total days follow up proportion of days with OME 
VT (N=88) 140 398 W/, 
WW (N=86) 275 394 70% 
Costs 
Ten patients in the W W group received also ventilation tubes (Table 2). Two patients in 
the W W group and five in the VT group received ventilation tubes for a second time 
(according to the protocol). Adenoidectomy was combined with the tube insertion in 3 
patients in the W W group. In the VT group 7 children underwent adenoidectomy next to 
the insertion of the tubes. The prices which were used in the cost-analysis are shown in 
Table 3. The mean total costs per child were $454 in the VT group and $120 in the W W 
group (Table 4) (P<0.()()1). The main costs were the costs directly related to the tube 
insertion. Other medical costs were also slightly higher in the treatment group which 
received tubes. 
Table 2. Volumes (total number in each group) 
VT (n=88) WW (n=8f)) 
insertion tubes 
adenoidectomies 
ENT outpatient visits 
GI' visits 
outpatient visit paediatncian 
visit homeopath 
93 
7 
143 
97 
1 
12 
10 
53 
47 
_ 
In 10 patients ( 7 in VT and 3 in WW) tubes and adenoidectomy were combined 
Extra outpatient visits, besides treatment protocol driven visits 
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Table 3. Cost prices (US $) and sources used for the calculation of the cost prices 
p m c source 
insertion tubes 
day tare 
ENT outpatient visits 
adcnoidcctomy 
adjuvant medication 
GP visit 
outpatient visits paediatrician 
* weighted mean of two cost prices 
Table 4. Mean, median, and inter-quartile (IQ) range of the costs per patient (US $) 
117* 
39* 
46* 
121 
anable 
18 
49 
calculation 
calculation 
calculation 
charge 
market prices""' 
guideline"2 
guideline222 
tube insertion 
adenoidectomy" 
ENT outpatient visits 
GP visits 
medication on prescription 
other medical costs 
total medical costs 
travelling 
medication not on prescription 
help at home 
other expenses 
total non-medical costs 
total costs 
mean 
"ill 
10 
76 
20 
8 
4 
429 
16 
2 
4 
4 
25 
454 
VT (n= 
median 
294 
0 
53 
18 
4 
0 
399 
9 
0 
0 
0 
16 
438 
=88) 
IQ range 
294 - 294 
0 - 0 
0 - 9 8 
0 - 3 6 
0 - 12 
0 - 0 
329 - 480 
0 - 2 7 
0 - 3 
0 - 0 
0 - 2 
3 - 34 
332 - 528 
mean 
41 
17 
29 
10 
4 
4 
104 
8 
4 
4 
0 
16 
120 
W W (n= 
median 
0 
0 
0 
0 
0 
0 
19 
0 
0 
0 
0 
4 
41 
86) 
IQ range 
0 - 0 
0 - 0 
0 - 4 9 
0 - 18 
0 - 0 
0 - 0 
0 - 9 8 
0 - 11 
0 - 3 
0 - 0 
0 - 0 
0 - 2 0 
4 - 161 
" including surgery, day care, and three outpatient visits to ENT surgeon 
including surgery and day care if adenoidectomy was not combined with tube insertion Otherwise, only 
the costs of surgery were calculated 
Cost-effectiveness analysis 
As we only found a significant difference in time without effusion, we used this effect 
measure in the cost-effectiveness analysis. The difference in the mean total costs between 
the VT group and the W W group were $454 - $120 = $334. The differences in the mean 
time without effusion between the VT group and the W W group were (398 - 140) - (394 
- 275) = 139 days = 4.5 months (Table 1). This means that $334 needed to be invested to 
gain 4.5 months without effusion. 
Trial results 
A sensitivity analysis was performed to establish the robustness of the findings The 
incremental cost-effectiveness ratio varied between $320 and $491 per 4 5 additional 
months without effusion 
Discussion 
In this trial, a small difference between the VT and W W group was found in time without 
effusion, but apart from this difference no effect was found in the language development 
Possibly, the natural course of the disease (spontaneous recovery in the W W group and 
recurrent effusion in the VT group) decreased the differences between the groups 
The mean total costs per patient were $4S4 in the VT group Several other studies 
presented the costs of treatment of otitis media, using different methods and applying to 
different populations2I*22"227 2," The costs in our VT group were low compared to costs 
presented in the literature Berman, for instance, estimated the costs related to tube 
insertion in the order of $957 - $1,800 ^ 
A first explanation might be that in this study differences in costs between the two 
groups were calculated This means that costs of outpatient visits before the surgery and 
costs of diagnostic tests (audiometry, tympanometry) were not included, because these 
activities were also performed in patients in the W W group 
Secondly, costs in this study were based on real cost prices rather then charges 
These pnees were partly based on the prices in a teaching hospital In this hospital, many 
activities were performed by registrars instead of registered E N T surgeons This means that 
the costs of employees were low 
Thirdly, treatment with antibiotics for O M E is rare practice in the Netherlands, 
while these antibiotics form a substantial part of the total medical costs is some of the 
studies reported in literature """ 
Finally, the non-medical costs were low In this study, the parental time was not 
included in the costs analysis, because the data on this aspect were deficient However, it 
was often the mother who attended the child during visits to the hospital, mostly not 
during paid work The travel expenses were also underestimated, because the travel 
expenses for the tube insertions in the VT group were not documented in the diaries 
The question of this cost-effectiveness analysis was whether a treatment with VT is 
cost-effective or whether cost reduction is possible We found that an additional 
investment of $334 per child yielded 4 5 extra months without effusion However, this 
investment did not improve in the mam outcome measure, the language development 
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Besides these primary outcome measures used m the cost-effectiveness analysis, we 
also measured hearing levels and quality of life in the trial For the hearing levels, we only 
found a beneficial effect of ventilation tubes in the short run (6 months), while in the long 
run (12 months) the effect had disappeared. N o substantial effect was found on the quality 
of life 
The overall tnal results are therefore consistent and show no need for a treatment with 
ventilation tubes for the total group of infants with persistent O M E traced by a population 
based screening programme. A watchful waiting approach in these infants appears 
therefore to be reasonable. 
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Summary 
Whether treatment with ventilation tubes in infants with persistent Otitis Media with 
effusion (OME) is justified or not, largely depends on the effect of these tubes on hearing, 
language development and quality of life In a multi-centre randomised clinical trial on a 
well-defined population of infants, ventilation tubes appeared to improve the hearing level, 
but did not have any substantial incremental effect on language development and quality of 
life. Therefore, a watchful waiting approach appears to be justified in these young children 
and consequently, screening programmes for conductive hearing loss in infants become 
redundant However, grommets should not be abandoned in all infants, because too little is 
known about their effects in specific subgroups and because of wide individual variability 
Introduction 
Otitis Media with effusion (OME) is one of the most common diseases in childhood, the 
annual health related cost is estimated to be approximately $ 2 billion in the U.S."" The 
most common surgical intervention for OME is the insertion of ventilation tubes', a 
technique introduced by Armstrong in 1954 "' The aim of inserting ventilation tubes is to 
restore hearing to a normal level and to prevent potential otological and developmental 
problems. 
In 1996, we started a tnal to study the effectiveness of ventilation tubes in infants 
with OME, because effectiveness trials had only been performed in children aged 3 years or 
older, while nowadays O M E is often detected and treated in younger children.4 ' 
Moreover, the prevalence of O M E is highest up to the age of three years, which is a 
critical penod for language development n It has also been suggested that ventilation tubes 
can have a remarkable effect on general health status (QoL). J I4" ' 
The main question addressed in this study was whether treatment with ventilation 
tubes in infants is useful. The outcome variables comprised the effect of ventilation tubes 
on hearing, language development and quality of life. 
In this paper, we attempt to answer this main question by critically discussing the 
design and results of the O M E trial in the context of available scientific evidence. 
Additionally, we provide a provisional guideline for managing infants with OME, based on 
all knowledge currently available. 
General DISCHWOII 
The randomised trial 
The study design has been desenbed in detail in other papers Figure 1 summarises the 
design and flow of children in the studv population (birth cohort) AO the children in the 
tnal were followed-up for 12 months language tests (Reynell '' and Schhchting ) and 
quality of life questionnaires (TAIQOL2 '"' and Enckson"" ) were administered within 2 
weeks after randomisation (before treatment) and at 6 and 12 months after randomisation, 
tympanometry and otoscopy were performed every three months, while audiometry was 
measured every 6 months 
Figure 1. Flow chart of the study population 
30 099 mt.mts born between 1 J a i u u n 1996 ind 1 April 1997 
2,457 lost to follow-up 
27,642 underwent population based hearing screening at 9 months of age 
"•1,192 lost to follow-up 
1.365 children failed the population based screening programme 
284 lost to follow-up 
1,081 infants visited an E N T department 
fc2()1 lost to follow-up 
386 children with persistent (4-6 months) bilateral O M E 
(eligible to participate) 
66 lost to follow-up 
187 parents gave mfomied consent for the trial 
93 ventilation tubes 
133 parents did not give informed consent, 
but agreed to follow -up for 12 months 
94 watchful waiting 
3 lost to follow-up 
90 children were 
followed-up for 
12 months 
36 ventilation tubes 
8 lost to follow-up 
86 children were 
followcd-up for 
12 months* 
97 watchful waiting 
8 lost to follow-up 
28 children were 
followed-up tor 
12 months 
19 lost to 
follow -up 
78 children were 
followed-up for 
12 months** 
* 10 children received 
ventilation tubes 
** 15 children received 
ventilation tubes 
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The trial results 
In summary, the following effects were found: 
The children in the ventilation tube group (VT group) suffered from bilateral OME 
for a mean of 142 days (36%) versus 277 days (70%) in the watchful waiting group 
(WW group). 
Treatment with ventilation tubes improved the hearing level in infants in the short 
term (6 months), but hearing also improved in the W W group The average 
improvement was 10.2 dB (95% CI 7 3 - 13.1) in the VT group and 4.6 dB (95%, 
CI 2 0 - 7 3) for the W W group 
At 12 months follow-up, the difference in hearing levels had become fully 
neutralised due to recurrent O M E in the VT group and spontaneous recovery in 
the W W group 
Children with larger hearing deficits at randomisation appeared to improve more 
after the insertion of ventilation tubes than the children with better thresholds 
The children in the VT group improved 0 7 month (95% CI - 0 3 - 0 7) more than 
the children in the W W group on comprehensive language skills And one month 
(95%CI - 0 4 - 2 4 ) behind on expressive language skills 
Disregarding the intervention contrast, improvement in language development 
(especially verbal comprehension) appeared to be related to improvement in 
hearing. 
Ventilation tubes had no substantial incremental effect on quality of life. 
N o subgroups could be distinguished that were likely to benefit more from 
treatment with grommets. 
Despite the fact that many clinicians involved in the care of children with OME and the 
parents have indicated that they observe a beneficial effect of ventilation tubes, this study 
could not demonstrate any benefit of ventilation tubes, other than a short-term effect on 
hearing. 
Inference 
Before we can answer the question whether the results of this tnal justify a change in 
current attitudes towards the treatment of O M E with ventilation tubes, a number of 
questions have to be addressed. 
General Discussion 
1. Is the underlying hypothesis (theor)') correct? 
Studies have shown that substantial (sensorineural) hearing loss results in delayed language 
development." ' We also know that children with O M E have a mild to moderate heanng 
loss.1"1 ltt61(i8 m However, it is still unclear whether the hearing loss due to middle ear 
effusion also causes delay in language development. Previous studies have shown mixed 
and often contradictory results: some found an association between early-life O M E and 
language development1""22216217, whereas others only found an association in subgroups, 
such as children in day care1", socially deprived children"H, or children with substantial 
heanng loss" . Another group of studies, however, did not find any association at all. 
We also failed to find an association between O M E and language development. However, 
it should be noted that at randomisation, most children already had a delay in language 
development compared to their age-expected values. This gives support to the theory that 
OME does indeed has an effect on language development. The theory is probably correct, 
but lacks sufficient detail, e.g. the dose-response relation and possible benefit for specific 
subgroups are not yet clear. 
2. Do ventilation tubes improve language development? 
On the basis of the delay in language development found in our study group (children with 
persistent bilateral OME), we assume that heanng loss due to O M E is indeed associated 
with language development. However, the question remains as to whether ventilation 
tubes lead to restoration of the hearing level and communicative skills in these children. 
In our trial, ventilation tubes only improved hearing in the short-term, while no substantial 
incremental effect was found on language development and quality of life. However, when 
the intervention contrast was disregarded, improvement in hearing was associated with an 
improvement in language development. 
In our opinion, the effect of ventilation tubes was minimal to absent. This was reflected by 
the short duration of the effect of ventilation tubes on heanng and the natural course of the 
disease, which resulted in spontaneous improvement in the W W group. 
This conclusion only relates to the mean effect in the total heterogeneous group of infants 
with persistent bilateral OME. It is therefore possible that some subgroups within this 
population, e.g. children with language depnvation or learning disabilities, might benefit 
from the intervention and the subsequent improvement in hearing. These subgroups 
should receive special attention. 
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3. Is the trial population representative for the population of infants encountered in medical 
practice? 
The trial population comprised screen-detected infants with persistent (4-6 months) 
bilateral O M E . Therefore, the large majonty did not have any OME-related complaints. In 
clinical practice, children with complaints related to O M E are nomially referred for 
treatment; in our study population, the number of infants with complaints was so small that 
we were not able to study this group in greater detail. 
It might be argued that the trial population was not representative, because of patient 
selection during follow-up from birth cohort to trial population. This issue of 
comparability has been addressed more extensively in two separate papers.""" Slight 
differences were found between subpopulations in some prognostic factors, but these 
factors did not modify the outcome. There were no differences in mean outcome between 
the randomised and non-randomised children. 
The trial population can therefore be considered representative for the study population, 
although the power was too low to study specific subgroups that may be dominant in 
clinical practice. 
4. Could the findings be biased, or do the effect estimates reflect reality? 
Uncontrolled confounding cannot be ruled out entirely, but much research has been done 
to detect possible confounders.D"M ' '1 '"' , ί ί ' , 9 l l"<'242-24<' i
n
 this study, all known confounders 
were measured and, if necessary, adjusted for in the multivariate analyses. 
As for bias due to misclassification of the outcome variables, it should be noted that all the 
measures used in this study, except for the TAIQOL, have been well-validated and are 
often used, so misclassification is unlikely. It is possible that other measures in more specific-
areas, such as central auditory perception or OME-specific quality of life, would have 
revealed differences between the VT and WW group. However, we believe that if these 
differences were relevant, they would have been detected by means of the tests used. 
O n the basis of current knowledge, it appears that the trial results reflected reality. 
5. Is the trial large enough to detect chnicaily relevant effects? 
Before starting this trial, a power calculation was performed. We calculated that to detect a 
difference in the duration of effusion of one month and/or a difference in language 
development of two months between two groups, 200 children had to be recruited. Our 
trial comprised 187 children. Therefore there was sufficient power to detect a clinically 
relevant effect. However, as mentioned above, the power to detect relevant effects in 
subgroup analyses was too low. T o study such subgroups, larger numbers or specific groups 
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of children should be included Another more practical approach would be to perform a 
meta-analysis on the raw data from all effectiveness trials performed so far. 
6 ha subséquent "equivalence" trial needed to confimi equal efficacy? 
The null hypothesis tested was that there was no difference in outcome between 
ventilation tubes and watchful waiting. Failure to detect any difference, however, does not 
automatically imply equivalence, it can only be concluded that if there was any real 
clinically relevant difference, it would have been detected (with a power of 0 80) Smaller, 
but relevant differences are likely to be obscured in tnals of this size. To demonstrate equal 
efficacy, a so-called "equivalence" trial can be performed on a population that is large 
enough to obtain an effect estimate with a pre-specified small confidence interval; in 
addition, intention-to-treat and per protocol analyses have to be performed "4 However, 
an equivalence tnal is only useful when there is evidence that the treatment has an effect on 
(in our case) hearing, language development and quality of life. As there was no clear 
evidence for such effectiveness, an "equivalence" tnal is not indicated. 
7. Was the follow-up long enough? 
In this study the children were followed-up for one year. The question is whether an effect 
would have appeared if the children had been followed-up for a longer penod. 
In view of the short duration of the effect of ventilation tubes, as well as the natural 
improvement in the watchful waiting situation, it is not to be expected that an effect would 
have appeared after a longer follow-up period Previous studies confirm that short-term 
effects do not correspond with effects in the long-term."14X 
8 Are the results in agreement with the literature'' 
So far, only a few adequately designed randomised controlled trials have been published on 
the effect of ventilation tubes on O M E . Most of these studies desenbed the effect on 
hearing'"' 1H'' "i8 "w and reported short-term improvement as was also found in our tnal. 
Maw et al. studied the effect of ventilation tubes on language development in 3 to 4-
year-old children. At 9 months follow-up, marginally significant differences were found in 
comprehensive and expressive language between the VT group and the W W group. 
However, 18 months after randomisation, 85% of the children in the W W group had 
received ventilation tubes and the groups no longer differed. 
Other non-randomised studies on children aged 3 years or younger did not find any clear 
association between O M E and speech and language development." Earlier studies on the 
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effect of ventilation tubes on quality of life lacked a control group Thus, our results are not 
in discordance with the findings reported by other investigators. 
Is it reasonable to abandon treatment with grommets? 
On the basis of our results, the following inferences can be made with respect to medical 
practice-
1 Ventilation tubes do not have any substantial effect on language development or 
quality of life in infants with bilateral persistent O M E detected by a population 
based screening programme 
2. Screening for hearing loss at the age of nine months detected a large number of 
children with conductive hearing loss However, there is no reason to continue or 
start such screening programmes, as nowadays it is possible to detect sensorineural 
hearing loss in the neonatal period. 
These statements give rise to the question whether it is justified to abandon grommets in 
all children of younger than two years' 
The answer to this question is no! So far, one tnal has been performed on this age group. 
Our study design only permits a statement about the effect of ventilation tubes on the 
entire group of infants detected by population based screening, e.g. predominantly infants 
without any obvious complaints. The results of our trial do not permit any conclusions 
about specific subgroups of infants with OME, such as high risk children (premature 
children, children with Down's syndrome, schisis etc.), children with upper respiratory 
tract infections and children with obvious hearing and/or language impairment These 
children might benefit from ventilation tubes, or from combinations of treatments. 
In view of the wide individual variability (unexplained variance), we cannot preclude that 
individual infants experienced substantial benefit from treatment with ventilation tubes 
Guidelines 
At present, guidelines for the treatment of persistent O M E in young children cannot be 
based on hard outcome measures from clinical tnals Nevertheless, some conclusions can be 
drawn' 
1. Screening programmes for hearing loss at the age of nine months will detect a large 
number of children with mild conductive heanng loss 
2. A watchful waiting approach is justifiable in young children, especially when there 
are no OME-related complaints 
General Discussion 
In individual children with obvious complaints and/or heanng loss of 30 dB or 
more, the clinician will need to make a choice from the available treatment options. 
He or she might consider ventilation tubes as an option, but adenoidectomy, 
antibiotics and watchful waiting might be alternative (or supplementary) treatments. 

Chapter 5.2 
Conclusions and recommendations for future research 
Chapter 5 
Conclusions 
The randomised controlled trial described in this thesis was the first experimental study on 
the effect of treatment with ventilation tubes on hearing, language development and 
quality of life in infants. Based on the results of this randomised controlled trial and 
previous studies, we were able to answer the research questions formulated in the 
introduction (Chapter 1). 
Previous studies have shown that the cumulative incidence of OME is high in pre-
school children. This was the first study that estimated the prevalence of persistent O M E in 
12-month-old children Persistent O M E was prevalent in very young children: 4 8% (95% 
CI 4 3 - 5 2%) Moreover, there was distinct seasonal variation the rates during the late 
winter months were twice as high as those dunng the late summer months 
Upper respiratory tract infections, attending a day care centre, having older siblings 
and a history of otitis media dunng the first year of life appeared to be prognostic factors 
for persistent O M E However, the factors were only prognostic when a sample of the 
original screening population served as referents. Contrastingly, when the children selected 
on the basis of impaired hearing and/or existing bilateral OME served as referents, the 
factors were no longer prognostic. This implies that a clinician can only ask the parents 
about the presence of these factors as a tool to decide which policy to follow when the 
child is referred early. Unfortunately, it is still not possible to distinguish children with a 
high or low risk for persistent O M E at the time of diagnosis of O M E on the basis of these 
or other factors. 
Ventilation tubes had a beneficial effect on hearing in the short-term (6 months), 
but this effect disappeared almost completely in the long-term (12 months) This finding is 
in agreement with the results of previous studies. As the children in this study were much 
younger than those in previous trials, we can conclude that the effect of ventilation tubes 
on hearing does not depend on the age of the child. 
Ventilation tubes did not appear to have any incremental effect on language 
development, which contrasts with the study of Maw et al., the only experimental study 
published so far on the effect of ventilation tubes on language development In the latter 
study at 9 months follow-up, ventilation tubes had a marginal beneficial effect of 3.2 
months on language development. At 18 months follow-up, most of the children in the 
W W group had received ventilation tubes, so the groups no longer differed. The 
dissimilarity in results between the trials might be explained by substantial differences 
between the two study populations. The children in our study were much younger (19 
months versus 3 years) and were selected on the basis of failing a population based 
screening programme, whereas the children in the study by Maw et al. were selected on 
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the basis of referral to the clinic because of clinical complaints or disruptions in speech, 
language, learning or behaviour. There were also methodological differences, especially in 
the way the outcome variables were adjusted for confounding variables: adjustment for 
important co-variables in the current trial versus no adjustment in the study by Maw et al 
Previous studies suggested improvement in quality of life after the insertion of 
ventilation tubes. However, these studies did not have a control group, were hospital-based 
and focussed on older children. Our study was the first randomised controlled trial in the 
field of OME in which quality of life was taken as an outcome parameter. The quality of 
life of the children treated with ventilation tubes did not improve substantially more than 
that of the children in the W W group. 
There is some indication that specific subgroups will benefit from treatment with 
ventilation tubes, but the power of our study was too small to detect these groups. 
As the trial results cannot be rejected due to methodological shortcomings, it can be 
concluded that a watchful waiting approach is indicated for the total population of infants 
with O M E traced by a population based screening programme. Therefore, an active 
screening programme for conductive hearing loss before the age of one year is not 
justified. At present, there is no finn evidence about the effect of ventilation tubes in 
specific subgroups, but ventilation tubes may be of benefit in individual cases of O M E at 
this age. 
Recommendations for future research 
Although this thesis provides scientific evidence on several important topics related to early 
detection and treatment of O M E in infants, it also shows that much more research is 
needed. 
First, to study whether specific subgroups of children benefit from treatment with 
ventilation tubes, larger numbers or specific groups of children should be recruited. 
However, a more efficient approach to detect these subgroups would be to perform a 
meta-analysis on the total pool of onginal data from all O M E tnals performed so far. 
Second, the association between heanng level and (language) development should 
be further explored by including children with more severe heanng loss and by using tests 
to detect more specific developmental outcomes. 
Third, the effect of other treatments or combinations of treatment should be 
studied, including vaccination against micro-organisms, because they are assumed to play a 
major role in the etiology and natural history of otitis media. Recently, another alternative 
has become available: treatment with a laser beam. The question is, however, whether the 
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effect and/or duration of laser treatment on the effusion is greater than that of ventilation 
tubes. 
Fourth, the cost-effectiveness of screening programmes for conductive and 
sensorineural hearing loss should be studied in groups of children that would not otherwise 
be detected in time. 
Fifth, implementation of the evidence from this and other studies in (clinical) 
practice should be studied, including evaluation of the various methods of implementation. 
Sixth, more research should be performed into the etiology and prognostic factors 
of O M E in children. Recent insights into the importance of local immunological 
development in the mucosa of the upper respiratory tract and middle ear in relation to the 
function of the Eustachian tube, provide valuable input for this line of research 
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Summary 
Otitis media with effusion (OME) is one of the most common diseases in young children, 
it refers to an accumulation of fluid in the middle ear cavity behind an intact tympanic 
membrane without any signs or symptoms of an acute infection. The presence of fluid 
usually results in mild to moderate hearing loss, which is presumed to have an adverse 
effect on language development. 
The aim of ventilation tubes is to restore hearing to a normal level and to prevent 
any potential developmental problems However, the literature on the effect of (treatment 
for) early persistent O M E on language performance is still controversial, especially in 
infants. 
In the present study, we investigated the effect of early treatment with ventilation 
tubes on hearing, language development, and quality of life in infants with persistent 
bilateral O M E who had failed a population-based screening programme. 
A complete birth cohort of 30,099 children was scheduled to undergo screening for 
hearing impairment at the age of nine months. The 1,081 children who failed the 
screening test three times in succession were referred to an E N T outpatient clinic for 
diagnosis and follow-up. A total of 386 children were diagnosed with persistent (4-6 
months) bilateral O M E and were invited to participate in our randomised clinical tnal. 
Informed consent was obtained from the parents of 187 children. These children were 
allocated at random to one of two groups: treatment with ventilation tubes (VT group, 
N=93) or watchful waiting (WW group, Ν=94) . The two groups were followed-up for 
one year with three monthly tympanometry and otoscopy; audiometry, speech, language 
and quality of life were measured every 6 months 
In Chapter 2 we studied the epidemiology of O M E in infants. In 1-year-old infants, upper 
respiratory tract infections and having older siblings were related to the development of 
O M E . A second study on prognostic factors for persistent O M E showed that children with 
4 prognostic factors at the time of screening (i.e. upper respiratory tract infections, 
attending a day care centre, having older siblings and a family history of otitis media) were 
at greater risk for persistent O M E However, when these children were older and had had 
O M E for some months, these factors were no longer prognostic This finding indicates that 
knowledge about the presence of these prognostic factors in early referrals with hearing loss 
due to O M E might help doctors with decisions about management and clinical policy. An 
extensive literature study was perfonned to gain insight into the association between 
attending a day care centre and O M E . Attending a day care centre was indeed a nsk factor 
for OME; especially the number of children at the centre appeared to be important for this 
effect, probably due to increased exposure to otitis media pathogens. To evaluate the 
prevalence of persistent O M E and the seasonal variation in 1-year-old infants, we studied 
the yield of the hearing screening programme. The overall prevalence was 4.8%, while the 
rates of bilateral O M E during the late winter months were twice as high as those dunng 
the late summer months 
In Chapter 3 we addressed several methodological aspects of the study. First, we studied the 
effect of a balanced allocation procedure. Simulation showed that a balancing procedure 
almost always led to perfect or almost perfect balance, whereas simple randomisation lead 
to greater imbalance A second simulation showed that in small trials, valid and precise 
treatment effect estimates can best be made if balanced allocation and multivariate analysis 
are performed. When multivariate analysis is performed in larger trials balanced allocation 
does not have any additional advantage over simple randomisation. 
Second, we studied the similarities and differences between the non-automated 
labour-intensive Ewing hearing test and the less labour-intensive CAPAS hearing test The 
CAPAS test appeared to be more practical than the Ewing test, but the latter seemed to be 
more reliable and valid for detecting conductive hearing loss. 
Third, we compared a portable visual reinforcement audiometry set developed for 
our trial to a standard visual reinforcement audiometry set (used at Audiological Centres). 
Our portable audiometry equipment appeared to be a good and valid alternative for 
referring all children to an Audiological Centre. 
Fourth, we developed a framework forjudging and augmenting external validity 
and permitting inference from studies on O M E To make a judgement of the 
generahsabihty of the trial results, we recommend that future O M E trials should: 1) 
describe every step from source to trial population, 2) obtain at least some demographic 
data on all cases not included at an early stage, 3) measure for every step all plausible effect 
modifiers; 4) describe all inclusion and exclusion criteria precisely; and 5) desenbe all 
possible effect modifiers over the cases that are included and excluded. 
Chapter 4 presents the actual trial results. Ventilation tubes improved the hearing level in 
infants, especially after 6 months follow-up. In the long-term, however, the hearing levels 
became equal again due to recurrent O M E in the ventilation tube group and spontaneous 
recovery in the watchful waiting group Children with greater heanng deficits at 
randomisation appeared to improve more after the insertion of ventilation tubes than the 
children with lower thresholds 
N o differences were found in expressive or comprehensive language development 
between the two groups However, all the children in the ventilation tube group and the 
watchful waiting group showed delays m expressive language compared to their age 
expected levels Moreover, improvement in hearing (disregarding the intervention 
contrast) appeared to be related to improvement in language development, especially in 
verbal comprehension. 
The quality of life of children treated with ventilation tubes did not improve substantially 
more than the quality of life of children in the watchful waiting group It is possible that 
specific subgroups of children benefited more than others, but the power of this study was 
too small to detect these subgroup effects. 
A cost-effectiveness analysis was performed to determine the differences in effects 
and cost, using time without effusion and language development as effect measures. The 
mean cost was $454 per child in the ventilation tube group versus $120 in the watchful 
waiting group over one-year follow-up. As we did not find any effect on language 
development, the time without effusion was the only effect measure that could be used in 
the cost-effectiveness analysis. The incremental cost effectiveness ratio showed that an 
investment of $334 was needed to yield 4.5 months extra without effusion per child in the 
ventilation tube group versus the watchful waiting group 
To study the generahsabihty of the trial results we compared the eligible but non-
randomised patients to the randomised patients. A slight difference was found in the 
distribution of some prognostic factors: more randomised children had older siblings, did 
not attend day care and had mothers with a lower educational level than the non-
randomised children These factors, however, did not modify the outcome. No differences 
were found in mean outcome measures between the randomised and non-randomised 
children. In other words, the results of the randomised and non-randomised patients were 
comparable. The results of the tnal, therefore, appear to be generahsable to the total 
domain population (which are the instances of illness for which the study was designed and 
to which the results are applicable) 
In Chapter 5 we summarise the main trial results and make an evaluation of the 
consequences of these findings on policy. As the tnal results cannot be attributed to bias, 
generahsabihty problems or other methodological failures, a watchful waiting approach is 
justifiable in infants with persistent OME, especially when they have no signs or symptoms. 
Moreover, as it has now become possible to detect sensorineural hearing loss in the 
neonatal period, there is no reason for an active screening programme to trace these 
children. However, we do not know enough about the effect of ventilation tubes on 
subgroups. Therefore grommets cannot be abandoned in all infants. Until we know more 
about these subgroups, the choice of treatment for these children remains the responsibility 
of the clinician. 
Samenvatting 
Otitis Media met Effusie (OME) is een zeer frequent voorkomende aandoening bij 
kinderen De aandoening gaat gepaard met een ophoping van vocht achter het 
trommelvlies zonder dat het kind hierbij duidelijke klachten of symptomen heeft De 
aanwezigheid van het vocht zorgt veelal voor een gering tot matig gehoorverlies en dit 
gehoorverlies heeft wellicht een nadelig effect op de (taal)ontwikkeling van de kinderen 
Het doel van het inbrengen van trommelvhesbuisjes is het vocht te verwijderen en 
daarmee het gehoor te herstellen om zo eventuele ontwikkelingsproblemen te voorkomen 
Over de relatie tussen persisterende O M E en (taal) ontwikkeling bij jonge kinderen, 
alsmede over het effect van de behandeling met trommelvhesbuisjes op de (taal) 
ontwikkeling bestaat in de literatuur geen eenduidigheid 
Het doel van de huidige studie was dan ook om het effect van vroegtijdige 
behandeling met trommelvhesbuisjes op het gehoor, de taalontwikkeling en de kwaliteit 
van leven van jonge kinderen met persisterende bilaterale O M E (opgespoord via screen ing) 
te onderzoeken 
De onderzoeksgroep bestond uit alle 30 099 kinderen geboren tussen 1 januari 1996 
en 1 apnl 1997 in een afgebakende regio in Oost-Nederland Deze kinderen zijn op een 
leeftijd van 9 maanden opgeroepen voor een gehoorscreemng op het consultatiebureau 
De 1081 kinderen die dne keer onvoldoende scoorden op deze screening zijn 
doorverwezen naar één van de 22 deelnemende KNO-artsen (verdeeld over 13 
ziekenhuizen). Indien er vervolgens sprake was van persisterende O M E (4-6 maanden) 
kwamen de kinderen in aanmerking voor deelname aan de interventiestudie Van de 386 
kinderen die in aanmerking kwamen, gaven 187 ouders toestemming voor deelname 93 
kinderen kregen buisjes en bij 94 kinderen werd een afwachtend beleid gevoerd Beide 
groepen werden vervolgens een jaar lang gevolgd waarin om de drie maanden 
tympanometne en otoscopie verncht werd, terwijl om de zes maanden audiometrie, 
taaltesten en kwaliteit van leven vragenlijsten afgenomen werden 
O M E blijkt ook bij jonge kinderen reeds veelvuldig voor te komen (hoofdstuk 2) Op 1-
jange leeftijd blijken verkoudheden en het hebben van oudere broers en/of zussen 
gerelateerd te zijn niet het krijgen van O M E Kinderen met verkoudheden, kinderen in 
kinderdagverblijven, kinderen met oudere broers en/of zussen, en kinderen met 
familieleden met otitis media op moment van screening blijken een grotere kans te hebben 
om persisterende O M E te ontwikkelen De prognostische betekenis van deze factoren 
verdwijnt echter wanneer de kinderen in een verder gevorderd stadium van de ziekte 
verkeren. Bij vroeg gesignaleerde kinderen met gehoorverliezen ten gevolge van O M E kan 
kennis omtrent deze factoren bijdragen aan het verwijs- en controle beleid. 
Een uitvoerige literatuurstudie naar de kans op O M E bij kinderen in 
kinderdagverblijven laat zien dat kinderen in kinderdagverblijven inderdaad een groter 
risico hebben om O M E te krijgen; met name het aantal kinderen in een verblijf blijkt van 
belang. Het verhoogde nsico is waarschijnlijk toe te schnjven aan de blootstelling aan otitis 
media pathogenen. 
(ielet op de relatief grote neiging tot spontaan herstel dient de aandacht met name 
gencht te zijn op de gevallen van persisterende OME. Een reéle schatting van de 
prevalentie van persisterende O M E op een leeftijd van 12 maanden is 4,8%; in de late 
wintermaanden werden echter twee keer zo hoge waarden gevonden dan in de late 
zomermaanden. 
O m een interventiestudie naar het effect van trommelvliesbuisjes op het gehoor, de 
taalontwikkeling en de kwaliteit van leven op te zetten bij kinderen met persisterende 
OME, die met behulp van de gehoorscreemng opgespoord zijn, dienen een aantal 
methodologische aspecten van de studie uitgezocht te worden (hoofdstuk 3). Op de eerste 
plaats is het effect van een gebalanceerde allocatie procedure bestudeerd met behulp van 
simulatie studies. Een gebalanceerde randomisatie blijkt altijd tot een perfecte balans te 
leiden; bij simpele randomisatie (bijv. het opgooien van een muntje) is de disbalans veel 
groter. Voorts blijkt dat in kleine interventiestudies valide en precieze effect schattingen 
verkregen kunnen worden door zowel gebalanceerde randomisatie als multivariate analyses 
uit te voeren. In grotere tnals geven, uitgaande van multivariate analyses, een 
gebalanceerde randomisatie en een simpele randomisatie dezelfde effect schattingen. 
Een vergelijking van de met geautomatiseerde Ewing screening met de 
geautomatiseerde CAPAS screening, leert dat de CAPAS test praktischer en minder 
arbeidsintensief is, maar dat de validiteit van de Ewing test voor het opsporen van 
conductieve gehoorverliezen iets beter is. Uit een vergelijking van een speciaal voor deze 
studie ontworpen draagbare audiometrieset met de in de audiologische centra gebruikte 
standaard audiometrie set (VRA), blijkt dat voor interventiestudies waaraan meerdere 
klinieken deelnemen en er op locatie gemeten dient te worden, de draagbare set een goed 
en betrouwbaar alternatief is. 
Tenslotte zijn de voorwaarden voor de generahseerbaarheid van interventiestudies 
naar O M E bestudeerd. O M E interventiestudies dienen: 1) iedere stap van de totale 
onderzoekspopulatie tot aan de uiteindelijke studiepopulatie te beschnjven; 2) enige 
informatie te geven over kinderen die al vroegtijdig afvallen; 3) voor alle stappen de 
mogelijke 'effect modifiers' (interactie-effecten) te meten; 4) de in- en exclusie criteria 
precies te beschrijven; 5) een beschrijving te geven van alle mogelijke 'effect modifiers' 
over de geincludeerde en gcéxcludeerde kinderen. 
De eigenlijke resultaten van de intcrventiestudie staan beschreven in hoofdstuk 4. 
Buisjes verbeteren het gehoor van jonge kinderen met name 6 maanden na het plaatsen 
van de buisjes. Na 12 maanden blijkt het gehoor van de kinderen met en zonder buisjes 
echter niet meer te verschillen. Dit komt door zowel het terugkeren van het vocht achter 
het trommelvlies bij kinderen die behandeld zijn, als door spontaan herstel bij de 
onbehandelde kinderen. Het gehoor van de kinderen die een groter gehoorverhes hadden 
op moment van randomisatie verbeterde meer dan dat van de kinderen met een geringer 
gehoorverhes. 
Voor de taalontwikkeling vonden we geen verschillen tussen beide groepen, noch 
voor het taaibegrip noch voor de taaiproductie. Wel blijken de kinderen in beide groepen 
(buisjes en afwachtend beleid) gedurende het gehele onderzoek voor wat betreft de 
taaiproductie achter te lopen ten opzichte van hun leeftijdsgenootjes. Bovendien bleek dat 
een toename in gehoor in beide groepen (los van de randomisatie) wel tot een toename in 
taaibegrip leidde. 
De kwaliteit van leven verbeterde niet meer in de kinderen met buisjes dan in de 
kinderen met een afwachtend beleid. Het is mogelijk dat bepaalde subgroepen meer baat 
hebben bij buisjes, maar het aantal kinderen in deze studie is te klein om hier ferme 
uitspraken over te kunnen doen. 
Een kosten-effectiviteitsanalyse is uitgevoerd om het verschil in effecten en kosten 
te bepalen, waarbij de O M E vrije penode en de taalontwikkeling als effectmaten gebruikt 
zijn. De gemiddelde kosten gedurende de 12 maanden follow-up waren Fl. 899,= voor de 
kinderen met buisjes en Fl. 237,= voor de kinderen met een afwachtend beleid. Daar we 
geen effect op taalontwikkeling gevonden hadden, was een kosten-effectiviteitsanalyse 
alleen zinvol voor de O M E vrije periode. De incrementele kosten-effectiviteitsratio het 
zien dat Fl. 662,= geïnvesteerd moet worden om de O M E vrije penode in de kinderen 
met buisjes ten opzichte van de kinderen zonder buisjes met 4,5 maand toe te laten nemen. 
O m de generahseerbaarheid van deze studie te onderzoeken zijn de kinderen in de 
interventiestudie vergeleken met de kinderen die hier voor in aanmerking kwamen maar 
waarvan de ouders geen toestemming voor deelname gaven. De kinderen in deze laatste 
groepen kregen de behandeling die de ouders en/of de KNO-arts prefereerden. Omdat 
geen verschillen werden gevonden in de verdeling van de prognostische factoren en in het 
gehoor op de verschillende meetmomenten tussen de kinderen met buisjes in beide 
groepen, noch tussen de kinderen met een afwachtend beleid in beide groepen, kan 
geconcludeerd worden dat de resultaten van deze studie generaliseerbaar zijn naar de totale 
groep van jonge kinderen met O M E die door middel van screening opgespoord zijn. 
Omdat de resultaten van de trial niet verworpen kunnen worden op grond van 
methodologische tekortkomingen, lijkt de bevinding een reële afspiegeling van de 
werkelijke effecten (hoofdstuk 5). Voor kinderen met persisterende bilaterale O M E die 
door middel van screening opgespoord zijn (dus zonder duidelijke klachten), lijkt een 
afwachtend beleid dan ook geïndiceerd. Daarmee vervalt tevens de noodzaak om voor 
conductieve gehoorverliezen een actief screeningsbeleid in stand te houden. Toch is 
persisterende O M E geen onschuldige aandoening; het is goed mogelijk dat specifieke 
subgroepen (bijvoorbeeld kinderen met recidiverende bovenste luchtweginfecties en/of 
taalachterstand) wel baat hebben bij een behandeling met trommelvhesbuisjes. Het 
onderscheidingsvermogen in deze studie is te genng om deze subgroepen te kunnen 
traceren (te lage power). Individuele afweging door huisarts en specialist blijft in deze 
gevallen dan ook noodzakelijk. 
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behorende bij liet proefschrift 
Otitis Media with Effusion in infants: 
The effects of ventilation tubes 
Maroeska M Rovers 
Kinderdagverblijven zijn een uitkomst voor veel werkende ouders, voor kinderen 
zitten er ook nadelen aan, zoals een verhoogde kans op otitis media (Dil pioeluhnlt) 
De interne en externe validiteit van een gerandomiseerde interventiestudie kuiiiieii 
wel degelijk tegelijkertijd goed zijn (Dit proeßchnß) 
De door artsen veelvuldig gerapporteerde verbetering in gedrag (kwaliteit \an leven) 
van een kind na een behandeling met trommelvliesbuisjes lijkt een voorbeeld van 
recall bias. (Dit procfsclmft) 
Het actief opsporen en doorverwijzen van kinderen met OME op het 
consultatiebureau door middel van de Ewing-screening lijkt ondoelmatig nu voor 
de opsporing van aangeboren perceptieve verliezen een alternatief voor handen is 
(Dil proeßchrtlt) 
Om het effect van het gehoorverlies ten gevolge van OME op de taalontwikkeling 
goed te kunnen beschrijven, zal de dosis-respons relatie beter bestudeerd moeten 
worden. (Dit proeficlmfi) 
6 De meest effluente manier om subgroepen van kinderen met OME α identifiiuui 
die wel baat hebben bij een behandeling met buisjes, is een meta-analysc op de 
oorspronkelijke gegevens van tot nu toe uitgevoerde tnals (Dil pnulvlmft) 
7 In wetenschappelijke publicaties dient elke subjectieve classificatie van ;)-u aarden 
zoals die in wel of met statistisch significant bij een grens van 0,()ï vermeden ti 
worden om de lezer de vnjheid te geven zelf te bepalen of een kans gioot of klem 
is 
8 Dat een kop op de voorkant van de Telegraaf tot afzeggingen van geplande 
behandelingen met trommclvlicsbuisjes leidde, suggereert dat de media meer invloed 
op de medisch praktijk hebben dan wetenschappelijke publicaties 
9 Pas als er sprake is van effect-modificatie is selectie van belang voor wat betreft de 
generahseerbaarheid van een onderzoek 
10 Tussen de eisen van een volksgezondheidsbeleid en de eisen van goede wetenschap 
zit soms een inherente tegenstelling 
11 Het is vreemd dat bij de interpretatie van statistische uitkomsten in klinisch 
epidemiologisch onderzoek nog zo weinig gebruik gemaakt wordt van de 
Bayesiaanse benadering, terwijl iedere belanghebbende lezer een a ρποπ opime 
heeft over het effect van een interventie 
12 Het streven naar consensus is zinvol, maar iedere consensus is verdacht 
Maroeska M Rovers 
November 2000 


